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Mobile group II introns are retroelements that insert site-specifically into DNA 
target sites by a process called retrohoming. Retrohoming is mediated by a 
ribonucleoprotein particle (RNP) that contains both the intron RNA and the intron-
encoded protein (IEP). My dissertation focuses on two mobile group II introns: 
Lactococcus lactis Ll.LtrB and Escherichia coli EcI5, which belong to structural 
subclasses IIA and CL/IIB1, respectively. Previous studies showed that the Ll.LtrB IEP, 
denoted LtrA protein, is pole localized in E. coli. First, I found that active LtrA protein is 
associated with E. coli membrane fractions, suggesting that LtrA pole localization might 
reflect association with a membrane receptor. Second, I found that EcI5 is highly active 
in retrohoming in E. coli and obtained a comprehensive view of its DNA target site 
recognition by selection experiments. I found that EcI5 recognizes DNA target sequences 
by using both the IEP and base pairing of the intron RNA, with the IEP having different 
target specificity than for other mobile group II introns. A computer algorithm based on 
the empirically determined DNA recognition rules enabled retargeting of EcI5 to 
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integrate at ten different sites in the chromosomal lacZ gene at frequencies up to 98% 
without selection. Finally, I developed methods for gene targeting in the frog Xenopus 
laevis by using Ll.LtrB RNPs for site-specific DNA modification in isolated sperm 
nuclei, followed by in vitro fertilization to generate genetically modified animals. The 
site-specific integrations were efficient enough to detect in fifty sperm nuclei for a 
multiple copy target site, the Tx1 transposon, and several hundred sperm nuclei for 
protein-encoding genes. Based on these results, I obtained transgenic tadpoles with site-
specific Tx1 integrations by simple screening. To facilitate screening for embryos with 
targeted integrations in protein-encoding genes, I constructed an intron carrying a GFP-
RAM (Retrotransposition-Activated Marker). By using this GFP-RAM with introns 
containing randomized sequences that base pair with the target DNA, I obtained tadpoles 
with intron integrations at different genomic locations, including protein-encoding genes. 
The methods for using group II introns for targeted sperm DNA modification in X. laevis 
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Chapter 1: Introduction 
1.1 GROUP II INTRONS 
Group II introns are mobile elements found in prokaryotes and eukaryotic 
organelles (Pyle and Lambowitz 2006). They are thought to be ancestors of spliceosomal 
introns and non-LTR retrotransposons in higher organisms. Group II introns consist of an 
autocatalytic intron RNA and a multi-functional intron-encoded protein (IEP), which has 
reverse transcriptase (RT) activity. The IEP acts together with the intron RNA to promote 
RNA splicing and reverse splicing into double-stranded DNA (retrohoming) by 
stabilizing the catalytically active RNA structure (Lambowitz and Zimmerly 2004; Pyle 
and Lambowitz 2006). Thus far, more than 200 group II introns have been identified, 
with the number increasing as new genomes are sequenced (Dai et al. 2003; Simon et al. 
2008). 
1.1.1 Group II intron RNA structure 
The conserved group II intron RNA secondary structure contains six double-
helical domains (Domain I-VI) extending from a central wheel (Michel and Ferat 1995) 
(see Figure 1.1). Domain I (DI), an essential domain, is involved in catalysis and the 
recognition of exons through base-pairing interactions (Mills et al. 1996; Mohr et al. 
2000; Pyle and Lambowitz 2006). These interactions involve intron RNA sequences 
denoted exon-binding sites 1 and 2 (EBS1 and 2) within DI, which bases pair with 5’-
exon sequences denoted intron binding sites 1 and 2 (IBS1 and 2) (Michel and Ferat 
1995). In group IIA introns, a third sequence denoted δ in DI bases pairs with the 3’-exon 
sequence denoted δ’, while in group IIB and IIC introns, a different DI sequence denoted 
EBS3 base pairs with the 3’-exon sequence, now denoted IBS3 (Michel and Ferat 1995; 
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Costa et al. 2000; Lambowitz and Zimmerly 2004). These base-pairing interactions 
position the 5’- and 3’-exon sequences at the intron’s active site and are required both for 
intron forward splicing and reverse splicing. Domain II (DII) contributes to intron RNA 
folding by providing essential tertiary contacts with DI (Chanfreau and Jacquier 1996; 
Costa et al. 1997; Fedorova et al. 2003). Domain III (DIII) is referred to as a catalytic 
effector (Pyle and Lambowitz 2006). It is not strictly required for catalysis (Koch et al. 
1992), but its presence substantially enhances the reaction rates of group II intron-derived 
ribozyme constructs (Fedorova et al. 2003). Among group II introns, the open reading 
frame (ORF) of the IEP is invariably located in Domain IV (DIV), outside the intron’s 
catalytic core. The IEP assists intron splicing under physiological conditions and is 
required for both intron splicing and retrohoming (Lambowitz and Zimmerly 2004). The 
subdomain DIVa is the high-affinity binding site for the IEP (Wank et al. 1999). Domain 
V (DV), another essential domain for intron catalysis, is the most conserved substructure 
of the intron (Michel and Ferat 1995). Sequences in DV interact with other domains to 
facilitate trans-splicing and coordinate divalent metal ions for catalysis (Jarrell et al. 
1988; Toor et al. 2008). Domain VI (DVI) contains a bulged adenosine residue that 
serves as the branch point during intron forward splicing (Michel and Ferat 1995; 
Lambowitz and Zimmerly 2004; Pyle and Lambowitz 2006). 
1.1.2 Group II intron lineages 
Based on RNA structure and sequence characteristics, three major classes of 
group II intron RNAs, denoted IIA, IIB, and IIC, have been distinguished (Figure 1.1) 
(Michel et al. 1989; Dai and Zimmerly 2002a; Toro 2003; Toro et al. 2007; Simon et al. 
2008). The major differences between IIA and IIB introns are indicated in the boxed 
region of Figure 1.1. The differences include the ε’ region in the internal loop C in DI, 
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the location of EBS2, and the presence of EBS3. EBS2 is located within a stem-loop in 
group IIA introns, in a bend or bulge within group IIB introns (Toor et al. 2001), and is 
absent in group IIC introns. Additionally, the 5’-exons of many group IIC introns 
resemble transcription terminators, a feature not present in group IIA and IIB introns 
(Granlund et al. 2001; Dai and Zimmerly 2002a). This may reflect an additional 
interaction required for splicing or mobility that is specific to group IIC introns. The 
EBS3 sequence is present in both group IIB and IIC introns, but absent in IIA introns. In 
group IIB and IIC introns, this sequence consists of one nucleotide residue that resides 
within a bulge in DI and interacts with the IBS3 in the 3’-exon. In group IIA introns, the 
δ sequence is adjacent to IBS1 and it base pairs with the δ’ sequence in 3’-exon. 
Mobile group II intron RNAs have co-evolved with their respective IEPs. Based 
on phylogenetic analysis of intron IEPs, group II introns are classified by lineages 
denoted chloroplast-like (CL), mitochondrial-like (ML), and bacterial A-F (Toor et al. 
2001; Zimmerly et al. 2001). CL and ML group II introns are found both in prokaryotes 
and in eukaryotic mitochondria and chloroplasts, possibly reflecting their association 
with bacterial endosymbionts that gave rise to these organelles, while bacterial A-F 
introns are found only in eubacteria and archaea (Toor et al. 2001). 
1.1.3 Group II intron splicing reaction 
Group II introns are ribozymes that catalyze their own splicing. Similarities in the 
splicing reaction mechanisms, splice site consensus sequences, and the structure and 
function of RNA domains provide evidence for an evolutionary link between 
spliceosomal introns and group II introns (Matsuura et al. 2001). 
Most group II introns splice via RNA-catalyzed transesterification reactions 
involving formation of a lariat intermediate. Some group II introns can self-splice in vitro 
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under non-physiological conditions with high salt, high Mg2+ concentrations and high 
temperature (Schmelzer and Schweyen 1986; Tabak et al. 1987; Perlman and Podar 
1996). In the branching pathway, the splicing mechanism consists of two consecutive 
transesterification reactions (Figure 1.2). In the first reaction, the 2’-hydroxyl of a bulged 
adenosine in the DVI stem attacks the 5’-splice site, creating a free 5’-exon and a 
branched intermediate consisting of intron lariat with the 3’-exon. In the second reaction, 
the 5’-exon attacks the 3’-splice site, leading to the ligation of the exons and concomitant 
release of the lariat intron. The excised intron lariat has a 2’-5’ linkage and a short tail 
(Lambowitz and Zimmerly 2004).  
Some group II introns can also self-splice in vitro through another pathway called 
hydrolytic splicing. In this pathway, a water molecule acts as the nucleophile in the first 
step and attacks the phosphate at the 5’-splice site. The resulting intermediate is a linear 
intron with the 3’-exon. The second step of splicing is the same as in the branching 
pathway, but now generates a linear intron and ligated exons (Daniels et al. 1996). 
1.1.4 Group II intron-encoded proteins (IEPs) 
About one-third of the known group II introns encode a multi-functional IEP with 
homology to reverse transcriptase (Lambowitz and Zimmerly 2004). The IEP functions in 
RNA splicing by stabilizing the catalytically active RNA structure and then remains 
bound to the excised intron RNA in an RNP complex. The RNA and IEP function 
together to carry out reverse splicing into DNA target sites during intron mobility (Guo et 
al. 2000; Matsuura et al. 2001; Noah et al. 2006).  
The IEPs are structurally conserved in evolution (Michel and Ferat 1995). The 
most detailed biochemical analysis has been done on the IEPs of group IIA introns, 
specifically the yeast mitochondrial introns cox1-I1 and -I2 and the Lactococcus lactis 
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LtrB (Ll.LtrB) intron. The IEPs of these introns contain four domains denoted reverse 
transcriptase (RT), a domain required for RNA splicing (maturase) activity (X), DNA 
binding (D), and DNA endonuclease (En) (Kennell et al. 1993; Mohr et al. 1993; 
Matsuura et al. 1997; Saldanha et al. 1999; San Filippo and Lambowitz 2002). The N-
terminal RT domain contains the conserved sequence regions, RT-1 to -7, which are 
found in retroviral and other RTs. RT-0 is at the N-terminus of the RT domain and is 
characteristic of the RTs of non-LTR retrotransposons (Malik et al. 1999; Zimmerly et al. 
1999). Domain X is a site of mutations that affect maturase activity in which the IEP 
binds specifically to the intron RNA and stabilizes the catalytically active RNA structure. 
It functions together with the RT domain to bind the intron RNA during RNA splicing 
and reverse splicing (Cui et al. 2004; Lambowitz and Zimmerly 2004; Blocker et al. 
2005). The D domain is critical for DNA target site binding in reverse splicing. The 
deletion of this region strongly hinders intron RNA reverse splicing into double-stranded 
DNA (San Filippo and Lambowitz 2002). The En domain is related to bacterial colicin 
and pyocin nucleases (Gorbalenya 1994). It is capable of cleaving the bottom strand of 
the double stranded DNA target site to generate a primer for reverse transcription (Guo et 
al. 1997; Singh and Lambowitz 2001). 
Notably, many bacterial group II introns encode IEPs lacking the En domain. 
Those En-deficient introns are still able to retrohome by reverse splicing into double- or 
single-stranded DNA and utilizing nascent strands at DNA replication forks to prime 
reverse transcription (Martinez-Abarca and Toro 2000; Dai and Zimmerly 2002a; Zhong 
and Lambowitz 2003). 
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1.2 LACTOCOCCUS LACTIS LL.LTRB INTRON 
The L. lactis Ll.LtrB group IIA intron has been studied extensively as a model 
system for understanding group II intron mobility mechanisms (Figure 1.5). This intron 
was discovered in a relaxase gene (ltrB) in an L. lactis conjugative element pRS01, and 
its splicing is essential to generate functional relaxase for conjugation (Mills et al. 1996; 
Shearman et al. 1996). 
Ll.LtrB encodes a multiple functional IEP, denoted LtrA protein, which has been 
a model system for group II IEPs. It contains four conserved domains: RT, X, D, and En. 
LtrA binds specifically to the Ll.LtrB intron RNA and promotes RNA splicing by 
promoting the formation of critical RNA tertiary interactions (Matsuura et al. 2001). It 
also plays a crucial role in retrohoming through target DNA-primed reverse transcription 
(Singh and Lambowitz 2001). 
The retrohoming reaction of Ll.LtrB is carried out by a RNP complex that is 
formed during RNA splicing and is composed of LtrA and spliced intron lariat RNA 
(Singh and Lambowitz 2001; Lambowitz and Zimmerly 2004; Noah et al. 2006). To 
initiate the reverse splicing, Ll.LtrB RNPs bind DNA and recognize target sites (Figure 
1.3) (Aizawa et al. 2003). The initial recognition is thought to occur through major 
groove interactions of LtrA with a small number of specific bases in the distal 5’-exon 
region, including T-23, G-21, and A-20 (Figure 1.4). These base interactions, together 
with neighboring phosphate-backbone contacts and possibly minor groove interactions 
with positions -18 and -14, result in local DNA melting, which enables the intron RNA to 
base pair with a 13-15 nt region of the DNA target site encompassing the intron-insertion 
site. The intron RNA sequences involved in this base pairing are EBS1, 2, and δ, and the 
complementary DNA target-site sequences are IBS1 and 2 in the 5’-exon and δ’ in the 3’-
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exon. After binding and base paring, the intron RNA reverse splices itself into the intron-
insertion site at the junction of the 5’- and 3’-exon of the DNA target site. LtrA then 
cleaves the bottom strand between position +9 and +10 to generate the primer for reverse 
transcription. This second-strand cleavage requires additional interactions between LtrA 
and the 3’-exon, of which the most critical is recognition of +5T position in the 3’-exon 
(Mohr et al. 2000; Singh and Lambowitz 2001). After second-strand cleavage, LtrA uses 
the 3’ end at the cleavage site as a primer for reverse transcription and synthesizes a full-
length intron cDNA, which is fully integrated into the DNA target site by host DNA 
repair mechanisms (Mills et al. 1997; Cousineau et al. 1998; Smith et al. 2005). 
In the absence of second-strand cleavage, the Ll.LtrB intron can still retrohome at 
a low frequency by using nascent leading or lagging strands at DNA replication forks as 
primers for reverse transcription (Zhong and Lambowitz 2003). A similar mechanism is 
also used for retrohoming by group II introns that encode IEPs lacking the En domain 
(referred as En- introns) (Lambowitz and Zimmerly 2004). Most En- introns are found on 
the lagging template strand and appear to preferentially utilize nascent lagging strands as 
primers for cDNA synthesis (Martinez-Abarca et al. 2004). 
Recent studies on LtrA localization in E. coli and L. lactis revealed that LtrA 
localizes to the cellular poles with or without co-expression of the Ll.LtrB intron RNA 
(Zhao and Lambowitz 2005). This polar localization of LtrA in E. coli could account for 
the preferential insertion of Ll.LtrB introns with randomized EBS and δ sequences into 
the chromosomal ori and ter regions, which are also pole localized during much of the 
cell cycles (Niki and Hiraga 1998; Draper and Gober 2002; Zhong et al. 2003; Zhao and 
Lambowitz 2005). Recent studies using an LtrA-GFP fusion and cellular microarrays to 
screen an E. coli transposon insertion library for mutations that alter LtrA localization 
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patterns showed that polyphosphate accumulation can affect the polar localization of 
LtrA and other basic proteins in bacteria (Zhao et al. 2008). 
1.3 ESCHERICHIA COLI ECI5 INTRON  
The E. coli EcI5 intron is a group IIB intron. It was discovered in a virulence 
plasmid pO157 in the pathogenic E. coli strain O157:H7 (Burland et al. 1998). The intron 
is inserted within a non-coding region of the plasmid, but in the same orientation as most 
other plasmid genes. Southern hybridizations and PCR analysis showed that EcI5 is also 
inserted at the same site in DNA isolated from 19 of 72 ECOR strains, although always in 
fragmented form (Dai and Zimmerly 2002b).  
The EcI5 intron has a standard IIB intron structure (Figure 1.6A), as previously 
discussed (see section 1.1). It contains EBS 1, 2 and 3 in DI, which pair with IBS1 and 2 
in the 5’-exon and IBS3 in the 3’-exon. These base-pairing interactions are required for 
intron splicing and the target site recognition during intron retrohoming (Zhuang et al. 
2009). The EcI5 IEP has all four conserved domains, RT, X, D, and En, shared with other 
group II IEPs (Figure 1.6B). Notably, the EcI5 intron is the only E. coli intron whose IEP 
encodes an En domain, which can potentially cleave the opposite strand of the double-
stranded DNA target site to generate a primer for reverse transcription (Zimmerly et al. 
2001). 
1.4 GROUP II INTRON BASED “TARGETRON” TECHNOLOGY 
The retrohoming process of group II introns is mediated by the RNP complex 
containing the IEP and the spliced intron RNA. It is known that both IEP and RNA are 
involved in the DNA target site recognition (Guo et al. 1997; Matsuura et al. 2001; Singh 
and Lambowitz 2001; Noah et al. 2006). Because base pairing of the intron RNA to the 
DNA target site contributes most of the DNA target specificity, one can retarget group II 
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introns to the desired sites by modifying the exon-recognition sequences in the intron 
RNA (Lambowitz et al. 2005). Our laboratory used the Ll.LtrB intron to develop 
“targetron” technology, which has been widely used for targeted gene disruption and site-
specific DNA insertion in diverse Gram-negative and Gram-positive bacteria (Karberg et 
al. 2001; Frazier et al. 2003; Zhong et al. 2003; Perutka et al. 2004; Chen et al. 2005; Yao 
et al. 2006; Pearson and Mobley 2007; Shao et al. 2007; Yao and Lambowitz 2007; 
Malhotra and Srivastava 2008). 
For gene targeting in bacteria, the Ll.LtrB intron is introduced via a donor 
plasmid, which expresses an Ll.LtrB-ΔORF intron with short flanking exons. The 
Ll.LtrB-ΔORF intron has most of the LtrA ORF deleted from DIV, and the LtrA protein 
is expressed instead from a position just downstream of the 3’-exon (Guo et al. 2000; 
Karberg et al. 2001). Based on previous genetic selection experiments, a computer 
algorithm was developed to scan the DNA target sequence for the best matches to the 
positions recognized by the IEP. PCR primers are then designed to modify the intron’s 
EBS and δ regions to base pair optimally to the IBS and δ’ region in the target site 
(Perutka et al. 2004). The positions recognized by the IEP are sufficiently few and 
flexible that the algorithm readily identifies multiple rank-ordered target sites in any 
gene. Furthermore, the intron can be targeted to insert into different orientations by 
targeting the sense or anti-sense strand of DNA target sites, making it possible to obtain 
either unconditional or conditional disruptions (Frazier et al. 2003; Yao et al. 2006). 
Selectable markers can be incorporated into the intron DIV in the place of the IEP ORF 
to facilitate the identification of desired integration events, which can be detected with 
nearly 100% efficiently after selection (Zhong et al. 2003). Additionally, targetrons with 
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randomized exon-recognition sequences can be used to generate libraries of random 
disruptants, analogous to transposon mutagenesis (Zhong et al. 2003). 
In addition to bacteria, “targetron” technology can potentially be applied in 
eukaryotes. The Ll.LtrB intron was retargeted to the HIV-1 provirus and the human gene 
encoding the HIV-1 co-receptor CCR5 with high frequency and specificity in E. coli 
plasmid assays (Guo et al. 2000). These retargeted group II intron RNPs retained activity 
in human cell assays, in which plasmid-based target sites and group II intron RNPs were 
introduced separately by liposome-mediated transfection. In these experiments, however, 
the group II intron integration reaction in human cells was much less efficient than in 
bacteria, requiring nested PCR for detection (Guo et al. 2000). E. coli assays also show 
that group II introns can be used for genetic repair, either by inserting a functional copy 
of the gene into a defective gene, or by inserting functional exons preceded by a splice 
acceptor site to avoid the defective exons located downstream (Jones et al. 2005).  
A recent Xenopus laevis oocyte microinjection assay showed that group II intron 
RNPs can insert efficiently into a plasmid target site in oocyte nuclei, but only after 
injection of additional Mg2+ (Mastroianni et al., 2008). In such assays under optimal 
conditions group II intron RNP integration frequencies were as high as 38% and targeting 
frequencies by double-strand break stimulated homologous recombination were as high 
as 4.8%. Interestingly, group II intron RNPs reconstituted in vitro with linear as well as 
lariat intron RNA can be used to introduce the double-strand break (Mastorianni et al. 
2008). Similar RNP microinjection assays showed relatively efficient Mg2+-dependent 
group II intron insertion into plasmid target sites in D. melanogaster and zebrafish 
embryos, as well as integration into chromosomal target sites in D. melanogaster 
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embryos (Mastroianni et al. 2008). These results demonstrate the potential use of group II 
introns for gene targeting in higher organisms. 
1.5 OVERVIEW OF DISSERTATION RESEARCH 
This dissertation research is focused on two group II introns: the group IIA intron 
Ll.LtrB from Lactococcus lactis and the group IIB intron EcI5 from E. coli. The 
dissertation is divided into three related subjects. First, following up the previous finding 
of polar localization of LtrA in E. coli, which raised the possibility of a membrane-
attachment site, I analyzed the distribution of the LtrA protein in E. coli subcellular 
fractions by using bacterial cell fractionation methods. These experiments showed that 
the majority of LtrA protein is found in membrane fractions. Further assays using sucrose 
gradient equilibrium centrifugation showed that LtrA can be found in both inner and 
outer membrane fractions. I also showed that the LtrA protein in membrane fractions is 
active in promoting the splicing of its own RNA precursor. Second, I analyzed the DNA 
target site sequences required for retrohoming of the EcI5 intron, including the sequences 
recognized by the IEP and base pairing of the intron RNA. Based on these target site 
recognition rules, I demonstrated that the EcI5 intron could be used for gene targeting in 
bacteria and appears to be more efficient and have higher specificity than does the 
Ll.LtrB intron. Finally, I used the Ll.LtrB intron for site-specific modification of genomic 
DNA in decondensed X. laevis sperm nuclei and then used the modified sperm nuclei for 
in vitro fertilization to generate genetically modified animals. I first optimized the RNP 
reaction conditions for efficient targeting in X. laevis sperm nuclei and developed 
conditions under which the modified sperm nuclei were able to fertilize eggs to yield 
viable embryos and tadpoles. Further, by using the Ll.LtrB intron with randomized EBS 
and δ sequence and a GFP marker inserted in intron DIV, I showed the Ll.LtrB intron 
12 
 
could be used not only for site-specific gene targeting but also in forward genetic screens 
to study gene function in X. laevis. This work produced the first viable eukaryotic 
organisms generated by group II intron gene targeting. 
This dissertation is written in four chapters. In the next chapter (Chapter 2), the 
LtrA protein distribution profile in E. coli subcellular fractions will be described. I found 
that 83% of LtrA is associated with cellular membrane fractions. By separating the inner 
and outer membrane, I found that 30% co-purified with the outer membrane and only 6% 
co-purified with the inner membrane. Further, biochemical assays showed that LtrA 
protein in membrane fractions is capable of promoting the in vitro splicing of Ll.LtrB 
RNA precursor at relatively low salt conditions in vitro. In Chapter 3, I will describe my 
research on DNA target site recognition by the EcI5 intron. In these experiments, I found 
that the DNA target site for the EcI5 intron extends from position –26 to +10 from the 
intron insertion site, with a 12-nt region from –13 to 9 and -6 to +1 recognized by base 
pairing of the intron RNA. The IEP recognizes a small number of bases flanking those 
recognized by the intron RNA, but their identity is different from those in previously 
characterized group II introns. A computer algorithm based on the empirically 
determined DNA target site recognition rules enabled retargeting of EcI5 to integrate 
efficiently and specifically at different sites in the E. coli chromosomal lacZ gene. 
Chapter 4 describes the development of group II intron-based gene targeting methods for 
X. laevis. I show that the Ll.LtrB intron can integrate site-specifically into the desired 
target sites in the sperm genome (Tx1, mitf and tyr). The targeting reaction in sperm 
nuclei is dependent on the temperature, reaction time and the decondensation level of 
sperm chromatin by nucleoplasmin. The modified sperm nuclei were then used for in 
vitro fertilization to generate transgenic animals. To facilitate screening larger numbers of 
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embryos for targeting protein-encoding genes, a GFP-RAM (Retrotransposition-
Activated Marker), which is expressed only after DNA integration, was incorporated into 
intron DIV. The GFP-RAM intron construct allowed me to perform a screen of efficient 
targetrons in X. laevis using an intron library with randomized EBS and δ sequences. My 
results also suggest that this method using an intron library and GFP-RAM marker could 
be employed for forward genetic screens for analysis of gene function in X. laevis. The 
technology I developed for group II intron-based gene targeting by sperm DNA 
modification in X. laevis has the potential to be broadly applicable to other animal 





Figure 1.1: Group II intron RNA secondary structure. 
The conserved secondary structure of group II introns consists of six double-
helical domains (DI-DVI) emanating from a central wheel, with sub-domains indicated 
by lower-case letter (e.g., DIa, DIVa). The ORF is encoded within DIV (dotted loop), and 
DIVa is the high-affinity binding site for the intron-encoded protein (IEP). Greek letters 
indicate sequences involved in tertiary interactions. EBS and IBS refer to exon- and 
intron-binding sites, respectively. The sequences involved in tertiary interactions are 
boxed. Some key differences between subgroup IIA, IIB and IIC introns are indicated 




Figure 1.2: Pathways for group II intron splicing. 
Group II introns splice via RNA-catalyzed transesterification reactions involving 
formation of a lariat or linear intermediate. For the branching pathway, the 2’ hydroxyl 
group of the A residue at the branch point in DVI attacks the 5’-splice site to generate a 
lariat intron attached to the 3’-exon and a free 5’-exon. In the second step, the 3’ 
hydroxyl group of the free 5’-exon attacks the 3’-splice site to generate ligated exons and 
a lariat intron. In the hydrolytic pathway, a water molecule attacks the 5’-splice site and 
cleaves the 5’-exon from the intron forming a linear intron with 3’-exon. The second step 
is the same as the branching pathway and results in a linear intron and ligated exons. The 
linear and lariat introns are depicted as solid black lines. Exons are shown as boxes. The 























Figure 1.3: Ll.LtrB retrohoming mechanism. 
Retrohoming occurs via target DNA-primed reverse transcription (TPRT). The 
lariat intron RNA in RNPs reverse splices directly into one strand of the DNA target site, 
while the IEP cleaves the opposite strand between position +9 and +10 of the 3'-exon, 
and then uses the cleaved 3' end as a primer to reverse transcribe the inserted intron RNA. 
The resulting intron cDNA is integrated into the recipient DNA via cellular 
recombination or repair mechanisms. Intron RNA is shown as a black line. DNA target 
site are shown as gray and black boxes. IEP is the gray oval. 5’ E and 3’ E denote 5’-













Figure 1.4: DNA target site recognition rules by Ll.LtrB intron. 
The DNA target site of Ll.LtrB intron is recognized by both the intron RNA and 
IEP (LtrA). The LtrA first contacts a small number of bases in the 5’ exon region of the 
DNA target site (T-23, G-21 and A-20, highlighted in gray) via major groove 
interactions. These base interactions and neighboring phosphate-backbone interactions 
trigger local DNA melting, enabling the EBS1, 2 and δ sequences in the intron RNA to 
base pair with the IBS1, 2 and δ’ sequences in the DNA target site. The intron RNA 
directly inserts into one strand of DNA by reverse splicing (IS represents the intron 
insertion site). The LtrA then cleaves the second strand after recognizing T+5 in the 3’-
exon (highlighted in gray). The LtrA cleavage site, denoted CS, is between position +9 








Figure 1.5: Group II intron Ll.LtrB and its IEP (LtrA).  
(A) Predicted secondary structure of Ll.LtrB RNA adapted from Michael 
Karberg’s dissertation 2009. The structure consists of six double-helical domains (DI-
VI). The 5’- and 3’-splice sites are indicated by arrows. The putative Shine-Dalgarno 
(SD) sequence, initiation and termination codons of the intron ORF, and sequences 
involved in tertiary interactions (Greek letters) are boxed. (B) Schematic of LtrA showing 
conserved domains. RT, containing conserved amino acid sequence blocks 1-7 
characteristic of the finger and palm regions of retroviral RTs; X, region associated with 
maturase activity corresponding in part to the RT thumb; D, DNA binding; and En, DNA 
endonuclease. 0, region conserved in RTs of non-LTR retroelements. The numbers at the 




Figure 1.6: Group II intron EcI5 and its IEP.  
(A) Predicted secondary structure of EcI5 RNA adapted from Dai and Zimmerly 
(2002b). The structure consists of six double-helical domains (domain I-VI). The 5’- and 
3’-splice sites are indicated by arrows. The putative Shine-Dalgarno (SD) sequence, 
initiation and termination codons of the intron ORF, and sequences involved in tertiary 
interactions (Greek letters) are boxed. Numbers indicate nucleotide positions counting 
from the first nucleotide of the EcI5 intron. (B) Schematic of the EcI5 IEP showing 
conserved domains. RT, containing conserved amino acid sequence blocks 1-7 
characteristic of the finger and palm regions of retroviral RTs; X, region associated with 
maturase activity corresponding in part to the RT thumb; D, DNA binding; and En, DNA 
endonuclease. 0, region conserved in RTs of non-LTR retroelements. The numbers at the 
bottom indicate the amino acid position number. 
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Chapter 2: Cellular distribution of LtrA protein in E. coli 
The Lactococcus lactis Ll.LtrB intron has been used as a model system for 
studying mobile group II introns. Ll.LtrB is highly mobile not only in L. lactis, but also in 
a variety of other Gram-negative and Gram-positive bacteria, including E. coli, where its 
mobility mechanism has been analyzed by using the extensive genetic and biochemical 
methods available for that organism (Cousineau et al. 1998; Mohr et al. 2000; Karberg et 
al. 2001; Yao and Lambowitz 2007; Malhotra and Srivastava 2008; Rodriguez et al. 
2008). The broad host range of the Ll.LtrB intron reflects that the ribonucleoproteins 
(RNPs) containing the intron-encoded protein (IEP) and intron RNA can carry out the 
RNA splicing, reverse splicing, and target DNA-primed reverse transcription reactions 
without relying on host proteins, while subsequent cDNA integration steps are carried out 
by common host DNA repair enzymes (Smith et al. 2005; Coros et al. 2008; Zhao et al. 
2008). 
Recent studies raised the possibility that Ll.LtrB might be associated with the cell 
membrane at the cell poles. First, experiments using an Ll.LtrB intron library with 
randomized EBS2, EBS1 and δ sequences showed that although the intron inserted at 
sites throughout the E. coli genome, insertion sites were strongly clustered around the 
bidirectional replication origin (oriC). In a sampling of ~100 insertion events, 57% of the 
insertion sites were within 5% of the chromosome on either side of oriC (Zhong et al. 
2003). A separate study of Ll.LtrB retrotransposition in a different strain of E. coli 
showed insertion sites clustered in both the oriC and ter regions (Ichiyanagi et al. 2002). 
In E. coli, the oriC and ter regions are localized near the cellular poles during much of 
the cell cycle (Niki and Hiraga 1998; Zhong et al. 2003). Thus, it is possible that the 
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clustering of Ll.LtrB insertions sites in the oriC and ter regions reflects the localization of 
Ll.LtrB RNPs near the cellular poles. 
Zhao and Lambowitz (2005) using LtrA-GFP fusions and immuno-fluorescence 
microscopy showed that LtrA does in fact localize to cellular poles in both E. coli and L. 
lactis and appears to be apposed to the cellular membrane in these regions. The polar 
localization of LtrA occurred with or without the expression of Ll.LtrB intron RNA, was 
observed over a wide range of cellular growth rates and expression levels, and was 
independent of replication origin function (Zhao and Lambowitz 2005). Additionally, the 
LtrA expression in E. coli interfered with the polar localization of co-expressed Shigella 
flexneri IcsA protein, suggesting competition for a common localization determinant 
(Lambowitz et al. 2005; Zhao and Lambowitz 2005).  
Finally, Zhao et al. (2008) using cell microarrays to screen a transposon-inserted 
library isolated E. coli mutants in which LtrA shows a more diffuse localization patterns 
away from the poles, and Ll.LtrB shows a more uniform genomic distribution of insertion 
sites in such mutants. These findings indicate that polar localization of LtrA accounts for 
the preferential insertion of the Ll.LtrB intron in the origin and terminus regions of the E. 
coli chromosome. Interestingly, all of the E. coli mutants in which LtrA shows more 
diffuse localization were found to accumulate intracellular polyphosphate, which appears 
to bind LtrA and delocalize it from the poles (Zhao et al. 2008).  
Together, the above findings raise the possibility that LtrA might be localized by 
binding to a receptor molecule in the membrane at the cell poles. At present, little is 
known about receptors that might mediate polar localization of proteins in E. coli. 
Based on these LtrA localization data, I began a screening for host factors 
interacting with LtrA in E. coli. To identify the host factors associating with LtrA, cells 
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were treated with cross-linking reagent formaldehyde and disrupted by sonication. The 
disrupted cells were subjected to centrifugation at 10,000×g for 15 min. The supernatant 
contains soluble proteins from cell lysate, and the pellet contains membranes, insoluble 
proteins and unbroken cells. In the non-crosslinked cells, the majority of LtrA can be 
found in the supernatant. However, after cross-linking, LtrA was no longer found in the 
supernatant. It could only be detected in the pellet. This finding suggested that LtrA 
might be cross-linked to large aggregates or associated with membranes or other large 
structures. 
To further understand this phenomena and the mechanism of LtrA polar 
localization, I investigated the subcellular localization of LtrA protein in E. coli. By 
taking advantage of the well-established cell fractionation procedures in E. coli, I 
characterized the distribution of LtrA protein in different cellular fractions (cytoplasm, 
inner membrane, outer membrane and periplasm). A high proportion of LtrA protein 
(36%) was found in the cellular membrane fraction, and the majority of LtrA protein co-
purified with the outer membrane after ultracentrifugation in a sucrose gradient. In vitro 
RNA splicing assays demonstrated that the LtrA protein within the membrane fractions 
was active in promoting the splicing of Ll.LtrB intron precursor RNA. 
2.1 CONSTRUCTION OF PLAC-LTRA 
To study the intracellular localization of LtrA in E. coli, I cloned the LtrA ORF 
downstream of a lac promoter in the place of GFP in the vector pGFPuv (Clontech). The 
resulting plasmid was named plac-LtrA. Previously, it was shown that the polar 
localization of LtrA was unaffected by co-expression of the intron RNA (Zhao and 
Lambowitz 2005). Thus I analyzed the subcellular distribution of LtrA expressed in E. 
coli from plac-LtrA without co-expressing Ll.LtrB RNA. Because over-expression of 
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foreign proteins can result in the formation of inclusion bodies (Strandberg and Enfors 
1991), I maintained a low level of expression of LtrA by basal transcription from the lac 
promoter. To do this, the E. coli HMS174(DE3) containing plac-LtrA was grown in LB 
with ampicillin at 37oC without isopropyl β–D-1-thiogalactopyranoside (IPTG) 
induction. 
2.2 LTRA IS PRESENT IN SPHEROPLASTS 
E. coli periplasm and spheroplast were separated by a lysozyme-EDTA-cold 
osmotic shock procedure (Osborn et al. 1972a; Osborn and Munson 1974). Freshly grown 
bacterial cells were treated with sucrose, lysozyme and EDTA on ice to disrupt the cell 
wall and peptidoglycan. After centrifugation, the supernatants contained the periplasmic 
fraction, and the spheroplasts formed a pellet. Using this method, conversion to 
spheroplasts was generally greater than 98%, as judged by phase contrast microscopy 
(Osborn et al. 1972b). 
To check the distribution of LtrA, proteins from the periplasmic fraction, 
spheroplasts and whole cells were separated in a 0.1% sodium dodecyl sulfate (SDS)/ 
7.5% polyacrylamide gel and analyzed by Western blotting using antibodies against LtrA 
and cellular marker proteins. The amount of each fraction loaded in gel was normalized 
to the same percentage of volume from each fraction, as described in the Methods section 
2.4.2. As shown in Figure 2.1A, almost all of the LtrA from the whole cell was found in 
the spheroplast fraction and virtually none was found in the periplasmic fraction.  
To assess the purity and enrichment of each cellular fraction in this and other 
experiments, I checked for the presence of different marker proteins by Western blotting. 
TatA, β-galactosidase, and DsbA proteins were used as markers for cellular membranes, 
cytoplasm and periplasm, respectively. TatA is one of three integral membrane proteins 
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in the twin-arginine transport (Tat) system, which translocates folded proteins across the 
bacterial cytoplasmic membrane (Lee et al. 2006). Studies in E. coli using a TatA-GFP 
fusion protein showed that TatA is present inner membrane, often with higher abundance 
at the poles (Berthelmann and Bruser 2004). E. coli β-galactosidase (lacZ) is a 
cytoplasmic enzyme and is widely used as a cytoplasmic marker (Gerard et al. 2002). The 
DsbA protein is a periplasmic enzyme which catalyzes disulfide bond formation (Belin 
and Boquet 1994). In Figure 2.1, all of the marker proteins showed the expected 
distribution between periplasm and spheroplasts, except for a light band corresponding to 
the membrane marker TatA in the periplasmic fraction. This light band could be due to a 
small amount of cross-contamination or leakage from the spheroplast gel lane during 
loading. 
2.3 LTRA IS PRESENT IN THE MEMBRANE FRACTION 
A spheroplast is a cell from which the cell wall has been almost completely 
removed. It still contains membrane and cytoplasm. To further examine the LtrA 
localization within the spheroplast, the cytoplasm and membrane were further separated 
from the spheroplast. Spheroplasts were lysed by using a cold French press to disrupt the 
cellular membrane. This method has the advantage of being more reproducible than other 
cell lysis methods (Nikaido 1994). The disrupted cells were centrifuged twice at 1200×g 
for 10 min to pellet any remaining intact cells. Then, the cell lysate was ultracentrifuged 
at 144,748×g for 2 h at 4oC to yield a cytoplasmic fraction and a membrane pellet. For the 
cytoplasmic fraction only the top layer of supernatant was collected for analysis in order 
to avoid contamination by the membrane fraction. After removing of the rest of the 
supernatant, the pellet was rinsed twice with 50 mM Tris-HCl pH 8.0 to remove any 
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residual cytoplasm, and the membrane pellet was resuspended in 50 mM Tris-HCl pH 
8.0. 
To check the LtrA distribution, normalized amounts of spheroplast, cytoplasmic, 
and membrane fractions were analyzed by 0.1% SDS/ 7.5% polyacrylamide gel 
electrophoresis and Western blotting (see Methods for normalization). As shown in 
Figure 2.1B, more than 80% of LtrA was present in the membrane fraction with only a 
small amount of LtrA detected in the cytoplasm. Western blotting to detect the TatA and 
β-galactosidase marker proteins confirmed them to be present mainly in the membrane 
and cytoplasmic fractions, respectively, although a small amount of TatA was detected in 
the cytoplasmic fraction. 
2.4 DISTRIBUTION OF LTRA PROTEIN IN THE INNER AND OUTER MEMBRANES 
The association of LtrA protein with membrane or a membrane receptor might 
explain its bipolar localization in E. coli. For gram-negative bacteria, the cell membranes 
consist of three morphologically distinguishable layers: an inner membrane surrounding 
the cytoplasm; a murein (peptidoglycan) layer external to the cytoplasmic membrane; and 
an outer membrane at the external surface of the cell (Murray et al. 1965). As a lipid 
bilayer membrane, the outer membrane behaves similarly to the inner membrane during 
cell fractionation. However, separation of the two membranes is possible because of 
differences in composition. One method is based upon their different buoyant densities. 
Another method is based on their different lipid compositions. Most of the lipids in the 
outer membrane are lipopolysaccharides (LPS), which have very different properties 
from those of the glycerophospholipids comprising the bilayer of the inner membrane. 
One can selectively solublize the inner membrane without dissolving much of the outer 
membrane. Finally the presence of LPS makes the outer membrane an intrinsically 
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unstable structure. By destabilizing the membrane, the outer membrane are shed off as 
blebs or vesicles, which can be collected (Nikaido 1994). 
Here I separated the inner and outer membrane on the basis of their different 
buoyant densities by equilibrium density gradient centrifugation. After breaking the cells, 
the membranes were separated by centrifugation through a sucrose density gradient 
(Osborn and Munson 1974; Nikaido 1994). Four discrete membrane bands appeared from 
the top to bottom of the gradient (Figure 2.2 and Methods). Bands L1 and L2 have been 
characterized as inner membrane, H as outer membrane, and the minor band, M, at an 
intermediate density as envelope fragments. The presence of band M is influenced by 
several factors such as growth medium and ionic strength (Osborn et al. 1972a). The 
separation of inner membrane fragments into two bands appears to reflect heterogeneity 
in the degree of contamination by outer membranes. To evaluate the efficiency of 
separation, I assessed the separation of inner and outer membrane by checking for the 
presence of the inner membrane marker protein, TatA, using Western blotting (Figure 
2.2), and other proteins detected by Coomassie staining of SDS-polyacrylamide gels 
(Figure 2.3). 
Figure 2.2 shows that the TatA protein was present mainly in fraction 29 to 39 
corresponding to the two inner membrane bands L1 and L2. A Coomassie stained 2% 
SDS/ 7.5% polyacrylamide gel (Figure 2.3) shows that two major bands of molecular 
weight ~32 kDa and a series of more rapidly migrating bands are specific to the outer 
membrane. As expected, the fractions with outer membrane proteins in Figure 2.3 
overlapped the H band in Figure 2.2 (fractions 45 to 62). The SDS-PAGE profiles of L1 
and L2 were indistinguishable from each other and contained a number of high molecular 
weight proteins (>50 kDa) in a Coomassie stained SDS-polyacrylamide gel (Figure 2.3).  
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After confirming the separation of inner and outer membranes, I checked the 
distribution of LtrA protein by Western blotting using antibody against LtrA. 
Surprisingly the LtrA was mainly found in outer membrane fractions (band M and H; 
fractions 40 to 58 in Figure 2.2), but with some trailing into the inner membrane fraction 
L2 (fractions 29 to 39 in Figure 2.2). 
Figure 2.4 summarizes the distribution of LtrA protein in the membrane fractions, 
the total protein concentration of each fraction, and the distribution of TatA and outer 
membrane proteins in the membrane fractions. The relative amount of LtrA and TatA 
proteins in each fraction was calculated from the band intensity of LtrA and TatA in the 
Western blots of Figure 2.2, as described in Methods. The relative amount of outer 
membrane proteins in each fraction was calculated from the band intensity of the two 
major outer membrane protein bands in Figure 2.3. The total protein concentration in 
each fraction of Figure 2.4 reflects the actual protein concentration. The amount of LtrA, 
TatA and outer membrane proteins in Figure 2.4 was normalized to a scale 0 to 4 to fit in 
the same plot. As shown in Figure 2.4, the peak of LtrA protein (blue line) overlaps that 
of outer membrane proteins (green line) and the H band ( red line). 
2.5 RELATIVE DISTRIBUTION PROFILE OF LTRA AMONG CELLULAR FRACTIONS 
The cell fractionation experiments above show LtrA to be present in different 
cellular fractions, including cytoplasm, inner and outer membranes. I quantified the 
amount of LtrA in the different cellular fractions (Figure 2.1C). The amount of each 
fraction loaded on the gel was normalized, as described in Methods, and the purity of 
each fraction was confirmed by the presence of different marker proteins (data not 
shown). Based on the analysis of band intensity by Bio-Rad Quantitative One software 
(Bio-Rad), 83% of LtrA protein was present in the total membrane fraction compared to 
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17% in the cytoplasm. 30% of LtrA protein was found in the outer membrane fractions 
and only 6% of LtrA protein was found in the inner membrane. A substantial amount of 
LtrA protein (47%) was found in the pellet after sucrose gradient centrifugation, possibly 
reflecting the lower solubility of LtrA in cell lysis buffer or aggregation after dissociation 
from cellular membranes. 
Because LtrA has a calculated pI of 9.60, it is positively charged at physiological 
pH and has a high non-specific binding affinity for nucleic acid (Singh and Lambowitz 
2001; Aizawa et al. 2003). Therefore, I next addressed the question of whether the 
distribution profile of the LtrA protein in different fractions is altered by treatment with 
nucleases. In Figure 2.5A, I repeated the cell fractionation using the same procedures as 
in Figure 2.1C, except for the addition of protease inhibitor, RNase-free DNase I, RNase 
A or different combinations prior to lysis of the spheroplasts (see Methods). As shown in 
Figure 2.5A, with addition of protease inhibitors only, LtrA was detected in both the 
cytoplasmic and membrane fractions. With the addition of DNase I, however, the amount 
of LtrA in the cytoplasmic fraction decreased and with addition of RNase A or RNase A 
and DNase I together, the amount of LtrA in the cytoplasmic fraction decreased to 
undetectable levels. Notably, in the presence of nucleases the amount of LtrA in the pellet 
increased. Meanwhile, the amount of LtrA in the other fractions was not significantly 
affected by the above treatments. These results suggest that soluble LtrA might be 
stabilized in the cytoplasm by binding to nucleic acids, especially RNA, and becomes 
insoluble after the nucleic acids are digested. 
Figure 2.5B shows a control experiment in which purified LtrA protein was added 
directly to HMS174(DE3) spheroplasts. After lysis, no LtrA was detected in the 
cytoplasmic fraction, or in the inner or outer membrane fractions. Instead, almost all of 
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the added LtrA became insoluble and was found in the pellet after centrifugation. This 
experiment provides evidence that the endogenous LtrA found in cytoplasmic and 
membrane fractions is physiologically relevant and does not result from non-specific 
interactions of soluble protein with membrane fractions after cell breakage. 
Together, the above experiments show that endogenous LtrA is present in both 
the cytoplasmic and membrane fractions, that endogenous LtrA found in the cytoplasmic 
fraction may contain bound RNA and DNA that keeps the protein soluble after cell 
breakage, and that the association of endogenous LtrA with cellular membranes was 
unaffected by nuclease treatment. 
2.6 LTRA IN THE MEMBRANE CAN PROMOTE LL.LTRB INTRON SPLICING IN VITRO 
I next determined whether the LtrA present in the membrane fraction is functional 
by assaying whether it could stimulate Ll.LtrB precursor RNA splicing in vitro. A 
splicing assay was done by using an in vitro transcript precursor RNA containing the 
Ll.LtrB-ΔORF intron and short flanking exons, as described previously (Saldanha et al. 
1999). LtrA from membrane fractions was prepared by sucrose gradient centrifugation, 
with Western blotting for LtrA and marker proteins used to assess the enrichment and 
purity of the fractions. In the splicing experiment, only fractions representing the peaks of 
inner and outer membranes were used (fractions 31 to 34 and 54 to 55, respectively). The 
amount of LtrA in these fractions was quantified by Western blotting using purified LtrA 
protein as a standard. In the splicing assay, 100 nM of Ll.LtrB precursor RNA and 20 nM 
of LtrA protein were used in each reaction. The RNA was renatured by heating to 55oC 
and slowly cooling to 37oC, and the splicing reaction was done at 30oC for 30 min.  
In the experiment of Figure 2.6, the splicing activity of purified LtrA protein and 
LtrA from inner and outer membrane fractions were checked at different NaCl 
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concentration (0, 50, 100 and 500 mM). The purified LtrA protein stimulated the splicing 
of Ll.LtrB precursor RNA at NaCl concentration from 0 to 500 mM, with the highest 
activity at 500 mM NaCl, as found previously (Saldanha et al. 1999). The LtrA protein in 
the inner membrane fraction also stimulated RNA splicing at all salt concentrations with 
the highest activity at 500 mM NaCl. However the splicing activity of LtrA in the inner 
membrane fraction was lower than that of purified LtrA at 500 mM NaCl. The splicing 
activity of LtrA in the outer membrane fraction was lower than that of either purified 
LtrA or LtrA in the inner membrane fractions and was detected only at 500 mM NaCl. In 
control experiments, the boiled inner and outer membrane fractions did not stimulate 
Ll.LtrB RNA splicing, suggesting that the observed splicing activity is due to LtrA 
protein and not to heat-resistant factors, such salts or lipids in the membrane fractions. 
The above data demonstrated that LtrA bound to membrane can promote the 
Ll.LtrB precursor RNA splicing. I next investigated whether there were other splicing 
factors in the membrane that increase the splicing activity of LtrA in the absence of salt 
or at a salt concentration closer to physiological conditions (100 mM NaCl). For this 
purpose, I carried out the same splicing assay with purified LtrA protein in the 
combination with the inner and outer membrane fractions from wild-type HMS174(DE3) 
cells not expressing LtrA protein. 
As shown in Figure 2.7, at 0 mM NaCl, the splicing activity of purified LtrA 
protein was barely detectable (lane 2). The inner membrane fraction by itself did not 
promote the splicing of the Ll.LtrB precursor RNA (lane 3). However, combining 20 nM 
of purified LtrA with the inner membrane fraction resulted in a higher level of splicing 
than with purified LtrA protein alone (lane 4, compare with lane 2). The inner membrane 
fraction contains nucleases that degrade precursor RNA, so it is possible that the activity 
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of LtrA plus inner membrane fraction is higher than appears from the gel. Notably, the 
addition of purified LtrA protein to boiled inner membrane showed somewhat higher 
RNA splicing activity than that of purified LtrA or LtrA with inner membrane (lane 6, 
compared to lanes 2 and 4). This finding suggests that heat-resistant factors present in the 
inner membrane fraction may stimulate LtrA splicing activity under low salt conditions. 
Similar results were obtained for the outer membrane fraction. The outer membrane 
fraction did not by itself stimulate Ll.LtrB RNA splicing (lane 7). However, LtrA 
together with outer membrane fraction or boiled outer membrane fraction stimulated 
splicing of the Ll.LtrB RNA to somewhat higher levels than were seen with purified LtrA 
protein alone (lane 8 and 10, compare to lane 2). 
In splicing assays with 100 mM NaCl, the splicing activity of purified LtrA was 
higher than that without NaCl (lane 2 and 11). Surprisingly, under these conditions, there 
was detectable splicing activity with the inner and outer membrane without LtrA protein 
(lane 12 and 16). This activity was abolished after boiling the inner and outer membrane 
fractions (lane 14 and 18). These findings suggest that heat sensitive factors in the inner 
and outer membranes can by themselves support Ll.LtrB RNA precursor splicing at 100 
mM NaCl, even without LtrA protein. Again, the splicing activity of Ll.LtrB with those 
unknown membrane factors might be higher than what was observed because a 
significant amount of RNA precursor was degraded in the reactions containing membrane 
fractions. RNA degradation may also contribute to the lower splicing activity of purified 
LtrA at 100 mM NaCl in the presence of inner membrane (lane 13) or outer membrane 
(lane 17) compared to that of LtrA only (lane 11).  
In summary, the splicing experiments using purified LtrA in combination with 
inner or outer membrane fractions gave two potentially interesting findings. First, the 
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experiments raise the possibility that the membrane fractions contain unknown heat-
sensitive splicing factors that can support Ll.LtrB intron splicing without LtrA at a 
condition close to physiological salt concentrations (100 mM NaCl). Second, in the 
absence of NaCl, boiled inner or outer membrane fractions may increase the splicing 
activity of purified LtrA. These findings raise the possibility that association of LtrA with 
E. coli membranes enhances its biological activity. Further experiments in which 
nuclease activities are inhibited will be required to confirm the increase in splicing 
activity for membrane fractions. 
2.7 DISCUSSION 
The results presented in this chapter showed that after cell breakage and 
fractionation, LtrA protein is present in E. coli cytoplasmic, inner and outer membrane 
fractions. Surprisingly, a high proportion of LtrA is found in the outer membrane 
fractions after sucrose density gradient centrifugation. These experiments, however, do 
not distinguish whether LtrA is bound to the outer membrane or is merely co-purifying 
with it. One possibility is that LtrA is bound to a specific dense fraction of inner 
membranes that co-purifies with the outer membrane. The LtrA protein recovered in the 
cytoplasmic fraction appears to be associated with nucleic acids, mainly RNA, whose 
removal causes the protein to become insoluble. Although splicing assays showed that 
the LtrA protein associated with inner and outer membrane was active in stimulating the 
splicing of Ll.LtrB precursor RNA, the biological function of LtrA in different cellular 
fractions remains to be analyzed in detail. Nevertheless, the binding of LtrA to a pole 
localized membrane receptor could account for the polar localization of LtrA in E. coli. 
An unexpected finding was that E. coli membrane fractions may contain heat- 
sensitive factors that can by themselves support Ll.LtrB precursor RNA splicing in the 
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absence of LtrA at lower salt concentrations (0 and 100 mM NaCl). The heat sensitivity 
of these factors is consistent with the possibility that they are proteins. Additionally, 
purified LtrA protein appears to splice more efficiently at low salt concentrations in the 
presence of inner membrane or boiled inner membrane, suggesting that membrane 
components, such as lipids, may enhance its activity. The stimulatory effects of 
membrane fractions in these experiments may be underestimated due to the presence of 
RNases that degrade precursor RNA, and future experiments with better control of RNA 
degradation (e.g., by addition of more RNase inhibitor) would increase the accuracy of 
the assays. It will also be of interest to assay the effect of membranes on other LtrA 
activities, such as reverse transcriptase, DNA endonuclease, and reverse splicing. 
2.8 METHODS 
2.8.1 E. coli strain and recombinant plasmids 
The E. coli strain HMS174(DE3) strain was used to express LtrA protein. plac-
LtrA is derived from pGFPuv (Clontech). To construct plac-LtrA, pGFPuv was first 
digested with HindIII and SpeI to remove the GFP gene. LtrA was amplified from pIMP-
lp (Saldanha et al. 1999) using primers LtrA184s (5’-
GCGGCGaagcttGATGAAACCAACAATGG-CAATTTTAG-3’) and LtrA185a (5’-
GCGGCGactagtTCACTTGTGTTTATGAAT-CACGTG-3’). LtrA184s appends a 
HindIII site, and LtrA185a appends a SpeI (restriction enzyme sites are in lower case 
letters in the primer sequences). The PCR product was digested with HindIII and SpeI 
and swapped for the GFP gene in the pGFPuv vector. plac-LtrA contains a β-lactamase 
gene, which confers ampicillin resistance. HMS174(DE3) transformed with plac-LtrA 
was grown in LB medium with 100 µg/ml ampicillin. 
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2.8.2 Bacterial cell fractionations 
E. coli HMS174(DE3) cells were electro-transformed with plasmid plac-LtrA and 
grown in the presence of ampicillin overnight at 37oC. The overnight culture was then 
subcultured 1:100 into fresh LB media with ampicillin and grown to an optical density at 
600 nm (O.D.600) of 0.5. Cellular fractions were prepared by a lysozyme-EDTA-cold 
osmotic shock procedure (Osborn et al. 1972a). 
Preparation of periplasmic fraction 
4 ml of cells (O.D. 600= 0.5) was harvested at 4oC by centrifugation at 6000×g for 
7 min. The cell pellet was then resuspended in 2 ml freshly made fractionation buffer 
(18% sucrose, 50 mM Tris-HCl pH 8.0, 1 mM CaCl2), and the cells were centrifuged 
again at 6000×g for 7 min at 4oC. 1 ml fractionation buffer was added to resuspend the 
cell pellet, and a 250 µl of aliquot was saved as a whole-cell fraction. 0.5 ml of the 
whole-cell fraction was added to a tube containing 1 µl 0.5 M EDTA and 5 µl of 100 
µg/ml lysozyme and incubated on ice for 30 min to form spheroplasts. Following 
centrifugation at 6000×g for 5 min at 4oC, 250 µl of supernatant was saved as the 
periplasmic fraction. The pellet was then resuspended in 500 µl fractionation buffer and 
saved as the spheroplast fraction. 
Preparation of cytoplasmic and membrane fractions 
50 ml of culture (O.D.600= 0.5) was harvested by centrifugation at 6000×g for 7 
min. The cells were then resuspended in 6 ml of 50 mM Tris-HCl, pH 8.0 and centrifuged 
again to remove any contaminants from the media. After the centrifugation, the cells 
were resuspended in 6 ml of 50 mM Tris-HCl, pH 8.0, 0.5 M sucrose, 2.5 mM EDTA and 
0.6 mg/ml lysozyme. The samples were left on ice for 30 min to disrupt the cell wall and 
peptidoglycan. Spheroplasts were then pelleted at 17,000×g for 10 min at 4oC, and the 
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supernatants were collected as the periplasmic fraction. The spheroplasts were 
resuspended in 3 ml of 50 mM Tris-HCl, pH 8.0, with a few flakes of DNase I (Roche) 
and one Complete, Mini, EDTA-free Protease Inhibitor Cocktail Tablet (Roche). The 
cells were then disrupted by passing twice through a cold French press (Carver) at a 
pressure of 20,000 lb/in2. Intact bacteria were removed by centrifuging twice at 1200×g 
for 10 min at 4oC. The supernatant, containing soluble proteins (cytosolic), insoluble 
proteins and membranes, was subjected to ultracentrifugation at 144,748×g for 1.5 h at 
4oC to pellet membranes and insoluble proteins. The supernatant was collected as the 
cytoplasmic fraction. Membrane and insoluble proteins were washed and resuspended in 
0.5 ml of 50 mM Tris-HCl pH 8.0 containing Complete, Mini, EDTA-free Protease 
Inhibitor Cocktail Tablets (Roche). Enrichment and purity of subcellular fractions were 
checked by Western blotting for known protein markers.  
The amount of each fraction loaded in the gel was normalized to the same 
percentage of total volume in each fraction. Fractions with large volume were 
concentrated by speed vacuum and resuspended in SDS-PAGE loading buffer. 
Separation of inner and outer membrane 
The separation of inner and outer membranes is based on published methods 
(Osborn and Munson 1974; Nikaido 1994). Cells containing plac-LtrA were grown 
overnight at 37oC. The overnight culture was inoculated into 1 liter of fresh LB medium 
containing ampicillin and grown to O.D.600= 0.6-0.8. After this step, cells and buffers 
were kept cold. The cells were harvested at 6000×g for 7 min at 4oC and resuspended into 
100 ml of buffer K (50 mM triethanolamine, 250 mM sucrose, 1 mM EDTA, pH adjusted 
to 7.5 by acetic acid). The cells were again pelleted at 6000×g for 7 min at 4oC and 
resuspended in 15 ml buffer K with or without 1 mg DNase I, 1 mg RNase A and a 
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Complete, Mini, EDTA-free Protease Inhibitor Cocktail Tablet (Roche) at 4oC as 
indicated for individual experiments. Cell membranes were disrupted by passing twice 
through a cold French press (Carver) at a pressure of 20,000 lb/in2, and cell envelopes 
and unbroken bacteria were removed by centrifuging twice at 1200×g for 10 min. The 
supernatant was subjected to ultracentrifugation at 45,000 rpm in a Beckman 70Ti rotor 
for 90 min at 4oC. The membrane pellet was rinsed with fresh buffer K twice to remove 
any cytoplasmic contamination and resuspended in 3 ml of buffer K with one tablet of 
Complete, Mini, EDTA-free Protease Inhibitor Cocktail at 4oC by repeated drawing in 
and squeezing out through a No.23 syringe needle (Becton Dickinson) (Nikaido 1994). 
The sucrose step gradients were composed of six layers containing 30%, 35%, 40%, 
45%, 50% and 55% sucrose. The step gradients were prepared by layering 5 ml of each 
sucrose solution starting with the highest concentration at the bottom of the centrifuge 
tubes. The interfaces between the layers were marked. The membrane suspension was 
layered over the sucrose step gradient and centrifuged at 25,000 rpm in a SW28 rotor 
(Beckman). The centrifuge was set at slow acceleration and was stopped without brake. 
Apparent equilibrium was reached after 30-36 h, but adequate separations were achieved 
by 18 h. 
The gradients were collected by puncturing the bottom of the tube with a piecing 
device and 60% sucrose was slowly and continuously pumped into the centrifugation 
tube through the hole to push the solution into a fraction collector. Each fraction 
contained 600 µl and the fractions were collected from the top to bottom of the 
centrifugation tube. The protein concentration of each fraction was calculated based on 
the equation: Protein Concentration (mg/ml) = 1.5×O.D.280 – 0.75×O.D.260 (Bollag et al. 
1996). After ultracentrifugation, the step gradient was converted into a continuous 
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gradient. Here the concentration of sucrose was considered to increase continuously. 
Usually, the inner membrane was found at sucrose concentrations of 24-42%, and outer 
membrane was found at sucrose concentration of 42-55%. 
For preparation of total inner and outer membranes, the separated fractions were 
directly removed from the centrifuge tube using needles attached to a syringe. Four 
bands, L1, L2, M and H, usually appeared after centrifugation. The lower, white band 
(band H) with strong turbidity corresponds to outer membranes with the still associated 
peptidoglycan layer, while inner membranes appear as a translucent, brownish upper 
bands (bands L1 and L2). The cytoplasmic membranes are found at the interface between 
the 24 and 42% sucrose, and the outer membrane at the interface between 42% and 55% 
sucrose. 
To pellet inner membranes, 18 ml of buffer M (100 mM triethanolamine, 2 mM 
EDTA, pH adjusted to 7.5 by acetic acid) was added to 3.5 ml of collected inner 
membrane fraction and subjected to ultracentrifugation at 47,600 rpm in a 70.1Ti rotor 
(Beckman) for at least 18 h at 4oC. After centrifugation, the brown pellet was 
resuspended in 300 µl buffer M with protease inhibitors. To pellet outer membranes, ~ 4 
ml of outer membrane fraction was diluted into 60 ml of buffer M, and 3 ml of 10% 
sarkosyl was added. The solution was mixed at room temperature by a constant rate 
mixer for 20 min and then centrifuged at 10,000×g for 1 h in an SW28 rotor. After 
centrifugation, the pellet was rinsed with buffer M and resuspended in 150 µl buffer M 
with protease inhibitor. 
2.8.3 Western blotting 
Cell extracts were subjected to sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) and transferred to PVDF membrane (Bio-Rad) using an 
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electro-transfer device (Pharmacia Biotech, model#EPS3500). After the transfer, 
membranes were blocked by 1% dry nonfat milk dissolved in 1×TBS (100 mM Tris-HCl, 
pH 8.0, 1.5 M NaCl) at room temperature for 1 h. The rabbit anti-thioredoxin and anti-
TatA antibodies were obtained from Dr. George Georgiou, UT Austin. The anti-LtrA 
antibody was the laboratory stock (Zhao and Lambowitz 2005). The anti beta-
galactosidase antibody was purchased from Molecular Probes (1:10,000). The secondary 
antibody used for all Western blotting was alkaline phosphatase conjugated anti-rabbit 
IgG(Fc) (Promega). BCIP (5-bromo-4-chloro-3-indolyl-phosphate) (Promega) was used 
in conjunction with NBT (nitro blue tetrazolium) (Promega) for the colorimetric 
detection of alkaline phosphatase activity. 
2.8.4 In vitro LtrA-promoted Ll.LtrB splicing assay  
LtrA-assisted splicing reactions were as described (Matsuura et al. 1997; 
Saldanha et al. 1999). Substrates for in vitro splicing were 32P-labeled in vitro transcripts 
synthesized with phage T3 RNA polymerase (Stratagene) from pGM–ΔORF linearized 
with BamHI. In vitro transcription was in 50 µl of reaction medium (Caprara et al. 1996) 
containing 1 µg of template DNA, 0.5 mM each of ATP, GTP, CTP, 0.4 mM UTP, and 5 
µCi [ α-32P]-UTP (3,000 Ci/mmole) for 4 h at 37°C. The DNA template was removed by 
DNase I treatment (Ambion; 10 units for 15 min at 37°C), and the precursor RNA was 
purified by electrophoresis on a denaturing 4% polyacrylamide gel. For splicing 
reactions, the 32P-labeled precursor RNA (100 nM; ~100,000 cpm) was dissolved in 20 µl 
of low salt reaction medium containing 5 mM MgCl2, 40 mM Tris-HCl at pH 7.5 and 2 
µl of SUPERase•In RNase inhibitor (Ambion, Cat#2694). The amount of NaCl in the 
reaction buffer was adjusted according to the experiments. The RNA was renatured by 
incubating to 55°C in a waterbath and then slowly cooling to 37°C. Splicing reactions 
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were initiated by adding of the 20 nM of purified LtrA protein or membrane fractions 
containing the equivalent amount of LtrA and incubated at 30°C for times specified for 
individual experiments. The reactions were terminated by phenol-chloroform-isoamyl 
alcohol (25:24:1) extraction and ethanol precipitation, and the products were analyzed in 




Figure 2.1: The distribution LtrA protein in E. coli cellular fractions. 
The figure shows Western blot analysis of cellular fractions from E. coli 
HMS174(DE3) expressing LtrA at a low level from the uninduced expression vector, 
plac-LtrA. The low expression level minimizes aggregation of the LtrA protein. Cellular 
fractions were prepared, and the amount of each fraction loaded in each lane was 
normalized as described in Methods. The purity and enrichment of each fraction was 
confirmed by immunoblotting for different marker proteins. TatA, β-galactosidase and 
DsbA were used as markers for membranes, cytoplasm, and periplasm respectively. The 
cellular fractions are indicated on the top of each Western blot, and the antibodies used 
are shown on the left of the gels. (A) Distribution of LtrA in periplasm and spheroplast 
fractions. (B) Distribution of LtrA protein in cytoplasmic and membrane fractions. (C) 
Distribution of LtrA protein among all cellular fractions. The last lane contains purified 
LtrA protein. The pellet was collected from the sucrose gradient centrifugation step. The 
relative amount of protein in each lane was calculated from the band intensity in the 




Figure 2.2: Distribution of LtrA protein in E. coli HMS174(DE3) inner and outer 
membranes.  
A total membrane fraction was prepared from E. coli HMS174(DE3) cells 
expressing LtrA protein. Inner and outer membranes were then separated by sucrose 
gradient ultra-centrifugation, as described in Methods. 600 µl fractions were collected 
from the top to bottom of the centrifuge tube. The absorbance of each fraction at 280 nm 
and 260 nm was measured by using a Nanodrop (Thermo scientific). The protein 
concentration was calculated based on the equation: Protein concentration (mg/ml) = 
1.5×O.D.280 – 0.75×O.D.260. Fours bands, corresponding from the top to bottom to protein 
concentration peaks L1, L2, M and H were observed after ultracentrifugation. The x-axis 
is the fraction number, and the y axis is the total protein concentration in each fraction. 
The presence of inner membrane protein marker, TatA, and LtrA protein in each fraction 
was checked by Western blot analysis (shown at bottom). Equal volumes of each fraction 












Figure 2.3: The distribution of outer membrane proteins in membrane fractions after 
sucrose gradient centrifugation. 
The protein profile of each fraction in Figure 2.2 was analyzed by electrophoresis 
in a 2% SDS/ 7.5% polyacrylamide gel. Equal volumes of fraction 13 to 62 collected 
from sucrose gradient centrifugation were loaded. The protein gels were then stained with 
Coomassie blue. The outer membrane proteins, indicated with arrows, were present in 
fractions 45 to 62, with a peak around fraction 51. M, protein ladder (Bio-Rad, Prescision 







Figure 2.4: Protein concentrations and relative distribution of LtrA, TatA and outer 
membrane proteins among sucrose gradient fractions. 
The protein concentration (red line) of each fraction was calculated as described 
in Methods, and plotted against fraction number. The relative amount of LtrA protein 
(blue line) and TatA protein (black line) in each fraction were calculated from the band 
intensity from the Western blots in Figure 2.2. The amount of outer membrane proteins in 
each fraction was calculated from the band intensity in Figure 2.3. Band intensities were 
determined by Quantitative One software (Bio-rad). The x-axis indicates the fraction 
number. The y-axis shows the amount of protein in each fraction. The relative amounts of 
LtrA, TatA and outer membrane proteins in the fractions were normalized to fall within 




Figure 2.5: Effect of nuclease treatment on the distribution of LtrA protein among E. coli 
cellular fractions. 
Cellular fractions were prepared as described in Methods from HMS174(DE3) 
cells expressing LtrA, or HMS174(DE3) cells with purified LtrA protein added to the 
extract prior to fractionation. (A) Effect of nuclease treatment on the LtrA protein 
distribution. Spheroplasts of E. coli HMS174(DE3) expressing LtrA were prepared and 
resuspended in buffer containing protease inhibitor, protease inhibitor with DNase I, 
RNase A or both, as indicated on the top of each gel. Cellular fractions were then 
prepared, and the relative amount of LtrA protein in each fraction was analyzed by 
Western blotting using anti-LtrA antibody. The amount of each fractions loaded on the 
gel was normalized, as described in Methods. The purity of each cellular fraction was 
assessed by Western blotting for protein markers TatA, β-galactosidase, and DsbA for 
cellular membranes, cytoplasm and periplasm, respectively. The distribution of outer 
membrane proteins was also checked (data not shown). (B) Control showing subcellular 
fractionation after addition of purified LtrA protein to an E. coli HMS174(DE3) cell 
extract. The purified LtrA protein was added to HMS174(DE3) cell extract, and cell 
fractions were prepared as before. Each fraction was then normalized and analyzed by 
Western blotting using an anti-LtrA antibody. The purity of each cellular fraction was 
assessed by Western blotting for protein markers as in panel A. The bottom right panel 
shows the parallel analysis for HMS174(DE3) cells without added LtrA protein. The last 


























Figure 2.6: LtrA protein within membrane fractions can promote the splicing of Ll.LtrB 
intron precursor RNA. 
100 nM of 32P-labeled Ll.LtrB precursor RNA was incubated with 20 nM LtrA 
protein or an equal amount of LtrA within inner or outer membrane fractions in splicing 
reaction buffer at 30oC for 30 min. The reactions were terminated by phenol-chloroform-
isoamyl alcohol (25:24:1) extraction, ethanol precipitation, and analyzed in a denaturing 
4% polyacrylamide gel, which was dried and scanned with a phosphorimager. Lane 
“Ll.LtrB” contains 100 nM Ll.LtrB intron precursor RNA. Lanes “LtrA” contains LtrA 
protein purified from E. coli expressing LtrA from pIMP-lp (Saldanha et al. 1999). Lanes 
“LtrA (inner)” and “LtrA (outer)” are the inner or outer membrane fractions containing 
LtrA protein prepared from HMS174(DE3) cells expressing plac-LtrA. The boiled LtrA 
(inner) and LtrA (outer) are the inner or outer membrane fractions containing LtrA 
protein treated by heating at 95oC for 5 min. The splicing activity of each sample was 
checked at different NaCl concentration (0, 50, 100 and 500 mM). The larger spliced 
product represents the spliced intron lariat with 3’ exon attached, and the smaller spliced 
product is the spliced intron lariat, as indicated schematically to the right of the gel. 
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Figure 2.7: LtrA in membrane fractions can stimulate Ll.LtrB intron splicing at lower 
NaCl concentration than purified LtrA protein. 
100 nM of 32P-labeled Ll.LtrB precursor RNA was incubated with 20 nM purified 
LtrA or the same amount of purified LtrA with 5 µl of inner or outer membrane fractions 
from HMS174(DE3) at 30oC for 30 min. Two NaCl concentrations (0 or 100 mM NaCl) 
were tested. The reactions were terminated by phenol–chloroform–isoamyl alcohol 
(25:24:1) extraction followed by ethanol precipitation, and analyzed in a denaturing 4% 
polyacrylamide gel, which was dried and scanned with a phosphorimager. Boiled inner or 
outer indicates the membrane fraction treated by heating at 95oC for 5 min. The splicing 
products lariat with exon 2 and lariat are shown schematically to the right of the gel. The 
addition of protein or membrane fraction is indicated at the top of gel by a “+”. 
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Chapter 3: EcI5, a group IIB intron with high retrohoming frequency: 
DNA target site recognition and use in gene targeting 
Group II intron EcI5 was discovered in the Escherichia coli virulence plasmid 
pO157 (Burland et al. 1998). It is a CL/IIB1 intron, whose IEP contains an En domain 
(Figure 1.6B) (Burland et al. 1998; Dai and Zimmerly 2002b). The intron was found to be 
actively mobile in E. coli in a screen of candidate introns using donor and recipient 
plasmid vectors that were used previously for mobility assays with Ll.LtrB (Guo et al. 
2000; Karberg et al. 2001; Karberg 2005). Previous studies with the group IIA intron 
Ll.LtrB showed that it could be retargeted to insert into different DNA target sequences 
by modifying the base-pairing sequences of the intron RNA (Guo et al. 2000; Mohr et al. 
2000). This feature made it possible to develop Ll.LtrB into a highly efficient bacterial 
gene targeting vector (“targetron”), which has programmable target specificity. Thus far, 
no other group II intron has been shown to be similarly useful for gene targeting, and it is 
not clear to what extent the required combination of characteristics would be found 
among other group II introns. Here, I show that EcI5 has very high retrohoming 
frequency in E. coli. Its DNA target site recognition rules were determined and this 
information was used to develop a computer algorithm that enables EcI5 to be retargeted 
to insert into new sites with high frequency and specificity. 
3.1 CONSTRUCTION OF AN ECI5-ΔORF INTRON AND ITS USE IN GENETIC ASSAYS OF 
INTRON MOBILITY 
Previous studies showed that the retrohoming frequency of the L. lactis Ll.LtrB 
intron expressed from a pACD-based donor plasmid could be increased as much as 
40,000-fold by deleting intron ORF sequences from DIV and expressing the IEP from a 
position downstream of the 3’ exon on the same plasmid (Guo et al. 2000). This 
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dramatically increased retrohoming frequency is thought to be due largely to the 
decreased nuclease susceptibility of the smaller ΔORF intron in E. coli. With this 
configuration, mobility frequencies for Ll.LtrB were high enough to carry out selection 
experiments using libraries of donor and recipient plasmids with randomized recognition 
elements, enabling determination of detailed DNA target site recognition rules for that 
intron (Guo et al. 2000; Zhong et al. 2003). 
To be able to do similar experiments for EcI5, a modified intron-donor plasmid 
pACD2-EcI5, which expresses an EcI5-ΔORF intron and short flanking exons, with the 
IEP expressed from a position downstream of the 3’ exon was constructed (Figure 3.1A). 
The EcI5-ΔORF intron was constructed by replacing intron ORF sequences (nucleotide 
residues 733-2265) from subdomain IVb with an MluI site (Figure 1.6A, inset upper 
right). The latter provides a convenient location for cloning cargo genes into the intron. 
The EcI5-ΔORF intron retains subdomain DIVa, which is a high-affinity binding site for 
the IEP in group IIA introns (Wank et al. 1999; Huang et al. 2003), as well as the residual 
DIVb stem, and subdomain DIVc, a small stem-loop structure found at the 3’ end of DIV 
(see Figure 1.6A). For quantitative mobility assays, a phage T7 promoter was cloned into 
the MluI site in DIV. The EcI5-ΔORF intron expressed from the pACD2-EcI5 donor 
plasmid was confirmed to splice efficiently in E. coli by RT-PCR (data not shown). 
For mobility assays, donor plasmid pACD2-EcI5 and the recipient plasmid 
pBRR3-EcI5, which contains the EcI5 target site (positions -30 to +15 from the intron-
insertion site) cloned upstream of a promoterless tetR gene, were co-transformed into E. 
coli HMS174(DE3). After induction of intron-expression with IPTG, integration of the 
EcI5-ΔORF intron carrying the phage T7 promoter into the recipient plasmid target site 
activates the expression of the downstream tetR gene, enabling selection of mobility 
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events by plating on LB agar containing tetracycline and ampicillin. Mobility efficiencies 
were then calculated as the ratio of TetR + AmpR to AmpR colonies. 
As shown in Figure 3.2A, the EcI5-ΔORF intron expressed from pACD2-EcI5 at 
a low level without IPTG induction had a mobility efficiency of 77% in this assay, about 
three-times higher than a similarly configured Ll.LtrB-ΔORF intron donor plasmid 
assayed in parallel (24%). When induced with 100 µM IPTG, both the Ll.LtrB-ΔORF 
and EcI5-ΔORF introns have mobility efficiencies close to 100%. As expected, mutations 
in the conserved YADD motif in the RT domain of the EcI5 IEP or a C-terminal 
truncation that deletes both the putative D and En domains (ΔD/En) abolished EcI5 
mobility without or with IPTG induction. Further, En-domain mutations (C-terminal 
truncation ΔEn or mutations H528A and H552A in the putative En active site) decreased 
EcI5 mobility frequencies without IPTG induction to < 0.61% (Figure 3.2A). 
Surprisingly, however, these En-domain mutants still gave high mobility when induced 
with 100 µM IPTG (Figure 3.2A), presumably by using alternate En-independent 
retrohoming mechanisms (Zhong and Lambowitz 2003). Together, these findings suggest 
that EcI5 uses retrohoming pathways similar to those for the Ll.LtrB intron, but with 
substantially higher integration frequencies, enabling the alternative En-independent 
pathways to operate at high efficiency. 
3.2 OVERPRODUCTION OF ECI5 IS NOT TOXIC TO E. COLI 
In the experiment of Figure 3.2B, it was surprising that IPTG-induction of EcI5 
expression in the presence of the EcI5 recipient plasmid is ~100-fold more toxic to E. coli 
than is induction of the Ll.LtrB intron in the presence of its recipient plasmid. As a 
potential gene targeting tool, it is a concern that this toxicity might reflect a high 
frequency of ectopic integration or indiscriminate cleavage of E. coli chromosomal DNA 
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by the over-expressed intron. Additional controls, however, showed that elevated toxicity 
is observed only when EcI5 is expressed in the presence of its own recipient plasmid and 
that EcI5 expressed by itself or with the Ll.LtrB recipient plasmid is not significantly 
more toxic than is expression of the Ll.LtrB intron or the benign protein GFP from the 
same donor plasmid (Figure 3.2C). A likely explanation is that the integration frequency 
of EcI5 into its recipient plasmid target site is so high that multiple plasmids are targeted 
in each cell, leading to over-expression of the tetR gene, which is known to be toxic 
(Eckert and Beck 1989). Thus, the experiment of Figure 3.2A may substantially 
underestimate the mobility frequency difference between EcI5 and Ll.LtrB. 
3.3 ECI5 INTRON DNA TARGET SITE RECOGNITION RULES 
3.3.1 Identification of critical nucleotide residues in the distal 5’-exon and 3’-exon 
regions of the EcI5 DNA target site 
To determine DNA target site recognition rules for the EcI5 intron, a plasmid-
based TetR selection assay was carried out using donor and recipient plasmid libraries in 
which different recognition elements were randomized. As an overview for these 
experiments, Figure 3.3 (top) shows the DNA target sequence for EcI5 and its predicted 
base-pairing interactions with the intron RNA. The EBS2, EBS1, and EBS3 sequences, 
each located in a different region of DI, potentially base pair to DNA target site 
sequences IBS2, IBS1, and IBS3, respectively, spanning positions -13 to +1 from the 
intron-insertion site. By analogy with the Ll.LtrB intron, the IEP is expected to recognize 
DNA target site positions both upstream and downstream of those that base pair with the 
intron RNA. 
To identify nucleotide residues potentially recognized by the IEP, Michael 
Karberg carried out a selection experiment in which the wild-type EcI5-ΔORF intron 
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integrates into recipient plasmid target sites with randomized nucleotide residues from 
positions -35 to -14 and +2 to +20 of the target sequence. After plating on LB agar 
containing tetracycline and ampicillin, plasmids containing integrated introns were 
isolated by a mini-prep procedure, and the sequences of active target sites were 
determined by sequencing the 5’- and 3’-integration junctions. In the experiment of 
Figure 3.3, target sequences were obtained from 101 active target sites selected in the 
experiment and 108 plasmids from the initial pool to correct for nucleotide frequency 
biases, as described in Methods. Figure 3.3 (bottom) summarizes the results in WebLogo 
format, along with nucleotide frequencies at each randomized position in both the 
selected target sites and the initial pool. 
In the distal 5’-exon region, the most strongly conserved nucleotide residues in 
the target sequence were C-18, C-17, A-15, and A-14, with A-14 found in 100% of the 
active target sites, and in the 3’ exon, the most strongly conserved nucleotide residue was 
T+5, which was found in 80% of active target sites. Several other 3’-exon positions in the 
EcI5 target site showed some selection for specific nucleotide residues (+2, +3, +4, +6, 
and +10). In agreement with the selection experiment, I found that single nucleotide 
substitutions at A-14, which was found in 100% of active target sites, strongly decreased 
mobility frequencies (A-14C, A-14G, and A-14T, 1. 0, 1.4, and 1.6% of wild type, 
respectively, average of two assays done as in Figure 3.2 without IPTG induction). As 
expected, single nucleotide substitutions at other key positions identified in the selections 
also inhibited mobility but less severely than mutations at A-14 (C-18T, A-15C, and 
T+5C, 8%, 2%, and 20% of wild type, respectively, without IPTG induction). 
In addition to identifying nucleotide residues potentially recognized by the IEP, 
the selection data in Figure 3.3 suggest that the EBS3/IBS3 interaction is limited to 
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position +1, because positions +2 and +3 do not show strong selection for nucleotide 
residues that could base pair with U-residues in the intron RNA to extend this interaction. 
DNA target site position +2 does show weak selection for a non-wild-type A-residue that 
could base pair with the U-residue at EBS3 +2, but also shows similar weak selection for 
a non-wild-type T-residue that cannot base pair with this U-residue. These weak 
selections may reflect that a weak A-T or T-A DNA base pair at target site position +2 
helps accommodate the EBS3/IBS3 interaction between the intron RNA and DNA target 
site at position +1. 
The selected target sites have GC contents ranging from 18-77% from position -
35 to -14 and 21-74% from position +2 to +20, indicating that EcI5 can integrate into 
DNA target sites having a wide range of melting temperatures (not shown). Analysis of 
30 selected target sites using DNA Mfold (http://mfold.bioinfo.rpi.edu/cgi-bin/dna-
form1.cgi) did not reveal any conserved stem-loop structures in the EcI5 DNA target site. 
Using a chi-square test with probability level P = 0.001 and nine degrees of freedom, two 
potential co-variations between nucleotide residues in the DNA target sequence 
(positions -24 and -18; chi2 = 30.3 and positions +9 and +11; chi2 = 28.8) were found. 
However, both are based on dinucleotides with low (< 10) observed counts, and their 
significance in this relatively small dataset is unclear. 
3.3.2 Rules for the EBS1/IBS1 pairing 
The predicted EBS1/IBS1 interaction between wild-type EcI5 and its DNA target 
site encompasses positions -5 to -1 from the intron-insertion site (Figure 3.4). To 
determine rules for base pairing between EBS1 and IBS1, the positions -7 to -1 in the 
EBS1 stem-loop in the intron and the corresponding positions in the IBS1 region of the 
DNA target site were both randomized (Figure 3.4A). Because the EBS1/IBS1 pairing is 
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also required for RNA splicing, IBS1 positions -7 to -1 in the 5’ exon of the donor 
plasmid were also randomized to provide complementary nucleotide combinations in the 
pool (Guo et al. 2000). After selection, the 5’-integration junctions were amplified from 
the selected TetR + AmpR colonies by colony PCR, and the PCR products were sequenced 
to identify active EBS1/IBS1 combinations. Sequences for 87 independent intron-
integration events, along with 94 unselected donor plasmids and 95 unselected recipient 
plasmids to correct for nucleotide frequency biases in the initial pools, were obtained. 
Figure 3.4B summarizes nucleotide frequencies at each of the randomized positions, with 
the results depicted in WebLogo format above, while Figures 3.4C and D and Table 3.1 
summarize base-pair frequencies between intron RNA and DNA target site positions. 
The results show selection for base pairing between the intron RNA and DNA 
target site from positions -6 to -1, with no selection for base pairing at position -7 (Figure 
3.4C; Table 3.1). The selection for base pairing at position -6 was unexpected because 
wild-type EcI5 cannot form a canonical Watson-Crick or wobble base pair with its DNA 
target site at this position. Ninety five percent of the selected intron/target site 
combinations have four or more base pairs in EBS1/IBS1, compared to only 21% for 
randomly paired introns and target-site combinations from the original pools (Figure 
3.4C). 
In the intron RNA, EBS1 positions -6 to -1, which base pair with the DNA target 
site, show some selection for wild-type nucleotide residues, with the strongest selection 
for C-6, G-5, and U-2 (Figure 3.4B). There is also weaker selection for complementary 
nucleotide residues in IBS1, leading to some preferences for specific base pairs between 
the intron RNA and DNA target site (e.g., C-G at position -6, G-C or G•T at position -5 
and U-A at position -2; Table 3.1; also observed when data are corrected for nucleotide 
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frequency biases; data not shown). The most likely explanation is that the selection for 
specific EBS1 nucleotide residues reflects constraints on the structure of the EBS1 RNA 
stem-loop, which in turn leads to selection for complementary nucleotide residues in 
IBS1. However, the weak selection for some IBS1 nucleotide residues also reflects 
constraints on DNA structure or partial recognition of IBS1 sequences by the IEP. It is 
also notable that some EBS1/IBS1 positions show selection for non-wild-type base pairs 
(e.g., U-A or C-G instead of U•G at position -4 and C-G instead of U-A at position -3; 
Table 3.1). Notably, EBS1 position -7, which does not base pair to the DNA target site, 
nevertheless shows strong selection for the wild-type U residue, almost certainly 
reflecting a constraint on the structure of the RNA stem-loop, as posited for the other 
EBS1 nucleotide residues (Figure 3.4B). 
3.3.3 Rules for the EBS2/IBS2 pairing 
Figure 3.5 shows the results of similar selection experiment for positions -13 to -7 
potentially involved in the EBS2/IBS2 interaction. In this experiment, I obtained 
sequences of 102 independent integration events, along with 99 unselected donor 
plasmids and 103 unselected recipient plasmids to correct for nucleotide frequency biases 
in the pools. The data show strong selection for RNA/DNA base pairing between 
positions -13 and -9, with selection against RNA/DNA base pairing at position -8, and no 
selection for or against RNA/DNA base pairing at position -7 (Figure 3.5C, D). 
Notably, the selection for base pairing in EBS2/IBS2 appears stronger than in 
EBS1/IBS1, with each position between -13 and -9 base paired in ≥ 95% of the selected 
combinations and positions -10 and -9 base paired in 100% and 99% of the selected 
combinations, respectively (Figure 3.5C). Additionally, 91% of the selected combinations 
have all five base pairs between positions -13 and -9, while randomly chosen intron-
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target site combinations from the original pool typically have three or fewer base pairs 
between these positions (Figure 3.5D). 
Within the region of EBS2 involved in base pairing (positions -13 to -9), positions 
-11 to -9 show moderate to high selection for specific nucleotide residues (Figure 3.5B). 
As in the case of EBS1, the most likely possibility is that the selection for these 
nucleotide residues reflects constraints on RNA structure, and these constraints in turn 
result in preferences for specific RNA-DNA base pairs at these positions (Table 3.1). 
Positions -11 and -10 show particularly strong selection for the wild-type C-G pairs, but 
some selection for C-G base pairs is also seen at positions -12 and -9, where the wild-
type base pair is in both cases A-T. In contrast to the EBS1/IBS1 interaction, when the 
data are corrected for nucleotide frequency biases in the initial pools, the wild-type 
EBS2/IBS2 base pair appears to be preferred at each position (data not shown). 
Intron RNA positions -8 and -7, which are not involved in base pairing with the 
DNA target site, nevertheless show strong selection for the wild-type A- and U-residues, 
respectively, again likely reflecting constraints on intron RNA structure (Figure 3.5C). 
Position -7 in the DNA target site shows no selection for a specific nucleotide residue, in 
agreement with the results in the EBS1/IBS1 selection above, while position -8 in the 
DNA target site shows some selection for G or A residues, possibly reflecting prohibition 
against base pairing with the strongly conserved A-residue at position -8 in the intron 
RNA. 
3.3.4 Rules for the EBS3/IBS3 pairing 
The EBS3/IBS3 interaction in EcI5 is predicted to involve a single base pair at 
position +1 (Figure 3.6). To confirm this prediction and assess nucleotide preferences for 
the EBS3/IBS3 interaction, a final selection experiment was carried out with a random 
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nucleotide in position +1 both in IBS3 of the recipient plasmid and EBS3 of the donor 
plasmid (Figure 3.6A). The results show selection for RNA/DNA base pairing, with 71% 
of the selected target sites having either a Watson-Crick or wobble G•T or U•G pair at 
position +1, compared to only 22% in the pool (Figure 3.6B). Notably, although all four 
Watson-Crick combinations and some mismatches (RNA/DNA C/A and G/A) are 
reasonably well represented, some nucleotide mismatches (A/C, U/C, A/G, G/G, C/T, and 
U/T) were not found, even though a relatively large number of events were analyzed for a 
selection involving a single base pair (Table 3.1). These findings raise the possibility that 
the EBS3/IBS3 interaction may be particularly sensitive to some mismatches. 
For this selection, position +1 in the 3’ exon of the donor plasmid was not 
randomized, and the donor plasmid retained the wild-type C-residue at this position. For 
the Ll.LtrB intron, the analogous δ-δ’ interaction between the intron and 3’ exon in the 
precursor RNA may contribute to the efficiency of RNA splicing, but generally has only 
a small effect on the overall intron-integration efficiency (Perutka et al. 2004). Our 
results suggest that this is also the case for the EBS3/IBS3 pairing in EcI5, with about 
half of the selected introns, those with A, C, or T residues at EBS3 +1, unable to form an 
EBS3/IBS3 base pair in the precursor RNA. Nevertheless, selection for an EBS3/IBS3 
base pair in the precursor RNA could contribute along with constraints on RNA structure 
to the observed bias for introns with the wild-type G-residue at EBS3 +1. 
3.4 A COMPUTER ALGORITHM FOR IDENTIFYING ECI5-INSERTION SITES AND 
RETARGETING ECI5 
The DNA target site recognition rules revealed by the selection experiments were 
further used to develop a computer algorithm that identifies potential EcI5 insertion sites 
and designs PCR primers for modification of the intron’s EBS sequences to insert into 
those sites. As done for the Ll.LtrB intron (Perutka et al. 2004), a simple probabilistic 
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model (zero-order Markov model), which assumes that the likelihood of occurrence of a 
nucleotide residue in the target sequence is independent of other residues in this 
sequence, was used. Model parameters are derived from the observed frequency of 
residues in a training set of trusted examples. Thus, the performance of the model 
critically depends on which target site positions are included in the calculation. Because 
the model is based on a limited amount of data, overtraining can occur, resulting in a 
model that is able to classify sequences from the training set correctly, but unable to 
make accurate predictions for sequences not drawn from the original training set. The 
more parameters that are included in the model, the greater the risk of overtraining. 
By a procedure described below, a minimal set of DNA target site positions 
sufficient for discriminating efficient target sites from inefficient ones includes: -26 to -
14, -8, -6, and +2 to +10, with A-14, which is present in 100% of the selected target sites, 
treated as a fixed position in the model. Positions -26 to -14 and +2 to +10 are the regions 
presumably recognized by the IEP. Positions -6 and -8, which are not thought to be 
recognized by the IEP, nevertheless have moderately high information content in the 
EBS1/IBS1 selection of Figure 3.3 and the EBS2/IBS2 selection of Figure 3.4, 
respectively. For position -6, this information content reflects selection for a nucleotide 
residue that extends the RNA/DNA base-pairing interaction, while for position -8, it 
reflects selection against a nucleotide residue that extends the RNA/DNA base-pairing 
interaction. 
The algorithm scores potential DNA target sites across a 36-bp sliding window 
with 1-bp increments by calculating a log-odds score S, which compares the probability 
P(seq|M) that the target sequence seq was generated by the model M to the probability 
P(seq) that the sequence was generated by chance (null model). P(seq|M) and P(seq) are 
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calculated as the products of individual probabilities P(np|M) and P(np) that a nucleotide n 
at position p in the target sequence was generated by the model and by chance, 
respectively, with the latter calculated from the frequencies )(selectednpf and )( poolnpf  for a 
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A positive score indicates that the model predicts the potential EcI5 target sequence 
better than the null model (see Perutka et al. 2004 for additional description). 
3.5 RETARGETING OF ECI5 TO INSERT INTO SITES IN THE E. COLI LACZ GENE 
To test the performance of different models, potential target sites in the E. coli 
lacZ gene were identified by different algorithms. The retargeted EcI5 was made by 
modifying its EBS1, 2, and 3 sequences to form Watson-Crick base pairs at the positions 
recognized by base pairing of the intron RNA (IBS2 -13 to -9; IBS1 -6 or -5 to -1; and 
IBS3, +1). IBS2, IBS1, and IBS3 in the 5’- and 3’-exons of the donor plasmid were also 
modified to be complementary to the retargeted EBS2, EBS1, and EBS3 sequences for 
efficient RNA splicing. 
Figure 3.7 shows potential target sequences in the lacZ gene and their base-
pairing interactions with the intron RNA, along with their log-odds scores computed by 
the algorithm for the model described in the preceding section. To facilitate retargeting, 
four different donor plasmids, pACD3-EcI5A, C, G and T were constructed. These 
constructs lack the T7 promoter in DIV and have the indicated nucleotide residues at 
EBS3 along with the complementary nucleotide residue at IBS3 for maximally efficient 
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RNA splicing. For retargeting, the appropriate donor plasmid whose EBS3 nucleotide 
residue is complementary to IBS3 in the DNA target site was used to introduce the 
required modifications into the donor plasmid’s EBS1, EBS2, IBS1 and IBS2 sequences 
by PCR, as diagrammed in Figure 3.8A. 
The donor plasmids containing the retargeted introns were transformed into E. 
coli HMS174(DE3). After induction of intron expression with 100 µM IPTG for 3 h at 
37oC, disruption of the lacZ gene was scored by plating on LB agar containing 5-bromo-
4-chloro-3-indolyl-D-galactopyranoside (X-gal), where LacZ+ colonies are blue and 
LacZ- colonies are white. For each retargeted intron, 100 to 1,000 colonies, depending on 
the targeting frequency, were screened and confirmed for integration at the desired site by 
colony PCR and sequencing both the 5’- and 3’-integration junctions for at least 12 white 
colonies (Figure 3.8B). 
Comparison of the experimentally determined targeting frequencies with the log-
odds scores computed by the algorithm for the model described in the preceding section 
showed that all efficient target sites (targeting frequencies 30-98%) have log-odds score 
higher than 8.2, while all less efficient target sites (targeting frequencies 0 to 4.0%) have 
log-odds scores less than 8.2 (Figure 3.7). More complicated models that included 
additional DNA target site positions or frequencies of EBS/IBS base pairs from the 
selection experiments did not give a similar clean separation of efficient and inefficient 
target sites. This situation likely reflects that the currently available selection data are too 
limited to accurately weight the effects of substituting different combinations of 
nucleotide residues in the EBS sequences of the intron RNA. The model will need to be 
improved as more data becomes available. As for Ll.LtrB targetrons, some retargeted 
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EcI5 introns with lower log-odds scores still gave experimentally useful targeting 
frequencies.  
All of the introns in Figure 3.7 were tested with a 5-bp EBS1/IBS1 interaction 
like that of the wild-type EcI5 with its DNA target site. Because the selection experiment 
of Figure 3.4 showed the potential for a sixth base pair at EBS1/IBS1 position -6, the 
insertion frequencies of a number of retargeted introns with five or six base-pair 
EBS1/IBS1 DNA target site interactions were compared. In four cases (1806s, 178a, 
1790a, 187s), the additional EBS1/IBS1 base pair gave the same or increased targeting 
frequencies, while in four other cases (912s, 1257s, 326a, 1878s), it decreased the 
targeting frequency significantly (Figure 3.7). These findings may reflect preferences for 
specific nucleotide residues at position -6 in the context of different EBS1 sequences. 
Until these effects are understood better, it seems preferable for retargeting EcI5 to leave 
the wild-type nucleotide residue at EBS1 position -6 and use the five base-pair 
EBS1/IBS1 interaction like that of wild-type EcI5 with its DNA target site. 
The EcI5 intron was also tested by expressing it from a broad-host range vector 
pBL1, which can be used in diverse Gram-negative bacteria without introducing a gene 
encoding phage T7 RNA polymerase (Yao and Lambowitz 2007). This plasmid expresses 
targetrons by using an m-toluic acid-inducible promoter (Pm) recognized by the host RNA 
polymerase. For EcI5 targetron LacZ1806s, pBL1-EcI5 gave a lacZ targeting frequency 
of only 4% compared to 98-99% for the same targetron expressed from pACD3-EcI5A. 
In previous work, pBL1 gave high insertion frequencies with several Ll.LtrB targetrons 
in different bacteria and appeared to be as efficient as pACD3 for expressing Ll.LtrB 
targetron LacZ635s in E. coli HMS174(DE3) (Yao and Lambowitz 2007). However, 
additional tests comparing other Ll.LtrB LacZ targetrons in E. coli HMS174(DE3) 
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showed that some targetrons function as efficiently when expressed from pBL1 as 
pACD3, while others function less efficiently (Yao and Lambowitz, unpublished results). 
A possible explanation is that targetrons with lower splicing efficiencies due to different 
EBS/IBS interactions in the precursor RNA benefit from more efficient expression by T7 
RNA polymerase. 
For four of the retargeted EcI5 introns expressed from pACD3-EcI5 in the 
experiment of Figures 3.7 and 3.8, genomic DNA from the disruptants was analyzed by 
Southern hybridization to confirm site-specific insertion. For three disruptants, 163s, 
1806s and 1790a, the Southern blots hybridized with an intron probe showed a band of 
the size expected for site-specific insertion into lacZ gene and no non-specific insertions 
(Figure 3.8C; the extra band for 1790a is due to residual donor plasmid). In the remaining 
case, 1257s, the disruptants obtained after induction with 100 µM IPTG for 3 h showed 
insertion at a second site in addition to the expected site in lacZ (not shown), but this 
ectopic targeting was not evident when the induction was done with a lower amount of 
IPTG for a shorter time (50 µM IPTG, 1 h; Figure 3.8C). Together, the above findings 
show that EcI5, like Ll.LtrB, can be retargeted to insert efficiently and specifically into 
desired chromosomal DNA targets. 
3.6 DISCUSSION 
The group II intron EcI5, a subclass CL/IIB1 intron discovered in an E. coli 
virulence plasmid (Burland et al. 1998), is highly active in retrohoming in E. coli, and 
was adapted for use in gene targeting. Like the well-studied group IIA introns S. 
cerevisiae aI1 and aI2 and L. lactis Ll.LtrB, EcI5 encodes a protein with conserved RT, 
X, D, and En domains. As expected for the retrohoming mechanism used by these group 
II introns, EcI5 retrohoming is abolished by mutations that inhibit IEP expression or the 
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ribozyme activity of the intron RNA, as well as by the mutation YADD→YAAA in the 
RT active site. Further, as shown for the Ll.LtrB intron (Zhong and Lambowitz 2003b), 
En-domain mutations strongly inhibit EcI5 retrohoming, but leave residual retrohoming 
by En-independent mechanisms. It is a measure of the high activity of EcI5 that such En-
independent retrohoming can occur at almost 100% efficiency when intron-expression is 
induced with IPTG. 
Both full-length EcI5 and a streamlined EcI5-ΔORF derivative with the IEP 
expressed from the same donor plasmid have higher mobility frequencies than do the 
corresponding Ll.LtrB intron constructs. These higher mobility frequencies could reflect 
more efficient production or higher stability of the intron RNA or IEP, more active RNPs, 
or the ability to efficiently use both En-dependent and En-independent retrohoming 
mechanisms. Biochemical analysis will be needed to determine whether EcI5 RNPs have 
inherently higher DNA integration efficiency than do Ll.LtrB RNPs. As for Ll.LtrB (Guo 
et al. 2000), the deletion of ORF sequences from DIV enables EcI5 to retrohome at near 
100% efficiency, presumably by decreasing the nuclease susceptibility of the intron 
RNA, which appears to be a major factor limiting the mobility of group II introns in E. 
coli (Guo et al. 2000; Smith et al. 2005). 
EcI5 was found in virulence plasmid pO157 in E. coli strain O157:H7 (Burland et 
al. 1998; Dai and Zimmerly 2002b). The intron is inserted within a non-coding region of 
the plasmid, but in the same orientation as most other plasmid genes. Southern 
hybridizations and PCR analysis showed that EcI5 is also inserted at the same site in 
DNAs isolated from 19 of 72 ECOR strains, although always in fragmented form (Dai 
and Zimmerly 2002b). The computer algorithm developed here for identifying EcI5 
target sites found no efficient target sites for wild-type EcI5 intron (log-odds score > 8.2 
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and Watson-Crick or wobble base pairs at all EBS/IBS positions) in sequenced E. coli 
O157 genomes (EC4115, EDL933, and Sakai), and only one such target site in the non-
essential gene cusS in the genome of E. coli K12 MG1655, which does not carry the 
plasmid. Thus, the spread of EcI5 to the E. coli chromosome may be limited by a 
combination of poor expression from a non-coding region of pO157 and a paucity of 
efficient insertion sites in the genome. 
Like other mobile group II introns, EcI5 recognizes DNA target sequences by 
using both the IEP and base pairing of the intron RNA. As expected for a class IIB intron, 
the base-pairing interactions involve EBS1 and EBS2, which base pair to the 5’ exon, and 
EBS3, which base pairs to the 3’ exon (Costa et al. 2000; Jiménez-Zurdo et al. 2003). 
Detailed analysis by selection experiments using randomized sequence libraries showed 
that the EBS1/IBS1 interaction can extend for six base pairs rather than five base pairs 
found for the interaction of the wild-type intron with its DNA target site. The selection 
experiments also suggest relatively strong constraints on the EBS2 sequence, likely 
reflecting the deleterious effect of nucleotide substitutions in the EBS2 loop on intron 
RNA structure. The constraints on the EBS2 sequence appear to be greater in EcI5 than 
in Ll.LtrB, perhaps reflecting that EBS2 is located in a junctional loop in the former and a 
stem-loop in the latter, a difference between IIB and IIA introns. 
As for other mobile group II introns, the EcI5 IEP appears to recognize sequences 
in both the distal 5’-exon and 3’-exon regions of the DNA target site. In the distal 5’-
exon region, the number of nucleotide residues critical for EcI5 recognition is similar to 
that for Ll.LtrB and other mobile group II introns, but their identity and location are 
different. Thus, for EcI5, the most critical distal 5’-exon nucleotide residues are C-18, C-
17, A-15, and A-14, with A-14 found in 100% of active target sites (Figure 3.3), while 
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for Ll.LtrB, the most critical nucleotide residues in this region are T-23, G-21, A-20, T-
19, and G-15, with none as stringently required as A-14 for EcI5 (Singh and Lambowitz 
2001; Perutka et al. 2004). In the 3’ exon, EcI5 is similar to Ll.LtrB in that the only 
critical nucleotide residue is T+5. In Ll.LtrB, T+5 is required for second-strand cleavage 
by the En domain, but not for the initial DNA target site recognition or reverse splicing 
(Mohr et al. 2000). If that is also true for EcI5, retrohoming of EcI5 to sites lacking T+5 
may occur by En-independent pathways. Although difficult to compare due to analysis by 
different methods, the target sequences for group II IEPs studied thus far have almost no 
critical nucleotide residue in common, and this divergence in IEP recognition sequences 
is seen even for very closely related introns, such as S. cerevisiae aI1 and aI2 (Guo et al. 
1997; Yang et al. 1998; Singh and Lambowitz 2001; Jiménez-Zurdo et al. 2003). These 
findings suggest that IEP recognition sequences can evolve rapidly to adapt the intron to 
retrohome to new sites (Singh and Lambowitz 2001). 
The selection experiments enable us to calculate values for the total information 
content of nucleotide residues putatively recognized by the IEPs of different introns. For 
EcI5, this value calculated for positions -26 to -14 and +3 to +10 is 6.96 bits, while for 
Ll.LtrB the value calculated for the same nucleotide positions is 5.21 bits (using 
nucleotide frequency data of Zhong et al. 2003). As both EcI5 and Ll.LtrB are similar in 
potentially forming 11 or 12 base pairs with their DNA target sites, these findings suggest 
that target site recognition for EcI5 may be somewhat more stringent than for Ll.LtrB. 
Attesting to their very high specificity, over-expression of neither EcI5 nor Ll.LtrB is 
toxic to E. coli, as would be expected if these introns could indiscriminately cleave or 
insert into non-target sequences. The high target specificity of mobile group II introns 
reflects that 11-15 nts of the DNA target sequence are recognized by base pairing of the 
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intron RNA and that base-pairing mismatches are expected to strongly affect the kcat for 
reverse splicing in addition to Km, thereby limiting off-target insertions (Xiang et al. 
1998). 
As a gene-targeting vector, the high retrohoming efficiency and novel target 
specificity of EcI5 expand the number of genomic target sites that can be targeted 
efficiently by group II introns. Analysis of the E. coli K12 genome for potential EcI5 
targeting sites using the computer algorithm developed here revealed 14,938 such sites on 
either DNA strand with log-odds scores > 8.2, an average of one highly ranked target site 
per 621 nucleotide residues. In the E. coli LacZ gene (3-kb), the Ll.LtrB intron has five 
potential targeting sites with log-odds scores > 8.2, of which two have been validated 
with targeting efficiencies > 10% (Yao and Lambowitz 2007; Zhao et al. 2008), while 
EcI5 has six completely different targeting sites with log-odds scores > 8.2 of which five 
have been validated (targeting efficiencies 30-98%). Including less efficient introns 
whose targeting sites have lower log-odds scores, a total of ten EcI5 target sites were 
validated in lacZ (Figure 3.7). To date, 219 full-length ORF-containing group II introns 
have been identified in different bacteria, and their insertion sites suggest a wide variety 
of IEP recognition sequences (Simon et al. 2008). Assuming that a significant fraction of 
these bacterial group II introns are mobile and can be adapted for gene targeting as shown 
here for EcI5, the diversity of homologous IEPs with novel target specificity should 
greatly expand the number of target sites accessible to group II introns without resort to 
protein engineering. 
Finally, EcI5 has a combination of characteristics that make it well-suited for 
gene targeting applications. These characteristics include high retrohoming efficiency, 
novel IEP recognition specificity, relatively long EBS/IBS interactions between the 
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intron RNA and DNA target, sufficient flexibility in its EBS sequences to retarget the 
EBS/IBS interactions, and a high degree of target specificity. The required combination 
of characteristics for gene targeting is most likely to be found among group IIA and IIB 
introns, whose IEPs have an En domain, enabling them to retrohome efficiently to both 
DNA strands without relying on nascent strands at DNA replication forks to prime 
reverse transcription. Group IIC introns, which recognize DNA stem-loop structures, 
have short EBS1/IBS1 interactions, and encode proteins lacking an En domain, are likely 
to have insufficient flexibility or specificity for gene targeting. The procedures described 
here for constructing a highly active EcI5-ΔORF derivative and rapidly determining 
targeting rules should be generally applicable to other group II introns, which when 
similarly developed will provide a wide range of different IEP target specificities and 
potentially other useful characteristics. 
3.7 METHODS 
3.7.1 Bacterial strains and growth conditions 
E. coli HMS174(DE3) recA1 (Novagen) was used for intron-mobility 
experiments, and DH5α and DH10B (Invitrogen) were used for cloning. Unless specified 
otherwise, cells were grown in Luria-Bertani (LB) medium, and antibiotics were added at 
the following concentrations: ampicillin, 100 µg/ml; chloramphenicol, 25 µg/ml; 
tetracycline, 25 µg/ml. 
3.7.2 Recombinant plasmids 
Previously described donor plasmids for the Ll.LtrB intron were pACD-LtrB, 
which expresses the full-length intron (Guo et al. 2000) and pACD2X, which expresses a 
0.906-kb Ll.LtrB-ΔORF intron with a phage T7 promoter inserted in DIV (San Filippo 
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and Lambowitz 2002). Both are pACYC184-based plasmids that carry a camR marker on 
the vector backbone and use a T7lac promoter to express the intron and short flanking 
exon sequences. In pACD2X, the ORF encoding the IEP (LtrA protein) is cloned 
downstream of the 3’ exon. 
Donor plasmids for EcI5 are derivatives of pACD2X. pACDF-EcI5 contains the 
full-length EcI5 intron and flanking exon sequences swapped for the Ll.LtrB and LtrA 
segments of pACD2X. It was constructed by PCR amplifying the EcI5 segment of E. coli 
virulence plasmid pO157 (Burland et al. 1998), using primers EcI5-5’exon and EcI5-
3’exon, which append XbaI and PstI sites, respectively (Table 3.2 for primer sequences). 
The PCR products were 5’ phosphorylated with phage T4 polynucleotide kinase (New 
England Biolabs), blunt-ended with T4 DNA polymerase (Invitrogen), and cloned 
between the blunt-ended HindIII and XhoI sites of pACD2X. Mutant derivatives of 
pACDF-EcI5 with a deletion of intron DV (intron positions 2332-2365; ΔDV) or a point 
mutation in the initiation codon of the intron ORF (ATG→ATT; G611T) were 
constructed via PCR with primers containing the mutations. 
pACD3-EcI5 contains a 906-nt EcI5-ΔORF intron and flanking exons, with the 
IEP cloned downstream of the 3’ exon. To construct this plasmid, 5’- and 3’-segments of 
EcI5 were amplified separately by PCR of plasmid pO157 DNA (see above), using 
primers EcI5-5’exon + EcI5-P1 and EcI5-P3 + EcI5-3’exon, respectively (Table 3.2). 
The two PCR products were then mixed and amplified with the outside primers EcI5-
5’exon and EcI5-3’exon to generate a 0.961-kb PCR product containing the EcI5-ΔORF 
intron and flanking exons with an MluI site inserted at the site of the ORF deletion in 
DIV. The PCR product was blunt-ended with T4 DNA polymerase (Invitrogen) and 
swapped for the Ll.LtrB-ΔORF intron between the XbaI and PstI sites of pACD2X (see 
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above). The LtrA ORF encoded downstream of the intron in pACD2X was then deleted 
by a single-primer PCR using primer E2-3’ORF (Table 3.2), which simultaneously 
inserts a SwaI site. Finally, the ORF encoding the EcI5 IEP was amplified from pACDF-
EcI5 by PCR using the primers EcI5-5’ORF and EcI5-3’ORF (Table 3.2) to generate a 
1780-bp product, which was blunt-ended with T4 DNA polymerase and cloned between 
the SwaI and SnaBI sites of the vector. Primer EcI5-5’ORF inserts the Shine-Dalgarno 
sequence of expression vector pET11c (New England BioLabs) upstream of the EcI5 IEP 
ORF. 
pACD2-EcI5 was derived from pACD3-EcI5 by cloning a T7 promoter sequence 
(annealed 5’-phoshorylated oligonucleotides T7MLU1-T and T7MLU1-B; Table 3.2) 
into the MluI site in DIV. Derivatives of pACD2-EcI5 with EcI5 ORF mutations 
YADD→YAAA (ORF nucleotide residues 838-843 changed from GATGAT to 
GCGGCG); H528A (ORF nucleotide residues 1582-1584 changed from CAT to GCT); 
and H552A (ORF nucleotide residues 1654-1656 changed from CAC to GCC) were 
constructed by site-directed PCR mutagenesis with primers that contain the mutant 
sequence, using a QuikChange Site-Directed Mutagenesis kit (Stratagene). C-terminal 
truncations ΔD/En (deleted amino acid residues 429-574), and ΔEn (deleted amino acid 
residues 518-574) were constructed by PCR with primer DelEnS, which anneals to an 
upstream ORF sequence containing a BglII site, and downstream primer DelD/EnA or 
DelEnA, respectively, which anneal at the site of the truncation and add a TGA stop 
codon and a SpeI site (Table 3.2). The PCR products were then digested with BglII and 
SpeI and swapped for the corresponding fragment of pACD2-EcI5. 
pACD3-EcI5A, C, G, or T are derivatives of pACD3-EcI5 in which EBS3 is 
either A, C, G or T and IBS3 is the complementary nucleotide residue. The plasmids 
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were constructed by site-directed PCR mutagenesis (QuikChange Site-Directed 
Mutagenesis kit; Stratagene), using pACD3-EcI5 as the template, with primers EBS3N 
and IBS3N (Table 3.2), where N is the desired EBS3 or IBS3 nucleotide residue. 
Donor plasmid pBL1 is a derivative of the broad-host-range vector pJB866 
(Blatny et al. 1997), which uses an m-toluic acid-inducible promoter Pm to express a 
cassette consisting of the Ll.LtrB-ΔORF intron with flanking exons followed by the IEP 
(Yao and Lambowitz 2007). A parallel construct expressing EcI5 targetron LacZ1806s 
was constructed by PCR amplifying the EcI5-ΔORF intron, flanking exon sequences, and 
EcI5 IEP from pACD3-EcI5A containing the retargeted intron (see below), using primers 
EcI5 5’ and EcI5 3’ (Table 3.2), then digesting the PCR product with HindIII and XhoI, 
and cloning it between the corresponding sites of pJB866. 
Recipient plasmid pBRR3-ltrB contains the Ll.LtrB intron-insertion site (ligated 
exon 1 and 2 sequences of the ltrB gene from position -30 upstream to +15 downstream 
of the intron-insertion site) cloned upstream of a promoterless tetR gene in an AmpR 
pBR322-based vector (Guo et al. 2000; Karberg et al. 2001). pBRR-EcI5 and pBRR3-
EcI5 contain different lengths of the EcI5 insertion site (i.e., ligated 5’- and 3’-exon 
sequences flanking EcI5 in virulence plasmid pO157) cloned in place of the Ll.LtrB 
insertion site in pBRR3-ltrB. The ligated-exon sequences in pBRR-EcI5 extend from 
positions -30 to +5 from the intron-insertion site, and those in pBRR3-EcI5 extend from 
positions -30 to +15. The plasmids were constructed by annealing two 5’-phosphorylated 
oligonucleotides, which contain the EcI5 target sequences and append AatII and EcoRI 




All constructs were sequenced to confirm the expected modifications and lack of 
adventitious mutations in regions subjected to PCR. 
3.7.3 Donor and recipient plasmid libraries 
pACD2-EcI5 donor plasmid libraries used in selection experiments contain 
randomized nucleotide residues at EBS1 positions -7 to -1, EBS2 positions -13 to -7, or 
EBS3 position +1. The EBS1 and EBS2 libraries also contain randomized nucleotide 
residues at the corresponding IBS1 and IBS2 positions in the 5’ exon to provide 
complementary sequences that can base pair with the randomized EBS1 and EBS2 
sequences for RNA splicing. The libraries were constructed by a two-step PCR of 
pACD2-EcI5 with primers that introduce the random nucleotide residues. In the first step, 
two parallel PCRs were done using the following primers: EBS1 library, primers 
EcI5IBS1-N + EcI5BASWT and EcI5EBS1-N + EcI5AVA2AS; EBS2 library, primers 
EcI5IBS2-N + EcI5EBS2-N, and EcI5EBS1WT + EcI5AVA2AS; and EBS3 library, 
primers pACD229s + EcI5 347a and EcI5EBS3N + EcI5AVA2AS (Table 3.2). In the 
second step, the gel-purified PCR products from the first step were used as templates in a 
second PCR with the outside primers (underlined), which append XbaI and AvaII sites. 
The products were digested with XbaI and AvaII and swapped for the corresponding 
fragment of a pACD2-EcI5 intermediate plasmid that contained a stuffer 33-bp 
oligonucleotide inserted between the XbaI and AvaII sites. The use of this intermediate 
eliminates the possibility of library contamination by undigested or self-ligated wild-type 
donor plasmids. 
Recipient plasmid libraries containing random nucleotide residues at different 
target site positions were constructed by PCR using primers that introduce random bases 
at the desired positions and append AatII and EcoRI sites, enabling the segment to be 
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swapped for the corresponding segment of pBRR3-ltrB. Libraries and the primers used to 
construct them were: -35 to -14/+2 to +20 library, EcI5-5’N22 + EcI5-3’N19; IBS1 
library, EcI5 IBS1A + EcI5 IBS1S; IBS2 library, EcI5 IBS2A + EcI5 IBS2S; and IBS3 
library, EcI5 IBS3A + EcI5IBS3S (Table 3.2). 
After construction, the libraries were electroporated into E. coli DH10B or DH5α, 
and the cells were grown overnight at 37oC in LB medium containing chloramphenicol 
(donor plasmid libraries) or ampicillin (recipient plasmid libraries). The complexity of 
the libraries was estimated by plating the transformed cells on LB agar containing the 
appropriate antibiotic and found to be 106 to 6 x 107. At least 25 colonies from each 
library were analyzed by PCR and sequencing and found to have unique combinations of 
randomized nucleotide residues. 
3.7.4 Intron mobility and selection experiments 
For mobility assays with the full-length EcI5 and Ll.LtrB introns, donor and 
recipient plasmids were co-transformed into E. coli HMS174(DE3), and cells were grown 
overnight at 37oC in LB medium containing ampicillin and chloramphenicol. The cells 
were then diluted 1/100 into fresh LB medium with the same antibiotics, grown at 37oC 
to early log phase (O.D.595 = 0.2-0.3), diluted ten-fold into fresh LB medium, and induced 
with IPTG under conditions specified in the figure legends for individual experiments. To 
detect intron integration by PCR, plasmid DNA was isolated from 5 ml of the induced 
culture by using a QIAprep Spin Miniprep Kit (Qiagen), and the 5’-integration junction 
was amplified by PCR with the primer RECSEQ01R and an intron-specific primer, either 
EcI5MOB01 for EcI5 or LtrBAs2.2 for Ll.LtrB (Table 3.2). For quantitative mobility 
assays using the TetR selection system, serial dilutions of the cells were plated onto LB 
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agar containing tetracycline + ampicillin, or ampicillin alone. Mobility efficiencies were 
determined as the ratio of TetR + AmpR/AmpR colonies (Guo et al. 2000). 
For selection experiments, donor and recipient plasmids or libraries were 
electroporated into HMS174(DE3), and the transformants were allowed to recover by 
growth in 1-ml SOC media for 1 h at 37oC. A small portion of the culture (10 µl) was 
then removed, serially diluted, and plated on LB agar containing chloramphenicol and 
ampicillin to yield unselected clones that were sequenced via colony PCR to determine 
nucleotide frequency biases in the libraries. The remainder of the culture was diluted with 
9-ml of LB medium containing ampicillin, chloramphenicol, and 20 mM glucose, the 
latter being added to decrease leaky expression of the intron from the T7lac promoter. 
After growing overnight at 37oC, the cells were harvested by centrifugation, washed with 
LB medium without glucose, and resuspended in 10 ml of fresh LB medium without 
glucose. In the experiment of Figure 3.3, a 5-ml portion of the culture was inoculated into 
20 ml of LB medium containing 100 µM IPTG and induced for 1 h at 37oC, while in the 
experiments of Figures 3.4 to 3.6, a 7-ml portion of the culture was inoculated into 30 ml 
of LB medium and incubated for 1 h at 37oC. After the incubations, the cultures were 
placed on ice for 5 min, and the cells were then harvested by centrifugation, washed 
twice by centrifugation in ice-cold LB medium if necessary to remove IPTG, and 
resuspended in 1.5-ml ice-cold LB medium. Finally, the cells were serially diluted, plated 
on LB agar containing ampicillin, chloramphenicol, and tetracycline, and incubated 
overnight at 37oC. 
Plasmids containing integrated introns from the selected colonies were either 
isolated using a QIAprep Spin Miniprep kit and sequenced (Figure 3.3) or analyzed by 
colony PCR and sequencing (Figures 3.4 to 3.6). Colony PCR was done as described 
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(Costa and Weiner 2003) with Taq polymerase (0.05 units/µl; New England Biolabs) and 
0.4 µM primers in reaction medium containing 20 mM Tris-HCl, pH 8.4, 50 mM KCl, 
2.5 mM MgCl2, and 200 µM dNTPs. Reactions were incubated at 94°C for 5 min, 
followed by 30 cycles of 94°C for 30 sec, 55°C for 30 sec, 72°C for 1 min, and a final 
extension for 10 min at 72°C. 
The nucleotide frequency at each of the randomized positions in the selected 
introns and target sites was corrected for biases in the initial pool by calculating the ratio 
pn
R of the frequency of each of the four nucleotides n at that position p in the selected 





























RN is the normalized ratio. For a given nucleotide residue, a normalized ratio of 
0.25 (or 25%) indicates no preference at that position, while larger values indicate 
selection for the nucleotide residue, and smaller values indicate selection against the 
nucleotide residue. The normalized frequencies were used to generate a sample set of 100 
active target sites and displayed in “WebLogo” format (Crooks et al. 2004). 
3.7.5 Retargeting EcI5 to insert into different sites 
Retargeted EcI5-ΔORF introns were constructed in and expressed from donor 
plasmids pACD3-EcI5A, C, G, or T, with the choice of donor plasmid dictated by the 
EBS3 nucleotide residue complementary to the IBS3 nucleotide residue in the DNA 
target site. The intron was retargeted by a two-step PCR, using the wild-type donor 
plasmid as template with three unique primers (P1, P2, and P3) and one fixed primer 
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(P4). P1 corresponds to 5’-exon positions -30 to -14, with modifications at positions -13 
to-1 to make IBS1 and IBS2 in the donor plasmid complementary to the retargeted EBS1 
and EBS2 for efficient RNA splicing; P2 is complementary to intron positions +238 to 
+296 with modifications at position +253 to +257 to make EBS2 complementary to IBS2 
in the DNA target site; P3 corresponds to intron positions +277 to +336, with 
modifications at positions +316 to +320 (5 bp) or +321 (6 bp) to make the EBS1 
complementary to IBS1 in the DNA target site; P4 is a fixed primer complementary to 
intron positions +473 to +505. First, overlapping segments of the donor plasmid were 
amplified by two parallel PCRs, one using primers P1 and P2, and the other using 
primers P3 and P4. Then, the gel-purified PCR products from the first PCR step were 
mixed and amplified with the outside primers P1 and P4 to generate a 549-bp PCR 
product containing sequences corresponding to the 5’ exon and 5’ end of the intron 
(nucleotide positions E1 -30 to intron +505). The final PCR product was purified in a 
0.8% agarose gel, digested with XbaI and AvaII, and swapped for the corresponding 
fragment of the donor plasmid. 
For lacZ gene targeting, the donor plasmid containing the retargeted intron was 
electroporated into E. coli HMS174(DE3). After recovery by growth in 1-ml of SOC 
media for 1 h at 37oC, the cells were diluted with 4 ml of LB medium containing 
chloramphenicol (25 µg/ml) for pACD3-EcI5 or tetracycline (15 µg/ml) for pBL1-EcI5 
and grown overnight at 37oC. A 50-µl portion of the overnight culture was then 
inoculated into 5 ml of fresh LB medium containing the same antibiotic and grown to 
early log phase (O.D.600 = 0.2-0.3). For induction, 200 µl of the early log-phase culture 
was inoculated into 5 ml of LB medium containing 100 µM IPTG (for pACD3-based 
donor plasmids) or 4 mM m-toluic acid (for pBL1-based donor plasmids) and incubated 
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at 37oC for 3 h. The cells were then washed with fresh LB medium and plated on LB agar 
containing X-gal (40 mg/l). The lacZ targeting frequency was determined by counting 
blue and white colonies. 
3.7.6 Southern hybridization 
Southern hybridizations were as described (Perutka et al. 2004), using DNA 
isolated from colonies grown up in LB medium with a Qiagen Genomic DNA Isolation 
Kit (Qiagen). The blots were hybridized with a 32P-labeled probe corresponding to intron 
positions 362-739. The probe was generated by PCR of pACD2-EcI5 using primers 
Ec501s and Ec5T7-AS (Table 3.2), followed by labeling with a High Prime DNA 













Figure 3.1: EcI5 intron donor and recipient plasmids used in intron mobility assays. 
(A) pACD2-EcI5 expresses the EcI5-ΔORF intron and flanking exons, with a 
phage T7 promoter (PT7; arrowhead in intron) inserted in DIV, and the IEP expressed 
from a position downstream of the 3’ exon. SD is the Shine-Dalgarno sequence for the 
intron ORF. (B) pBRR3-EcI5 contains an EcI5 target site (ligated E1 and E2 sequences) 
cloned upstream of a promoterless tetR gene. Donor plasmids are derivatives of 
pACYC184 and carry a camR marker, while the recipient plasmid is a derivative of 
pBR322 and carries an ampR marker. T1 and T2 are E. coli rrnB transcription 
terminators. T1 terminates both E. coli and phage T7 RNA polymerase, while T2 
terminates E. coli but not phage T7 RNA polymerase. Tφ is a phage T7 transcription 
























Figure 3.2: Mobility assays for wild-type and mutant EcI5 introns. 
(A) Donor plasmids (pACD2X for Ll.LtrB and pACD2-EcI5 or derivatives 
expressing mutant IEPs for EcI5) and recipient plasmids (pBRR3-ltrB for Ll.LtrB and 
pBRR3-EcI5 for EcI5) were transformed into E. coli HMS174(DE3). The cells were 
grown at 37oC to early log phase and incubated with 0 or 100 µM IPTG for 1 h. The 
introns carry a phage T7 promoter in DIV and integrate into a target site cloned in the 
recipient plasmid upstream of a promoterless tetR gene, thereby activating that gene (see 
Figure 3.1 and Methods). After induction, cells were plated on LB agar containing 
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ampicillin or ampicillin plus tetracycline, and mobility efficiencies were calculated as the 
ratio of (TetR + AmpR)/AmpR colonies. The bar graphs show the mean for three 
determinations, with the error bar indicating the standard deviation. (B) Cell viability 
after over-expression of the EcI5-ΔORF intron. E. coli HMS174(DE3) cells from the 
mobility assays of panel A were serially diluted after induction and plated on LB medium 
without antibiotics. (C) E. coli HMS174(DE3) with or without the indicated donor and 
recipient plasmids was grown to early log phase at 37° in LB medium containing the 
appropriate antibiotics, then induced with 100 µM IPTG for 1 h at 37°C. After induction, 
the cells were serially diluted and plated on LB medium without antibiotics. The bar 
graphs show the mean for at least three determinations, except for D/GFP (pAC-GFP; 
two determinations). The error bars indicate the standard deviation. Abbreviations: 
D/EcI5, donor plasmid pACD2-EcI5; D/Ll.LtrB, donor plasmid pACD2X; R/EcI5, 
recipient plasmid pBRR3-EcI5; R/Ll.LtrB, recipient plasmid pBRR3-ltrB; D/GFP, pAC-
GFP, a derivative of pACDX that expresses GFP instead of the Ll.LtrB-ΔORF intron and 












Figure 3.3: Identification of critical nucleotide residues in the distal 5’- and 3’-exon 
regions of the EcI5 DNA target site.  
E. coli HMS174(DE3) containing the wild-type intron-donor plasmid pACD2-
EcI5 and a recipient plasmid library with random nucleotide residues at positions -35 to -
14 and +2 to +20 from the intron-insertion site was grown at 37oC to early-log phase and 
induced with 100 µM IPTG for 1 h. The cells were then plated on LB agar containing 
tetracycline and ampicillin to select those in which the EcI5-ΔORF intron carrying a 
phage T7 promoter integrated into functional target sequences upstream of the 
promoterless tetR gene in the recipient plasmid. The targeted plasmids were isolated and 
sequenced using primer ForpBRR for the 5’ integration junction and Rev2pBRR for the 
3’-integration junction. The top shows the EcI5 DNA target sequence from positions -35 
to +20 and its predicted EBS2/IBS2, EBS1/IBS1, and EBS3/IBS3 base-pairing 
interactions. The arrow indicates the intron-insertion site. The WebLogo representation 
(Crooks et al. 2004) depicts nucleotide frequencies at each randomized position in 101 
selected target sites, corrected for biases in the initial pool based on sequences of 108 
unselected recipient plasmids, as described in Methods. Nucleotide frequencies (percent) 
at each position in the selected and unselected plasmids are summarized below. In some 
cases, percentage totals do not equal 100 due to rounding off. This experiment was done 
by Michael Karberg. 
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Figure 3.4: Analysis of EcI5 DNA target site EBS1/IBS1 base-pairing interactions by in 
vivo selection. 
A selection experiment was done using a pBRR3-EcI5-based recipient-plasmid 
library with random nucleotide residues at DNA target site positions -7 to -1, and a 
pACD2-EcI5 based donor-plasmid library with random nucleotide residues at the 
corresponding positions in the EBS1 stem-loop. The IBS1 positions in the 5’-exon of the 
donor plasmid were also randomized to provide complementary nucleotide combinations 
for RNA splicing. The selection was done as in Figure 3.3, except that IPTG induction of 
the donor plasmid library, which decreased cell viability, was replaced with a 1-h 
incubation at 37oC in the absence of IPTG. After plating the cells on LB agar containing 
tetracycline, ampicillin, and chloramphenicol, colonies containing recipient plasmids 
with integrated introns were picked, and the region from 5’-exon position -210 to intron 
position +505 was amplified by colony PCR using primers ForpBRR and EcI5AVA2AS 
and sequenced using primer Rseq (see Table 3.2). (A) Predicted EBS1/IBS1 base-pairing 
interactions between the intron RNA and the top strand of the DNA target site. The 
nucleotide residues randomized in the selection are highlighted in gray. The arrow 
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indicates the intron-insertion site. (B) WebLogo representation of nucleotide frequencies 
at randomized positions in 87 selected integration events, corrected for biases in the 
initial pools based on sequences of 94 unselected donor and 95 recipient plasmids from 
the initial pools. Nucleotide frequencies (percent) at each position in the selected and 
unselected plasmids are summarized below. In some cases, percentage totals do not equal 
100 due to rounding off. (C) Percentage of base pairs at each EBS1/IBS1 position in 87 
selected integration events (black bars) and 94 randomly paired donor and recipient 
plasmids from the initial pools (white bars). (D) Percentage of introns that have different 
numbers of EBS/IBS1 base pairs with the target site in 87 selected integration events 
(black bars) and 94 randomly paired donor and recipient plasmids from the initial pools 
(white bars). In (C) and (D), both Watson-Crick and wobble U•G and G•T pairs are 









Figure 3.5: Analysis of EcI5 DNA target site EBS2/IBS2 base-pairing interactions by in 
vivo selection. 
A selection experiment was done as in Figure 3.4, using a pBRR3-EcI5-based 
recipient plasmid library with random nucleotide residues at DNA target site positions -
13 to -7, and a pACD2-based donor plasmid library with random nucleotide residues at 
the corresponding positions in the EBS2 loop. The IBS2 positions in the 5’-exon of the 
donor plasmid were also randomized to provide complementary nucleotide combinations 
for RNA splicing. Colonies were selected and plasmid sequences determined via colony 
PCR, as described in Figure 3.4. (A) Predicted EBS2/IBS2 base-pairing interactions 
between the intron RNA and the top strand of the DNA target site. The nucleotide 
residues randomized in the selection are highlighted in gray. The arrow indicates the 
intron-insertion site. (B) WebLogo representation of nucleotide frequencies at 
randomized positions in 102 selected integration events, corrected for biases in the initial 
pools based on sequences of 99 unselected donor plasmids and 103 unselected recipient 
plasmids. Nucleotide frequencies (percent) at each position in the selected and unselected 
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plasmids are summarized below. In some cases, percentage totals do not equal 100 due to 
rounding off. (C) Percentage of base pairs at each EBS2/IBS2 position in 102 selected 
integration events (black bars) and 99 randomly paired donor and recipient plasmids from 
the initial pools (white bars). (D) Percentage of introns that have different numbers of 
EBS2/IBS2 base pairs in 102 selected integration events (black bars) and 99 randomly 
paired donor and recipient plasmids from the initial pools (white bars). In (C) and (D), 















Figure 3.6: Analysis of EcI5 DNA target site EBS3/IBS3 base-pairing interactions by in 
vivo selection. 
A selection experiment was done as in Figure 3.4 with pBRR3-EcI5 randomized 
at IBS3 position +1 and pACD2-EcI5 randomized at EBS3 position +1. After selecting 
colonies containing recipient plasmids with integrated introns, the region extending from 
75-bp upstream of EBS3 to 500-bp downstream of the inserted intron was amplified by 
colony PCR using primers EcI5 279s and Rev2-pBRR and sequenced using primer EcI5 
297s (see Table 3.2). (A) WebLogo representation of nucleotide frequencies in 79 
selected integration events, corrected for biases in the initial pools based on sequences of 
59 unselected donor plasmids, and 59 unselected recipient plasmids. Nucleotide 
frequencies (percent) at the randomized position are summarized below. In some cases, 
percentage totals do not equal 100 due to rounding off. (B) Percentage of introns having 
Watson-Crick or wobble U•G and G•T base pairs at EBS3/IBS3 in the 79 selected 























Figure 3.7: DNA target site sequences and base-pairing interactions for EcI5 introns 
retargeted to insert at different sites in the E. coli lacZ gene. 
The retargeted EcI5 introns (targetrons) are denoted by a number that corresponds 
to the nucleotide position 5’ to the intron-insertion site in the target gene’s coding 
sequence, followed by “a” or “s” indicating antisense or sense-strand, respectively. DNA 
target sequences in the lacZ gene are shown from positions -26 to +10 from the intron-
insertion site, with nucleotide residues that match those in the wild-type (WT) EcI5 target 
site highlighted in gray. The arrow indicates the intron-insertion site. Log-odds scores 
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determined using the computer algorithm described in the text are indicated to the right, 
along with the targeting frequency determined by plating on LB agar containing X-gal 
and counting blue and white colonies. Targeting frequencies were determined for 
targetrons having 5 or 6 bp EBS1/IBS1 interactions. The values are the mean ± the 



















Figure 3.8: Retargeting of EcI5 to insert into different sites in the E. coli lacZ gene. 
E. coli HMS174(DE3) was transformed with pACD3-EcI5 expressing the 
retargeted introns, grown at 37oC to early-log phase, and induced with 100 µM IPTG for 
3 h unless noted otherwise. The cells were then plated on LB agar containing X-gal (40 
mg/l), and the lacZ targeting frequency (Figure 3.7) was determined by counting blue and 
white colonies. (A) Two-step PCR used to retarget the EcI5-ΔORF intron by modification 
of EBS and IBS sequences in the donor plasmid. The donor plasmid used as template was 
pACD3-EcI5A, C, G, or T according to the desired EBS3 nucleotide residue. P1-P4 are 
primers used to modify the intron’s EBS1 and 2 to be complementary to IBS1 and 2 in 
the DNA target site, and IBS1 and 2 in the 5’ exon of the donor plasmid to be 
complementary to the retargeted EBS1 and EBS2 for efficient RNA splicing (see 
Methods). The final PCR product containing the modified sequences was digested with 
XbaI and AvaII and swapped for the corresponding fragment of the same donor plasmid. 
(B) Colony PCR of E. coli lacZ disruptants obtained using retargeted EcI5 introns. 
Colony PCR was done with primers LacZP3 and LacZP4 flanking the intron-insertion 
site in the lacZ gene (see Table 3.2). The figure shows representative data for three of the 
retargeted introns. “- colony” is a parallel PCR without a colony, and WT is a parallel 
PCR done on a colony of wild-type HMS174(DE3). (C) Southern hybridizations. 
Genomic DNA was isolated from E. coli HMS174(DE3) (WT) and the indicated lacZ 
disruptants grown under non-selective conditions. The DNA was digested with BglI, run 
in a 0.8% agarose gel, blotted to a nylon membrane, and hybridized with a 32P-labeled 
intron probe (see Methods). The donor plasmid pACD2-EcI5 digested with BglI was run 
in a parallel lane. The numbers to the left of the gel indicate the positions of size markers 
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(1-kb plus ladder; Invitrogen). The schematics to the right depict the BglI fragments of 
the lacZ gene containing the inserted EcI5 intron. The insertion of targetron LacZ1257s, 
1790a, or 1806s results in a 3.0-kb BglI fragment. The insertion of targetron LacZ163s 
disrupts the BglI sites at position 164, resulting in a larger fragment (4.7 kb). The 
LacZ1709a disruptant shows an additional band due to residual donor plasmid, which 














Table 3.1: Observed base-pair frequencies in selection experiments for the EBS1/IBS1, 
EBS2/IBS2, and EBS3/IBS3 interactions between the EcI5 intron RNA and 
its DNA target site. 
The table shows the percentage of introns having the indicated RNA-DNA base 
pair or mismatches at each position in the EBS1/IBS1, EBS2/IBS2, and EBS3/IBS3 DNA 
target site interactions in the selection experiments of Figures 3.4 to 3.6. The wild-type 
base pair at each position is boxed. Base-pairing interactions between wild-type EcI5 and 
its DNA target site are shown at the top. 
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Table 3.2: DNA oligonucleotides used in Chapter 3. 
DNA oligonucleotides were synthesized by Integrated DNA Technologies. 
91 
 
Chapter 4: Gene targeting in Xenopus laevis via site-specific 
modification of sperm DNA using mobile group II introns 
Mobile group II introns found in bacterial and organelle genomes have been 
developed into highly efficient bacterial gene targeting vectors (“targetrons”) 
(Lambowitz and Zimmerly 2004). The utility of mobile group II introns for gene 
targeting derives from their unique site-specific DNA integration mechanism in which 
the intron RNA reverse splices directly into a DNA strand and is then reverse transcribed 
by its intron-encoded protein (IEP). This process is mediated by a ribonucleoprotein 
particle (RNP) that contains the IEP and the excised intron RNA. Both the IEP and intron 
RNA are involved in DNA target site recognition, with most of the specificity coming 
from base pairing of the intron RNA to the target sequence (Eskes et al. 1997; Guo et al. 
1997; Guo et al. 2000; Singh and Lambowitz 2001). Thus, it is possible to retarget the 
intron to insert into desired DNA sites simply by modifying the base pairing sequences in 
the intron RNA (Guo et al. 2000; Mohr et al. 2000; Perutka et al. 2004; Lambowitz et al. 
2005).  
The Ll.LtrB group II intron has been used as a model system to study group II 
intron mobility and to develop gene targeting applications (Lambowitz and Zimmerly 
2004). The catalytically active intron RNA consists of six conserved domains (DI-VI; 
Figure 4.1A; (Michel and Ferat 1995; Lehmann and Schmidt 2003). The IEP (denoted 
LtrA protein), which is encoded in a large “loop” in DIV, binds specifically to the intron 
RNA to stabilize the catalytically active RNA structure and form RNP particles. The 
RNPs can carry out site-specific DNA integration by reverse splicing. RNPs initiate DNA 
integration by binding to DNA target sites, with the LtrA recognizing a small number of 
bases in the distal 5’-exon region and triggering local DNA melting, enabling intron RNA 
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sequences denoted EBS2, EBS1, and δ to base pair to sequences denoted IBS2, IBS1, and 
δ’ spanning a 13-nt region of the DNA target sites (Figure 4.1B). After base pairing, the 
intron RNA reverse splices into one strand of the DNA, while LtrA cleaves the opposite 
strand a short distance downstream (between position +9 and +10) and uses the cleaved 
3’ end as a primer for reverse transcription of the inserted intron RNA (Cousineau et al. 
1998; Smith et al. 2005). The retargeting of the Ll.LtrB intron into different sites can be 
achieved simply by modifying the EBS2, EBS1, and δ sequences in the intron RNA. Its 
high insertion efficiency and specificity have made it possible to develop the Ll.LtrB 
intron into a highly efficient gene targeting vector (targetron) for use in diverse bacteria 
(Karberg et al. 2001; Perutka et al. 2004; Yao et al. 2006). 
In principle, mobile group II introns can be used for gene targeting in eukaryotes, 
but challenges include getting a sufficiently high concentration of active group II RNPs 
into the nucleus and the chromatin structure of DNA target sites (Mastroianni et al. 
2008). One way to circumvent these problems is to use group II introns for in vitro 
modification of chromosomal DNA in decondensed sperm nuclei, which can then be used 
for in vitro fertilization to obtain transgenic animals. Procedures for generating transgenic 
animals via random modification of sperm DNA are well established in X. laevis (Kroll 
and Amaya 1996; Amaya and Kroll 1999; Sparrow et al. 2000), and analogous 
approaches have been developed for zebrafish (Jesuthasan and Subburaju 2002), mice 
(Perry et al. 1999; Kaneko et al. 2005; Smith and Spadafora 2005), livestock (Rieth et al. 
2000; Kaneko et al. 2005; Smith and Spadafora 2005) and monkeys (Chan et al. 2000b; 
Chan et al. 2000a). 
For X. laevis, the standard sperm transgenesis protocol involves mixing 
permeabilized sperm nuclei with a linear DNA fragment, then partially digesting sperm 
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genome with a restriction enzyme, and injecting the mixture into eggs (Kroll and Amaya 
1996; Amaya and Kroll 1999; Sparrow et al. 2000). The exogenous DNA then inserts 
into the double-strand DNA breaks introduced by the restriction enzyme and integrates 
into chromosomal DNA by host cell DNA repair mechanisms. The procedure is very 
rapid, enabling the generation of hundreds of transgenic embryos per day. With current 
methods, however, the DNA fragment integrates randomly throughout the genome and 
multiple copies of DNA can insert at different locations. Consequently, this technique has 
been limited to gain-of-function experiments. By adding retargeted group II RNPs and 
eliminating the restriction enzyme from the Xenopus transgenesis protocol, it is possible 
to integrate the intron site-specifically rather than randomly into sperm nuclei (Figure 
4.2). By using the targeted sperm nuclei for in vitro fertilization, one can then generate 
site-specific transgenic animals. 
In this chapter, I show that the mobile Lactococcus lactis Ll.LtrB group II intron 
(Ll.LtrB) can site-specifically insert at desired chromosomal sites in Xenopus laevis 
sperm nuclei, and that the resulting modified sperm nuclei can then be used for in vitro 
fertilization to generate genetically modified animals. Because the targeted gene 
modification occurs in a germ line cell prior to fertilization, the resulting embryos and 
animals are not chimeric. These results constitute proof-of-principle that group II introns 
can be used for gene targeting in eukaryotes via sperm DNA modification. 
4.1 SELECTION OF LL.LTRB TARGET SITES IN XENOPUS 
Ll.LtrB intron target sites in X. laevis were chosen by a computer algorithm. First, 
the algorithm scans a gene sequence for the best matches to positions recognized by the 
LtrA. It then designs primers for PCR modification of the EBS1, 2, and δ sequences 
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within the intron RNA to base pair optimally to the DNA target site for efficient intron 
integration (Perutka et al. 2004). 
The required sequence modifications were introduced into an intron expression 
construct, pACD2 or pACD3, which contain a 0.9-kb Ll.LtrB-ΔORF intron and flanking 
exons, cloned behind a phage T7 promoter. Another T7 promoter was inserted into intron 
DIV in pACD2 but not in pACD3. The targeting efficiency of the modified introns was 
assessed both by an established E. coli mobility assay in vivo (Guo et al. 2000) and by a 
target DNA-primed reverse transcription assay (TPRT assay) in vitro (Saldanha et al. 
1999). For the in vivo assay, the modified pACD2 donor plasmid expressing the 
retargeted intron with a phage T7 promoter in intron DIV was introduced into E. coli 
HMS174(DE3) with an ampicillin-resistant recipient plasmid containing the intron’s 
target site (Guo et al. 2000). The intron target site is located upstream of a promoterless 
tetR gene, and the insertion of intron into the target site activates the expression of that 
gene. Thus the targeting efficiency of modified introns can be determined as the ratio of 
tetracycline-resistant + ampicillin-resistant colonies to ampicillin-resistant colonies. 
For the in vitro TPRT assay, the intron RNA precursor is transcribed directly from 
the linearized pACD3 vector and self-spliced under conditions of high salt and Mg2+ 
concentration (Matsuura et al. 2001). The spliced RNA is then reconstituted with purified 
LtrA protein to form RNPs that promote DNA integration. During the in vitro TPRT 
reaction, plasmids containing the DNA target site are incubated with reconstituted RNPs, 
dNTPs and [32P]-labeled dTTP. The [32P]-labeled dTTP is then incorporated into cDNA 




Several X. laevis genes (28S rRNA, transposable element Tx1, tyr and mitf) were 
chosen. The 28S rRNA gene and Tx1 gene are multiple-copy genes in the X. laevis. 
There are about 200-300 copies of the 28S rRNA gene per genome (Roger et al. 2002) 
and about 150 copies of the Tx1 transposon per genome (Garrett and Carroll 1986). The 
existence of multiple copies in the genome provides a higher chance for intron 
integration. In addition, two single-copy genes, tyr, encoding tyrosinase (Tyr), and mitf, 
encoding microphthalmia-associated transcription factor (Mitf) were chosen (Kumasaka 
et al. 2003; Kumasaka et al. 2004). Tyrosinase is required for melanin production in 
melanocytes, and homozygous mutants are albino in medaka fish (Koga et al. 1995), 
mice (Rinchik et al. 1993), and humans (Oetting and King 1993). Mitf positively 
regulates the transcription of pigmentation-related genes (e.g., tyr, trp1, oa1) in several 
cell lineages, including melanocytes and retinal pigment epithelial cells in mice and 
zebrafish (Lister et al. 1999; Gaggioli et al. 2003). In Xenopus, Mitf is expressed in 
premigratory melanoblasts and retinal pigment epithelium (Kumasaka et al. 2004). Mice 
and frogs have two Mitf isoforms, Mitf-A and Mitf-M, which are produced by alternative 
splicing in the eye and body, respectively. Further, in X. laevis (but not X. tropicalis), the 
mitf gene is duplicated, the two genes being referred to as mitf-α and mitf-β. In mice, a 
dominant negative mitf allele has been shown to down-regulate tyrosinase expression in 
melanocytes (Vachtenheim and Drdova 2004). In Xenopus, expression of a dominant 
negative mitf-α results in failure of differentiation and pigmentation of the eye 
(Kumasaka et al. 2005). The tyr and mitf genes were chosen because they have easily 
visible, localized expression patterns, facilitating detection of intron insertion with GFP 
marker strategies (see section 4.6) (Bronchain et al. 1999) and because homozygous 
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mutants are viable with phenotypes that are readily scorable in embryos by loss of 
pigmentation. 
The DNA target site sequences in the four chosen genes are shown in Figure 4.3. 
For single copy protein coding genes, targetrons were designed to insert specifically into 
tyr exon 2 (targetron Tyr-401a) and mitf-α-M exon 6 (targetron Mitf-α-M-609s). The 
targetrons were validated by the in vivo E. coli plasmid-based mobility assay. The 
mobility frequencies were 86%, 59%, 56% and 65% for the targetron 28S-3205s, Tx1-
2768a, Tyr-401a and Mitf-α-M-609s, respectively. Additionally, the reverse splicing 
activity of each RNP was assessed by in vitro TPRT assay. Figure 4.3C showed that the 
Mitf-α-M-609s, Tyr-401a and Tx1-2768a targetron RNPs can site-specifically reverse 
splice into their own target site and promote target DNA-primed reverse transcription into 
their own target plasmids (similar results were obtained for the 28S-3205s intron in a 
separate in vitro TPRT assay). Both full and partial reverse splicing products were 
detected in the reactions (Saldanha et al. 1999; Mastroianni et al. 2008). Smaller size 
cDNA synthesis products were also detected. No product was detected when the 
retargeted RNPs were incubated with recipient plasmid with a mock target site (data not 
shown), demonstrating the specificity of the retargeted introns. 
4.2 SPERM TARGET DNA-PRIMED REVERSE TRANSCRIPTION (TPRT) ASSAY 
The group II intron-mediated gene targeting method developed for X. laevis is 
based on the current transgenesis protocol. As outlined in Figure 4.2, the sperm nuclei 
were incubated with in vitro reconstituted RNP particles, nucleoplasmin, dNTPs and 
Mg2+ in sperm dilution buffer (SDB) at specific temperatures to allow intron insertion 
into the desired target sites in the sperm genome. The sperm nuclei used in the reaction 
were permeabilized with lysolecithin and the chromatin structure was decondensed 
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during the reaction using purified recombinant nucleoplasmin (Banuelos et al. 2003). 
These treatments enable RNPs to enter the sperm nuclei and access the DNA target sites. 
The intron integration can be checked right after the sperm reaction. This is important as 
numerous factors need to be tested to optimize the intron targeting conditions. Although 
the same thing can be done with oocytes, the collection of oocytes is very laborious 
compared to sperm. The amount of sperm that can be collected from a male frog is 
thousands of times more than that of oocytes collected from a female one. 
To check the targeting efficiency, the sperm reaction was terminated by heating at 
75oC for 10 min. If intron-mediated integration occurs at the chosen target site, cDNA 
synthesis initiates in the presence of dNTPs after the intron reverse splicing. The newly 
synthesized cDNA joined with the bottom strand of intron 3’-exon can be detected by 
PCR. However, the cDNA and intron 5’-exon junction does not exist in sperm reactions 
either because of incomplete cDNA synthesis or the lack of DNA repair enzymes in 
sperm (Derijck et al. 2006). 
To detect the intron 3’-integration junction, a sense strand primer annealing near 
the 3’ end of Ll.LtrB and an antisense strand primer annealing to the target gene sequence 
located downstream of the intron-insertion site were used for PCR. The PCR 
amplification of the 3’-integration junction was found to be improved by treating the 
reacted sperm DNA with RNase H, which implies the existence of an intron RNA and 
cDNA hybrid after the sperm reaction. The removal of the intron RNA strand by RNase 
H facilitates the PCR amplification. To determine the intron targeting efficiency in the 
sperm reaction, the same PCR was applied to the serially diluted sperm reaction DNA. 
The targeting efficiency was also verified by real-time PCR. For the intron targeting in 
Tx1, mitf and tyr gene, the 3’-integration junction was detected in as few as 50, 500 and 
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301 sperm nuclei respectively (Figure 4.4 and 4.7, targeting efficiency for tyr gene is not 
shown here). I will refer to the sperm reaction followed by PCR analysis as the sperm 
TPRT assay in this chapter. 
During the initial experiments, sperm TPRT reactions were focused on getting 
high intron targeting efficiency. The sperm nuclei were treated at relatively high 
temperature (33oC or above) compared to the frog’s optimal living temperature (18oC), 
long reaction time (30 min), and extensive chromatin decondensation by nucleoplasmin. 
It is known that the exposure of sperm nuclei to high temperature can reduce their 
fertility, change sperm morphology, and alter chromatin packing (Banks et al. 2005). In 
transgenesis experiments done in our laboratory, extensive chromatin decondensation 
was found to have similar effects. Thus, it is critical to establish sperm reaction 
conditions that allow efficient intron integration without damaging the sperm nuclei. 
4.2.1 The targetron integration efficiency is proportional to the amount of RNPs 
used in the sperm reaction 
The targetron Tx1-2768a RNP was found to successfully target the Tx1 
transposon in sperm nuclei. As shown in Figure 4.4B, Tx1-2768a intron integration 
efficiency was checked with 1, 5 and 10 µl of Tx1-2768a RNP (1.8 mg/ml lariat RNA 
based on O.D.260). No targeted product was detected in the reaction using 1 µl of Tx1-
27678a RNP (lane 1 and 5). The targeted product was only present in the reactions with 5 
or 10 µl of RNP (lane 2, 3, 6 and 7). Furthermore the band intensity of PCR product was 
proportional to the amount of RNPs used the reaction. A negative control with 10 µl of 
heat-inactivated RNPs did not yield the same targeted product (lane 4 and 8), confirming 
that the detected products resulted from the activity of the RNPs. In summary, the active 
RNP is required for the intron integration into the target site in sperm nuclei and the 
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integration efficiency is proportional to the amount of active RNPs used in the sperm 
TPRT reaction.  
Two nucleoplasmin protein concentrations (4.7 and 23.7 µM) were tested in the 
Tx1-2768a intron sperm TPRT reaction (Figure 4.4B). Surprisingly, no significant 
difference was observed between the two concentrations. This result implies that for the 
Tx1-2768a targetron, the amount of nucleoplasmin required for maximally efficient 
intron integration might be 4.7 µM or less. It also demonstrated that excess 
nucleoplasmin did not increase the intron targeting efficiency. More detailed optimization 
of nucleoplasmin in the sperm TPRT reaction will be discussed in the section 4.2.3.  
In Figure 4.4B lane 9, 1 µl of RNPs was incubated with extracted sperm genomic 
DNA in the absence of nucleoplasmin. Surprisingly, the targeted product was detected 
with the extracted genomic DNA, but not with sperm nuclei plus nucleoplasmin (lane 1 
and 5). This finding confirms that chromatin structure is one of the obstacles for group II 
intron targeting in eukaryotes. The same conclusion was reached in X. laevis oocyte 
targeting experiments (Mastroianni et al. 2008). 
Next, the Tx1-2768a intron targeting efficiency was determined by the same PCR 
method using the serially diluted sperm TPRT reaction DNA. During the preparation of 
sperm nuclei, the amount of sperm nuclei per µl was determined by counting Hoechst 
stained sperm nuclei on a hemacytometer (Smith et al. 2006). The number of sperm 
nuclei used in sperm TPRT reaction was known (within the range of 4~8×105 per 
reaction). For the Tx1-2768a RNP, the targeted product can be detected as few as 54 
sperm nuclei (Figure 4.4B). No targeted product was detected in the PCR negative 
controls, distilled water. The products indicated by the arrow corresponding to the 
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targeted 3’-integration junction were confirmed by sequencing (Figure 4.4C). All other 
bands were PCR primer dimers or PCR artifacts. 
As shown in Figure 4.4D, the Tx1-2768a intron integration efficiency was later 
confirmed by real-time PCR. Two sets of primers were designed to specifically amplify 
the 3’-intron integration junction of the Tx1-2768a targetron (Target) and the single copy 
mitf gene, as a measure of the number of sperm nuclei. The intron targeting efficiency is 
equal to the ratio of “Target” copy number to the “mitf” gene copy number. Figure 4.4D 
showed the Ct values of “Target” and “mitf” from two different amount sperm TPRT 
reaction DNA. The ΔCt =CtTarget-Ctmitf represents the fold of “Mitf” copies over “Target” 
copies in the sperm TPRT reaction. The targeting efficiency was determined by the 
equation shown in Figure 4.4D. The targeting efficiency based on the real-time PCR is 
12.2%, which is higher than that determined by the dilution experiments in Figure 4.4B. 
The difference could be due to higher sensitivity of real-time PCR than direct PCR. 
In summary, the intron integration in sperm requires active RNP, and higher 
integration efficiency can be obtained by adding more RNPs to the reaction. Recently 
improved methods have made it possible to obtain RNP concentrations of almost 10 
mg/ml based on the RNA absorbance at O.D.260. It has not yet been tested how very high 
concentrations of RNPs in the reaction affect the intron targeting efficiency. 
4.2.2 The targetron integration efficiency is dependent upon temperature in the 
sperm reaction 
The Ll.LtrB intron can reverse splice efficiently at the growth temperature of its 
natural host, L. lactis (30oC) and the well-studied host, E. coli (37oC). However the 
optimal living temperature for the X. laevis is between 18oC and 23oC (Sive et al. 2000). 
Incubating X. laevis sperm nuclei at higher temperatures can damage the integrity of 
sperm DNA and cause failure in fertilization or embryo development (Paul et al. 2008). 
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Therefore, it is important to optimize the sperm reaction temperature to allow efficient 
intron targeting without impairing in vitro fertilization and the embryo development. 
First, sperm TPRT of the Tx1-2768a targetron was assayed at different 
temperatures. Earlier transgenesis experiments showed that incubating sperm nuclei 
above 33oC dramatically decreased the fertilization efficiency (data not shown). 
Therefore, the temperature optimization experiments were focused on temperatures 
ranging from 25oC to 33oC. As shown in Figure 4.5, the Tx1-2768a intron targeted 
product can be detected at all of the above temperatures, but not in the DNA from sperm 
nuclei that had not been treated with the targetron or incubated with heat inactivated 
RNPs. It was unexpected to detect the targeted product at 25oC. This result indicates that 
the RNPs can reverse splice into sperm DNA at suboptimal temperature. By checking the 
integrated product in diluted sperm reaction DNA, it was found that the Tx1-2768a intron 
targeting efficiency at 25oC was 10 times less than that at 30oC (data not shown). 
A similar temperature optimization experiment was done with Mitf-α-M-609s 
targetron RNPs for several reasons. First, the Tx1 gene is a multiple copy gene. The 
targeting efficiency cannot be accurately determined by PCR analysis of extracted sperm 
DNA. It could not differentiate between targeting 10 copies of Tx1 gene in one sperm 
from targeting 1 copy of the Tx1 gene in 10 sperm nuclei. However experiments with 
single copy genes do not have this problem. Second, the temperature for targeting 
multiple copy genes may not be the same for single copy genes. Based on the results 
from Tx1-2768a RNPs, sperm TPRT of the Mitf-α-M-609s targetron was tested at 
temperatures of 25, 27, 29, 31 and 33oC (Figure 4.5). Perhaps due to the lower number of 
target sites in the genome, the intron targeted product can only be detected through nested 
PCR. No targeted product was detected at temperature of 25 or 27oC. The targeted 
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product can only be detected at temperatures of 29oC or above. The efficiency of 
targeting at 33oC (1 in 126 sperm nuclei) is almost 10-fold that at 29oC (1 in 1257 sperm 
nuclei). Compared to the Tx1-2768a intron, lowering the reaction temperature has a more 
dramatic effect in decreasing the target efficiency for the Mitf-α-M-609s targetron. 
The above experiments assessing intron integration efficiency at different 
temperatures helped me determine the optimal temperature for different RNPs in 
transgenesis. For the Tx1-2768a intron, the intron targeting efficiency at 25oC was 10 
times lower than that at 30oC. Based on transgenesis experiments of fertilizing untreated 
sperm nuclei with eggs, the percentage of healthy embryos at 25oC was twice that at 
30oC. Balancing both considerations, an incubation temperature of 30oC may be best for 
obtaining the largest number of transgenic animals. 
The results in this section showed that Ll.LtrB intron integration in sperm nuclei 
is a temperature-dependent reaction. Within the permissible temperature range, higher 
temperature results in higher integration efficiency. However, to minimize the damage to 
sperm nuclei, incubating the sperm TPRT reaction around 30oC to 33oC is acceptable to 
ensure the efficiency of intron targeting yet mild enough for transgenesis purposes. It is 
critical to balance between high targeting efficiency and maintaining the integrity of 
sperm nuclei for transgenesis. 
4.2.3 Nucleoplasmin in the sperm reaction 
In group II intron-based X. laevis transgenesis, the recombinant nucleoplasmin is 
used to decondense sperm nuclei chromatin structure instead of X. laevis egg extract used 
in the standard transgenesis protocol (Smith et al. 2006). Nucleoplasmin is a nuclear 
protein that mediates the correct association of DNA with histones. During fertilization, 
nucleoplasmin can remodel the highly condensed paternal chromatin by replacing sperm 
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basic protein with histones. Each monomer of this pentameric protein consists of two 
domains: the core and the C-terminal tail. The core domain is responsible for 
nucleoplasmin oligomerization and confers extremely high stability to the protein (the 
denaturing temperature of the recombinant core domain at neutral pH is 120oC). The 
activity of nucleoplasmin is modulated by phosphorylation (Cotten et al. 1986; Leno et 
al. 1996). The recombinant core can be activated through mutations that mimic 
phosphorylation. Such a mutant Core8D nucleoplasmin was found to dramatically 
decondense sperm chromatin structure at 32 µM and 64 µM (Banuelos et al. 2003). 
The strong decondensation activity and extreme stability of nucleoplasmin makes 
it very attractive for transgenesis applications. First, it is a protein naturally involved in 
sperm chromatin remodeling. Therefore, it is not toxic to the sperm or embryos. Second, 
its extreme stability facilitates protein purification. By contrast, the decondensation 
activity of egg extract can vary from batch to batch due to egg quality and/or preparation 
procedures. The storage time of egg extract is also not as long as that of nucleoplasmin. 
Third, for the sperm TPRT optimization, the degree of sperm nuclei decondensation can 
be controlled by the amount of nucleoplasmin in the reaction, while such control is more 
difficult to achieve with egg extracts. Last, the purified nucleoplasmin is cleaner than egg 
extracts in terms of nucleases, which can inactivate the RNP by degrading the intron 
RNA. 
Tx1-2768a intron sperm TPRT experiments followed by real-time PCR analysis 
showed that using 0.63 µM and 1.26 µM of nucleoplasmin in the reaction gave 23% and 
16% intron integration efficiency, respectively (data not shown), suggesting that higher 
concentrations of nucleoplasmin can inhibit intron targeting. Similar inhibition was 
observed in the Mitf-α-M-609s intron targeting (data not shown). It is possible that 
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excess nucleoplasmin disassembles the RNP particles by binding to the nucleic acid in 
the RNP. Thus, for a specific intron, the optimal amount of nucleoplasmin used in the 
reaction needs to be determined. Too much nucleoplasmin may not only inhibit the RNP 
activity, but also lead to excessive decondensation that is detrimental to the sperm. 
Nevertheless, sufficient nucleoplasmin is needed to enable efficient intron integration.  
4.3 TRANSGENIC TADPOLES WITH TX1 INTRON INTEGRATION 
In situ hybridization experiments have shown the Tx1 element is distributed over 
all chromosome arms within the X. laevis genome (Garrett and Carroll 1986). The 
abundance of Tx1 gene throughout the genome increases the chance of intron integration. 
To obtain embryos containing targeted Tx1 integrations, a sperm TPRT reaction 
was done by incubating 10 µl of Tx1-2678a targetron RNPs (1.8 mg/ml lariat RNA based 
on O.D.260) with 4.7 µM nucleoplasmin and sperm nuclei at 30oC for 15 min. After the 
reaction, the reaction mixture was diluted 30 times using sperm dilution buffer (SDB) and 
injected into freshly prepared X. laevis eggs. In one experiment, 2,200 eggs were injected 
and 48 viable embryos were obtained. Sixteen out of the 48 embryos developed into 
healthy tadpoles, which were subjected to tail-clipping for PCR analysis as shown in 
Figure 4.6A. The remaining 32 embryos were not healthy and were frozen after stage 22 
(Nieuwkoop 1994) for the genomic DNA extraction. Three of these embryos were found 
to have the expected 3’ junction for site-specific integration of the Tx1-2768a targetron 
(Figure 4.6B). 
Further inverse PCR analysis showed that each of the three tadpoles contained a 
5’-truncated intron inserted into a Tx1 target site. The 5’ ends of truncated introns in 
tadpoles were indicated in the Ll.LtrB RNA secondary structure (Figure 4.10). The 5’ 
termini of tadpole B34 and 93 are present in a single-strand loop region and the 5’ 
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terminus of the tadpole 80 is located near a single-strand loop. This suggests that the 5’ 
truncations could result from incomplete cDNA synthesis due to the nicked or degraded 
intron. It could also be due to the dissociation of RT in loop regions prior to regions of 
stable RNA secondary structure. Another possibility is the 5’ truncations are due to 
degradation of the cDNA by enzymes involved in strand resection at a double-strand 
break that occurs during intron integration. However, from the inverse PCR, the 
sequences upstream of integrated introns were not the expected Tx1 gene but some 
unknown sequences (Figure 4.6B). It is possible that the 5’ exon was resected during 
ligation and repair. The unknown sequences could be unsequenced intron regions in X. 
laevis genome. 
A second transgenesis experiment using the Tx1-2768a intron showed the 
successful integration of full-length Ll.LtrB intron into X. laevis genome. In this 
experiment, the sperm TPRT reaction was done by incubating 10 µl of RNP 
(approximately 3 mg/ml lariat RNA based on O.D.260) with 4.7 µM nucleoplasmin and 
sperm nuclei at 33oC for 15 min. After the incubation, the reaction mixture was diluted 30 
times with SDB buffer and injected into 1,500 freshly prepared eggs. After two hour 
incubation at room temperature, 399 embryos reached the normal 4-cell stage and were 
sorted into fresh incubation buffer, as described in Methods. After overnight incubation, 
only 3 embryos were healthy at the gastrulation stage possibly due to the poor egg quality 
since a high proportion of control eggs injected with untreated sperm nuclei also failed to 
develop normally. Although the embryos were not healthy, they continued growing to 
hatching. Eventually, 40 embryos developed for at least 76 h post-fertilization. DNA was 
extracted from the individual embryo for PCR analysis. As shown in Figure 4.6C, the 
embryo 28 was found to have both the expected 5’- and 3’-intron integration junction 
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within the Tx1 gene. In a negative control, genomic DNA from an untreated tadpole did 
not give the same PCR bands. The identities of PCR bands corresponding to the 5’- and 
3’- integration junctions were further confirmed by sequencing (Figure 4.6C). 
The above transgenesis experiments demonstrated that the Ll.LtrB intron can 
integrate site-specifically into a desired target site in a eukaryotic genome. The results 
proves that: (i) sperm nuclei containing targeted group II intron modifications can 
fertilize eggs and develop into healthy tadpoles with the site-specific modification in 
sperm; (ii) transgenic frogs with a disrupted Tx1 gene are viable until the tadpole stage; 
(iii) both full-length or 5’-truncated introns can be integrated into the Tx1 gene. 
4.4 SPERM TPRT REACTIONS FOR SINGLE COPY PROTEIN CODING GENES (TYR AND 
MITF) 
The Tyr-401a targetron is designed to target exon 2 of the tyr gene in X. laevis. 
An in vitro sperm TPRT reaction for targetron Tyr-401a is shown in Figure 4.7A. In this 
reaction, I used 10 mM Mg2+, 5 µM nucleoplasmin, 4 µl of sperm nuclei and 13.4 µl of 
RNP (2 mg/ml lariat RNA based on O.D.260). The reaction mixture was incubated at 33oC 
for 10 min. dNTPs were then added to 0.2 mM and the reaction continued for another 20 
min at 33oC. The reaction was stopped by heating at 75oC for 10 min. The total DNA 
from sperm TPRT reaction was extracted and analyzed by PCR. Due to lower targeting 
efficiency in single copy genes, a nested PCR was required for efficient detection of the 
targeted integration. Figure 4.7A shows detection of the 3’ junction of the integrated 
intron into the tyr gene target site. No targeted product was present in a parallel sperm 
TPRT reaction using the same amount of heat inactivated Tyr-401a RNP, which 
demonstrated that the targeted product arose from Tyr-401a intron reverse splicing 
activity. The other bands in the figures are unspecific PCR products and verified by the 
sequencing analysis. Further PCR analysis using serial diluted sperm DNA from the 
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reaction revealed that the targeting efficiency of Tyr-401a targetron was 1 in 301 sperm 
nuclei (0.3%, data not shown). 
The Mitf-α-M-609s targetron is designed to target exon 6 of the mitf gene in X. 
laevis. An in vitro sperm TPRT reaction for targetron Mitf-α-M-609s is shown in Figure 
4.7B. Targeting with Mitf-α-M-609s was achieved by incubating 14 µl of RNPs (1.5 
mg/ml lariat RNA based on O.D.260) with 10 mM Mg2+, 4 µl of sperm nuclei, 2.2 µM of 
nucleoplasmin at 30oC for 5 min. dNTPs were then added to 0.2 mM, and the reaction 
was continued for another 10 min. The sperm TPRT reaction was then stopped by heat 
inactivation. The total nucleic acid was extracted and the 3’-integration junction was 
detected by nested PCR as shown in Figure 4.7B. After serially diluting the sperm TPRT 
DNA, the targeted product of the Mitf-α-M-609s intron was detected in 508 sperm nuclei 
(0.2% integration efficiency). The PCR product, indicated by arrow, is the expected 
junction product. Other bands were checked by sequencing and confirmed to be 
unspecific PCR products. The same intron targeting efficiency was subsequently 
confirmed by real-time PCR (data not shown). 
4.5 STUDY OF LINEAR GROUP II INTRON LL.LTRB 
Like spliceosomal introns, most group II introns splice via two sequential 
transesterification reactions that result in the formation of an intron lariat RNA (Pyle and 
Lambowitz 2006). For mobile group II introns, the splicing reactions are assisted by the 
intron-encoded RT, which binds specifically to the intron RNA to stabilize the 
catalytically active RNA structure and then remains bound to the excised intron lariat 
RNA in RNPs that promote intron mobility (Saldanha et al. 1999; Matsuura et al. 2001). 
Some group II introns differ in using a variation of the splicing mechanism in 
which cleavage at the 5’-splice site occurs by hydrolysis rather than branch-point 
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formation, leading to the production of linear rather than lariat intron RNA. Such 
“hydrolytic splicing” was first observed in group II intron self-splicing reactions under 
non-physiological conditions (i.e., high salt and/or Mg2+ concentrations) (Van Der Veen 
et al. 1987; Jarrell et al. 1988; Daniels et al. 1996) and shown to occur in vivo by using 
branch-point mutants of the yeast mt group II intron aI5γ intron (Podar et al. 1998). Some 
naturally occurring group II introns lack a bulged branch-point nucleotide in domain VI, 
and at least one of these, a plant chloroplast trnV group II intron, splices in vivo by a 
mechanism that produces linear RNA without detectable amounts of lariat RNA (Vogel 
and Borner 2002). In addition to hydrolytic splicing, linear group II intron RNA can also 
be generated from excised lariat RNAs by the action of debranching enzyme, which is 
used in eukaryotes for the debranching and turnover of excised spliceosomal introns 
(Green 1986). 
Linear group II intron RNAs cannot carry out both steps of reverse splicing and 
were thus thought to be immobile. However, the linear intron RNAs can carry out the 
first step of reverse splicing into RNA or DNA sites, thereby ligating the 3’ end of the 
RNA to the 5’ end of the 3’ exon (Morl and Schmelzer 1990; Mastroianni et al. 2008; 
Roitzsch and Pyle 2009). This partial reverse splicing reaction could potentially be used 
for mobility. If partial reverse splicing occurs into RNA, then the recombined RNA 
would need to be reverse transcribed and the resulting cDNA integrated into the host 
genome by recombination, while if partial reverse splicing occurs into DNA, the attached 
intron RNA could be reverse transcribed and the intron cDNA integrated by DNA repair. 
The latter pathway is most likely for group II introns that encode IEPs because 
association with the IEP in RNPs strongly biases the intron RNA to reverse splice into 
DNA rather than RNA sites (Zimmerly et al. 1995a). 
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Recently, we investigated whether Lactococcus lactis Ll.LtrB intron RNPs 
reconstituted with purified IEP and linear intron RNA (Lin RNPs) could use their reverse 
splicing and second-strand cleavage activities to introduce a double-strand break at a 
DNA target site (Mastroianni et al. 2008). The introduction of a recombinogenic double-
strand break by protein endonucleases, such as a Zn-finger nucleases or meganucleases, 
is a favored mode of gene targeting in higher organisms (Porteus and Carroll 2005), and 
we reasoned that group II introns might be advantageous for this approach, as they can be 
retargeted readily to introduce the double-strand break at desired locations simply by 
modifying the EBS and δ sequences in the intron RNA (Perutka et al. 2004). 
4.5.1 Biochemical activities of linear group II intron Ll.LtrB RNPs 
I carried out biochemical assays to test whether Ll.LtrB Lin RNPs could 
efficiently carry out the first step of reverse spicing into DNA target sites, En domain 
cleavage and reverse transcription of the attached linear intron RNA (Mastroianni et al. 
2008). Figure 4.8A shows an experiment in which linear and lariat intron RNPs were 
incubated in vitro with an internally labeled double-stranded DNA oligonucleotide 
substrate containing the Ll.LtrB-insertion site, and the products were analyzed by 
electrophoresis in a denaturing polyacrylamide gel. As found previously (San Filippo and 
Lambowitz 2002), the RNPs containing lariat RNA gave products resulting from both 
full and partial reverse splicing of the intron RNA into the top strand, along with two 
closely spaced fragments resulting from IEP cleavage of the bottom strand (Figure 4.8A, 
lane 3). By contrast, the RNPs containing linear intron RNA did not yield the same fully 
reverse-spliced product and intermediate containing attached lariat RNA as did lariat 
RNPs, but did cleave the top strand by partial reverse splicing, resulting in a small band 
corresponding to the 5’-exon (5’ top) and a high-molecular weight product containing 
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linear intron RNA attached to the 5’ end of the 3’-exon (Figure 4.8A, lane 2). The RNPs 
containing linear intron RNA also carried out IEP cleavage of the bottom strand, 
producing the same two closely spaced fragments as lariat RNPs (5’ and 3’ bottom; 
Figure 4.8A, lane 2). 
Figure 4.8B and C show additional reactions in which RNPs containing linear or 
lariat intron RNA were incubated with DNA substrates labeled at the 5’ end of the top or 
bottom strand, respectively, in the presence of dNTPs to support target-DNA-primed 
reverse transcription. The reactions with the 5’ top-strand labeled substrate confirm that 
RNPs reconstituted with linear intron RNA cleave the top strand and show that the 
reaction can occur as efficiently as cleavage by lariat RNA (Figure 4.8B, lanes 1 and 2). 
The reactions with a 5’-labeled bottom strand show that the cleaved bottom strand can be 
used as a primer for reverse transcription of the linear intron, yielding higher molecular 
weight product with different lengths of attached cDNA (Figure 4.8C, lanes 1 and 2). The 
gels also show that cDNA synthesis increases the proportion of fully reverse-spliced 
product obtained with lariat RNPs, presumably by pulling the unfavorable equilibrium for 
full reverse splicing toward completion (Figure 4.8B, lane 2) (Aizawa et al. 2003), and 
that lariat or linear intron RNPs reconstituted with mutant LtrA protein that lacks RT 
activity can still carry out reverse splicing and top- and bottom-strand cleavage even 
though they cannot synthesize cDNA (Figure 4.8A, lanes 4 and 5, and Figure 4.8B and C, 
lanes 3). 
Importantly for gene targeting, the biochemical experiments show that group II 
intron RNPs reconstituted with linear intron RNA can introduce a double-strand break 
resulting from top and bottom strand cleavage at the DNA target site. As predicted from 
the biochemical experiments, X. laevis oocyte nuclei microinjection experiments showed 
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that RNPs containing linear Ll.LtrB intron RNA could be used to introduce a double-
strand break at a plasmid target site, thereby stimulating gene targeting by homologous 
recombination with a coinjected DNA fragment (Mastroianni et al. 2008). 
4.5.2 Retrohoming of group II intron Lin RNPs in X. laevis oocyte nuclei 
In addition to demonstrating the potential utility of group II introns for gene 
targeting by double-strand-break-stimulated homologous recombination, the above 
experiments raised the possibility that group II intron Lin RNPs might also be able to 
retrohome in vivo by a mechanism involving partial reverse splicing of the linear intron 
RNA into the DNA target site followed by reverse transcription of the attached RNA, 
provided the resulting intron cDNA could be integrated into the recipient DNA by DNA 
repair (Mastroianni et al. 2008). 
To test the retrohoming of Ll.LtrB Lin RNPs, we used a plasmid-based assay first 
developed for bacteria (Guo et al. 2000) and later adapted to test retrohoming of Ll.LtrB 
lariat RNPs (Lar RNPs) microinjected into X. laevis oocyte nuclei (Mastroianni et al. 
2008). In this assay, an Ll.LtrB intron with a phage T7 promoter inserted near its 3’ end 
integrates into a target site cloned in a recipient plasmid upstream of the promoterless tetR 
gene, thereby activating that gene. For assays in X. laevis oocytes, we use the recipient 
plasmid pBRR3-ltrB, which carries the Ll.LtrB target site/tetR gene cassette and a 
separate ampR marker, and RNPs reconstituted with purified IEP and in vitro-synthesized 
0.9-kb Ll.LtrB-ΔORF intron RNA carrying a T7 promoter. The recipient plasmid was 
injected first into the nucleus of stage 6 oocytes, followed within 1 min by Ll.LtrB Lar or 
Lin RNPs. After incubation for 2 h at 25oC, nucleic acids were isolated and transformed 
into E. coli HMS174(DE3), which expresses phage T7 RNA polymerase. The cells were 
then plated on LB medium containing ampicillin plus tetracycline or ampicillin alone, 
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and the integration efficiency (%) was quantified as the ratio of TetR + AmpR/AmpR 
colonies. 
First, we used this assay to compare the retrohoming efficiencies of Lar and Lin 
RNPs. In initial experiments, we tested two forms of the linear intron RNA, one whose 5’ 
end corresponds precisely to that of the Ll.LtrB intron (Lin) and the other with two extra 
5’ G residues (GG-Lin), enabling more efficient transcription by phage T3 RNA 
polymerase (Bailey et al. 1983). These extra 5’ residues are not expected to affect the 
ability of the GG-Lin RNA to carry out the first step of reverse splicing, nor to serve as a 
5’-exon for RNA splicing to produce lariat RNA (Jacquier and Rosbash 1986), which 
was confirmed by in vitro splicing assays (data not shown). 
Table 4.1 summarizes the results of four separate experiments, with ten injected 
oocytes pooled for each condition in each experiment. The retrohoming efficiency of 
Ll.LtrB Lar RNPs in these experiments was 8-22%, in agreement with previous results 
(Mastroianni et al. 2008), while the retrohoming efficiencies of the Lin and GG-Lin 
RNPs were 0.004-0.04%, readily detectable in these assays but more than 500- to 2,000-
fold lower than for Lar RNPs. Controls showed no retrohoming for GG-Lin RNPs 
reconstituted with an RT-deficient mutant LtrA protein (DD-; Table 4.1), as shown 
previously for lariat-containing RNPs (Mastroianni et al. 2008). Thus, retrohoming of 
both Lin and Lar RNPs in X. laevis oocyte nuclei requires the RT activity of the group II 
IEP. 
The reverse splicing activity of linear intron RNA depends critically upon the 
RNA having the correct 3’ nucleotide residues. This dependence is problematic for RNAs 
synthesized with phage T7 RNA polymerase, which adds extra non-templated nucleotide 
residues to the ends of run-off transcripts (Milligan et al. 1987), necessitating the use of 
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special measures, such as transcription from DNA templates with 2’-OMe nucleotide 
residues at the penultimate or last two nucleotide, to reduce 3’ end heterogeneity (Kao et 
al. 2001; Roitzsch and Pyle 2009). For our experiments, linear Ll.LtrB intron RNAs were 
transcribed with phage T3 RNA polymerase, which differs from T7 RNA polymerase in 
giving run-off transcripts with homogenous 3’ ends (Majumder et al. 1979). As expected, 
GG-Lin intron RNAs transcribed with T3 RNA polymerase from DNA templates 
containing 2’-OMe nucleotide residues at the last two positions did not significantly 
increase retrohoming frequencies (Table 4.1). 
Finally, we confirmed that GG-Lin RNPs with the branch-point A-residue deleted 
(GG-Lin-ΔA2486) still retained substantial retrohoming activity, albeit two- to four-fold 
lower than that for wild-type GG-Lin RNPs assayed in parallel (0.001-0.002% and 0.002-
0.008%, respectively; Table 4.1). The insertion of the ΔA2486 intron was confirmed by 
sequencing through the branch-point region. These findings indicate that retrohoming of 
GG-Lin RNPs is not dependent upon branching at the normal site. It is not clear whether 
the somewhat decreased retrohoming efficiencies of GG-Lin-ΔA2486 RNA are 
significant and if so, whether they reflect differences in the quality of the RNP 
preparations or somewhat decreased reverse splicing activity due to the effect of deleting 
the branch-point nucleotide on the intron RNA structure. 
4.5.3 Sequences of integration junctions for retrohoming of Ll.LtrB Lin RNPs in X. 
laevis oocyte nuclei 
To confirm retrohoming of the linear intron RNA, we carried out PCR of 
randomly selected TetR + AmpR colonies, using primers flanking the intron-insertion site 
in the recipient plasmid. For Lar RNPs, the colony PCR gave products of the size 
expected for insertion of the full-length Ll.LtrB-ΔORF intron for all retrohoming events 
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analyzed, while for Lin RNPs, the colony PCR gave some products of the size expected 
for insertion of the full-length intron, along with smaller products (Figure 4.9A). 
Sequencing of the 5’- and 3’-integration junctions for Lar RNPs showed precise 
insertion of the full-length intron at the target site, as expected for full reverse splicing (> 
23 retrohoming products analyzed in this and previous work (Mastroianni et al. 2008)). 
For Lin RNPs. sequencing showed that all 24 retrohoming products analyzed had the 3’-
junction sequences, expected for the first step of reverse splicing into the DNA target site. 
However, only one event analyzed for Lin RNPs gave insertion of full-length intron with 
accurate 5’- junction sequences (Figure 4.9B). The remainder had 5’-junctions sequences 
with some combination of: (i) resection of 5’-exon sequences; (ii) insertion of 5’-
truncated introns; and/or (iii) insertion of extra nucleotide residues at the integration 
junction, presumably reflecting errors during the DNA repair process used for ligation of 
the intron cDNA to the 5’ exon (Figure 4.9B). Similar 5’- and 3’-junction sequences were 
found for retrohoming products of the GG-Lin RNA (data not shown). A number of the 
junction sequences, particularly those with large 5’ intron truncations, showed 
microhomologies of 1-5 nt residues between the 5’ end of the intron and the ligated exon 
sequences (Figure 4.9B). The characteristics of the 5’ junctions for retrohoming of Lin 
and GG-Lin RNPs are similar to those for ligation junctions formed during DNA repair 
by non-homologous end-joining (NHEJ) (Hagmann et al. 1998; Weterings and Van Gent 
2004). 
The fully analyze the spectrum of retrohoming products for Lin RNPs and 
confirm that cDNA ligation occurred in the eukaryotic host, we carried out direct PCR of 
5’- and 3’- integration junctions in nucleic acids extracted from X. laevis oocyte nuclei 
without transformation into E. coli (Figure 4.10). As expected from the colony PCR 
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results, the 5’-junction PCR for Lin and GG-Lin RNPs showed some products of the 
same size as those for Lar RNPs, along with multiple smaller products (Figure 4.10A). 
Sequencing of cloned PCR products confirmed that the larger products (PCR band a) had 
insertions of full-length or almost full-length introns, while products of decreasing size 
(PCR bands b and c) had insertions of introns with progressively longer 5’ intron 
truncations (Figure 4.10B). The direct PCR permitted the recovery of introns with longer 
5’ truncations that delete the T7 promoter required for the genetic selection in the 
bacteria. The 5’-junction sequences also showed variably sized 5’-exon resections 
insertion of extra nucleotide residues at the integration junction, and microhomologies in 
some cases, similar to the junction sequences analyzed by colony PCR (Figure 4.10B). 
By contrast to the 5’ junction, the 3’-junction PCR for retrohoming products of Lin and 
GG-Lin RNPs gave a single prominent band of the same size as that for Lar RNPs 
(Figure 4.10), and sequencing showed the expected junction corresponding to the 3’ end 
of the intron inserted precisely at the target site by partial reverse splicing in all cases 
(data not shown). 
4.5.4 Model for retrohoming of linear group II intron RNA 
Our results indicate that RNPs containing linear group II intron RNA retrohome 
in vivo by the mechanism shown in Figure 4.11. The pathway begins with the linear 
intron RNA catalyzing the first step of reverse splicing into a DNA target site, resulting 
in the ligation of the 3’ end of the intron to the 5’ end of the 3’ exon DNA. The 
associated IEP then uses its En domain to cleave the opposite strand and synthesizes a 
cDNA copy of the linear intron RNA. These initial steps were demonstrated previously 
for purified GG-Lin RNPs in vitro (Mastroianni et al. 2008). A key step shown here to 
required to retrohoming in vivo is the ligation of the free end of the intron cDNA to the 
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upstream exon DNA. This step occasionally leads to the precise insertion of the intron, 
just as for retrohoming of lariat RNA, but more frequently occurs with loss of 5’-exon or 
5’- intron sequences and insertion of additional nucleotide residues at the junction. As we 
observed no duplication of target site sequences resulting from the initial staggered 
double-strand break made by the RNPs, we infer that the single-stranded 5’ overhang 
attached to the 5’ exon on the bottom strand must be resected prior to cDNA ligation. The 
retrohoming of linear intron RNA is presumably completed like retrohoming of lariat 
RNA by the degradation or displacement of the intron RNA template strand followed by 
second-strand DNA synthesis and the sealing of nicks by host DNA polymerases and 
ligases (Smith et al. 2005). The characteristics of the cDNA ligation step, in particular the 
5’-exon resection and the insertion of extra nucleotide residues at the ligation junction, 
suggest that it occurs by non-homologous end joining (Hagmann et al. 1998; Weterings 
and Van Gent 2004).  
The insertion of 5’- truncated introns likely results from degradation of the linear 
intron RNA rather than abortive cDNA synthesis, as such 5’ truncations are not observed 
for retrohoming via lariat RNA, which is identical to linear intron RNA except that its 5’ 
end is protected first by the 2’-5’ linkage and then by ligation to the 5’ exon after the 
second-step of reverse splicing. The majority of 5’ truncated ends (60-70%) fall in single-
stranded loop regions, which are expected to be particularly sensitive to ribonucleases, 




4.6 LL.LTRB INTRON WITH GFP-RAM (RETROTRANSPOSITION-ACTIVATED 
MARKER) 
To apply group II intron-based gene targeting in sperm nuclei to protein-coding 
genes, it is desirable to incorporate a genetic marker into the intron to facilitate the 
screening of embryos for intron integrations. Two problems were: (i) inserted genetic 
markers often decrease the efficiency of group II intron RNA splicing and reverse 
splicing reactions, likely by impeding RNA folding, leading to substantially decreased 
DNA integration frequencies (Plante and Cousineau 2006), and (ii) RNPs reconstituted 
with in vitro transcribed intron RNA generally contain small amounts of residual 
template DNA. This residual DNA is difficult to remove even with extensive DNase 
treatment and could integrate randomly producing a background of embryos expressing 
the marker from the integrated DNA.  
To address these problems, a GFP-RAM marker that functions efficiently when 
inserted into intron DIV was developed (Figure 4.13A). This marker consists of a GFP 
coding sequence, which has been optimized for function in X. laevis embryos (Zernicka-
Goetz et al. 1996), transcribed from a CMV promoter and inserted in the reverse 
orientation to the intron transcription, but interrupted by an efficiently self-splicing group 
I intron (phage T4 td intron) in the forward orientation. After in vitro transcription, the td 
group I intron is excised by self-splicing to yield Ll.LtrB-ΔORF intron RNA with an 
intact GFP marker for RNP reconstitution. To make this barrier even more stringent, I 
used a mutant td intron (G67A mutation in P5 element) that requires higher Mg2+ 
concentrations (8 mM) for self-splicing, ensuring that it cannot be removed by self-
splicing under in vivo conditions (Mohr et al. 1992). Because of the presence of the td 
intron, green fluorescent embryos cannot arise from random integration of residual DNA 
template. For linear introns, the RNA can be used directly for RNPs reconstitution after 
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in vitro splicing of the td intron. For lariat introns, an additional Ll.LtrB self-splicing step 
is required to form a lariat RNA with an intact GFP marker in DIV. 
4.6.1 The splicing efficiency and in vitro TPRT activity of Ll.LtrB intron with GFP-
RAM 
Inserting genetic markers into group II intron DIV often decreases the efficiency 
of group II intron RNA splicing and reverse splicing (Plante and Cousineau 2006). Here, 
I assessed the splicing efficiency of the Ll.LtrB intron with the GFP-RAM by 
electrophoresis in a denaturing 4% polyacrylamide gel and real-time PCR. 
The Ll.LtrB intron with the GFP-RAM was found to splice efficiently based on 
electrophoresis in a denaturing 4% polyacrylamide gel analysis (Figure 4.13B). In this 
experiment, a precursor RNA containing the Ll.LtrB intron with the GFP-RAM was 
transcribed from the linearized plasmid pACD-GFP-RAM. Two splicing steps were 
carried out, one to splice the td intron, and the other to form the lariat Ll.LtrB intron with 
intact GFP. The initial transcript and spliced product were loaded in parallel lanes for 
comparison. The major band in the transcript lane was the precursor RNA. Other smaller 
bands arose from low level td splicing which occurred during the transcription. 
Compared to the input lane, about half of precursor RNA converted into the lariat form, 
corresponding to the top band in the “Spliced” lane. Some precursor was converted into a 
smaller linear form. This linear form could be linear intron RNA with or without the td 
intron, which are indistinguishable on the gel. The result was repeatable and 
demonstrated that the Ll.LtrB with GFP-RAM marker can splice efficiently in vitro. 
However, the splicing efficiency of the td intron could not be determined from the 
gel. It was checked by a one step RT real-time PCR using power SYBR Green RNA-to-
CT 1-Step Kit (Applied Biosystems). To compare the amount of RNA with or without the 
td intron, two primers were designed to specifically amplify the designated products (blue 
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arrows in Figure 4.13A). The forward primer for precursor RNA (Ppre) anneals to the 3’ 
end of the td intron, ending 2-nt upstream of the 3’-splice site, while the forward primer 
for the spliced product (Psp) spans the splice junction, with 24-nt in the 5’-exon and 4-nt 
in the 3’-exon, thereby ensuring that it will only amplify the ligated exons and not 
precursor RNA. The common reverse primer (Prev) is complementary to a sequence 127-
nt downstream of the splice site. The specificity of the primers for their intended 
amplicons was checked by RT-PCR. Both sets of primers only amplified the designed 
products (data not shown). Therefore the td splicing efficiency can be determined by the 
ratio of spliced RNA/ (precursor RNA + spliced RNA) = 2ΔCt/ (1+2ΔCt), in which ΔCt = 
Ctprecursor-Ctspliced. Based on the real-time PCR results, the td splicing efficiency is about 
70% (Figure 4.13C). 
Furthermore, sperm TPRT reactions analyzed by real-time PCR to quantitate the 
3’-integration junction indicated that Tx1-2768a and Tx1-2768a GFP-RAM RNP are 
about equally efficient for site-specific DNA integration (data not shown). In vitro TPRT 
assay showed that Mitf-α-M-609s GFP-RAM RNPs can actively reverse splice into the 
DNA target site in the plasmid, although the reverse splicing activity was lower than that 
of Mitf-α-M-609s RNP in the same experiment (data not shown). Together, these 
findings indicate that although the Ll.LtrB-GFP-RAM construct may have somewhat 
decreased splicing and reverse splicing activity as compared to Ll.LtrB-ΔORF construct, 
it still retains relatively high activity in both the forward and reverse splicing reactions. 
4.6.2 Site-specific gene disruptions using an Ll.LtrB intron with a GFP marker 
A construct named pACD-Mod4-GFP was made during the construction of 
pACD-GFP-RAM. It contained an Ll.LtrB intron with the GFP cassette but no td intron. 
This construct was used to make Tx1-2768a RNPs for transgenesis. In this experiment, 
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the sperm TPRT reaction contained 10 mM Mg2+, 0.2 mM dNTP, 15.5 µl of RNP (1.5 
mg/ml lariat RNA based on O.D.260) and permeabilized sperm nuclei in SDB buffer. 
Nucleoplasmin was not used to increase the chance of obtaining healthy tadpoles. The 
reaction mixture was incubated at 30oC for 10 min and then diluted 30 times using SDB 
with 5 mM Mg2+ for transgenesis. A total of 2,720 eggs (~160 eggs per plate, 17 plates 
total) were injected with reacted sperm nuclei. After incubating at 18oC for 3 h, 11.5% ~ 
21.2% of the embryos in each plate developed normally to the 4-cell stage and 58% ~ 
80.2% of these healthy 4-cell embryos in each plate developed to stage 19 (Nieuwkoop 
1994). After 8 days, 61 embryos developed into healthy swimming tadpoles. Although 
GFP expression was not detected in any of the embryos (81 embryos including the 61 
healthy tadpoles and 20 unhealthy ones), they were checked by PCR for the 3’-intron 
integration junction. Eight embryos showed to have the correct 3’ intron integration 
junction (data not shown). The fact that none of them showed the expression of GFP 
throughout the development could reflect the integration of 5’-truncated introns that lack 
part or all of the GFP marker. Some tadpoles grew in the lab for more than three months, 
confirming that the disruption of the Tx1 gene did not affect embryo development. 
4.7 LINEAR LL.LTRB-GFP-RAM INTRON LIBRARY WITH RANDOM EBS 1/2 AND δ  
SEQUENCES 
In previous experiments with E. coli, a library of Ll.LtrB-ΔORF introns with 
randomized EBS and δ sequences integrated at sites throughout the E. coli genome, 
generating a gene disruption library (Zhong et al. 2003). The integrated introns, which 
contain EBS and δ complementary to the IBS and δ’ sequences at their insertion sites, 
could be recovered by PCR and in many cases, used directly without further modification 
to generate the desired single disruptions (Yao et al. 2005). This approach has the 
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advantages of identifying accessible target sites and efficient introns without resorting to 
the computer algorithm. 
A similar procedure was applied in X. laevis by using an Ll.LtrB-GFP-RAM 
intron library containing linear intron RNA with randomized EBS1/2 and δ sequences. A 
lariat GFP-RAM RNP library was difficult to obtain because of the low splicing 
efficiency of precursor RNA with random IBS and EBS sequences (Jacquier and Michel 
1990), but the discovery that linear intron can promote intron integration by reverse 
splicing and nonhomologous end-joining in X. laevis oocytes resolved this problem. By 
using the linear Ll.LtrB intron, the transcribed RNA with randomized EBS1/2 and δ 
sequences can be used directly for in vitro RNP reconstitution after the td splicing. The 
GFP expression was used to screen the embryos for intron integrations (Figure 4.14A). 
In the first experiment, 13 µl of GFP-RAM RNP library (linear RNA 
concentration 2.2 mg/ml based on O.D.260) was used in a sperm reaction with 10 mM 
Mg2+, 2 mM dNTP, and 2.5 µM nucleoplasmin. The reaction was incubated at 30oC for 
10 min and the modified sperm nuclei were diluted 30 times in 1×SDB with 5 mM Mg2+, 
and then used directly for fertilization. After incubation at 18oC, embryos were checked 
under the fluorescent stereoscope to check GFP expression. Figure 4.14B showed a field 
view of embryos that developed for three days at 18oC. Under the UV light, around 5% of 
the embryos in the field show GFP expression. The individual GFP+ embryos were frozen 
and genomic DNA was extracted for PCR analysis. 
To identify the integrated introns and their insertion sites in the GFP+ embryos, 
TAIL PCR (Thermal Asymmetric Interlaced PCR) was used. This allowed amplification 
of the 5’ part of Ll.LtrB intron, including the modified EBS1/2 and δ sequences, along 
with the X. laevis genomic DNA sequences upstream of integrated intron. After the TAIL 
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PCR, a sequence specific primer annealing to the genomic DNA upstream of the 
integrated intron was designed and used for confirmation the 5’-intron integration 
junction by direct PCR amplification. 
Table 4.2 summarizes the confirmed 5’-integration junction sequences for this 
experiment (Exp 1). The results show that the introns integrated into both protein coding 
regions and unsequenced regions of the X. laevis genome (denoted “Unknown”). Both 
truncated and full intron integrations were found in this experiment. Based on the 
sequences of 5’-integration junctions, eight of the integrations had full-length Ll.LtrB 
introns, while the other four had 5’ truncated introns. Some embryos have more than one 
intron integration, e.g., introns 12, 13 and 14 were recovered from one embryo. Further, 
the same intron integration was found in several different embryos (note multiple 
occurrences for introns 9 and 13 in Exp. 1, Table 4.2). These results suggest that some 
introns may be very active and/or that some target sites may be hot spots for intron 
integration. The introns 12 and 14 integrated into genome at the same site with identical 
5’ truncations (Table 4.2 Exp.1). While I cannot exclude that this is due to PCR 
contamination, such contamination was not detected in the PCR water control done in 
parallel. Because the EBS and δ sequences are deleted, we cannot deduce whether these 
are the same intron or different introns that coincidently integrated with the same 5’ 
truncation. Some integrated introns have similar EBS1, EBS2 or δ sequences and 
integrated into the same site in the genome – e.g., introns 22 and 27, which have exactly 
the same δ and EBS1 sequences and EBS2 sequences differing by one T residue. 
The second experiment was carried out using the same transgenesis conditions as 
the first one, but with a different preparation of the GFP-RAM RNP library (linear RNA 
concentration 9.5 mg/ml based on O.D.260). After screening for embryos with GFP 
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expression and confirming intron integration by PCR, three different introns were found. 
Interestingly intron 1 in Exp. 2 integrated into four different embryos. Sequencing results 
revealed that it had wild-type Ll.LtrB intron sequences for EBS1/2 and δ. 
Most of the embryos with GFP fluorescence in the previous trials showed 
developmental abnormities (Figure 4.14B). As I found in the course of this work that 
using less nucleoplasmin in the sperm TPRT reaction improves the frequency of 
generating healthy embryos, I carried out a third transgenesis with the same linear 
Ll.LtrB-GFP-RAM library as in Exp. 2 but less nucleoplasmin. In this experiment, the 
sperm reaction was done with 0.75 µM of nucleoplasmin and 8 µl of GFP-RAM RNP 
library (linear RNA concentration 9.5 mg/ml based on O.D.260). A total of 1,440 eggs 
were injected, and 9 embryos developed into tadpoles, four of which expressed GFP 
(Figure 4.14C). Genomic DNA was isolated from tail clippings of these tadpoles for 
DNA analysis. The TAIL PCR detected introns integrated into these tadpoles. The intron 
EBS1, 2 and δ sequences and flanking X. laevis genomic sequences are summarized in 
Table 4.2 Exp.3. Tadpole A and I (Figure 4.14C) were found to have the same intron 
(intron 3 in Exp.3, Table 4.2). However due to difficulties in this TAIL PCR, the genomic 
sequences upstream of intron were not readable. It is possible that some secondary 
structure impedes the progression of the DNA polymerase used in the PCR. Notably, 
intron 3 in Exp. 3 is the same as intron 1 in Exp. 2, with wild type EBS1/2 and δ 
sequences (Table 4.2). The TAIL PCR suggests that it integrated at the same site in the 
Cripto-1 gene, but this could not be confirmed by direct PCR due to difficulty with the 
PCR reactions. Tadpole H (Figure 4.14C) was found to have intron 2 in Exp. 3. The same 
intron sequence and integration site were also found in Exp. 2 (intron 6). The tadpole F 
(Figure 4.14C) contains intron 3. Sequencing result showed the intron integrated into an 
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unsequenced region in the genome. This transgenic experiment demonstrated that by 
using less nucleoplasmin, healthy tadpoles with random intron integrations can be 
obtained. 
The above experiments showed that the Ll.LtrB intron with randomized EBS1/2 
and δ sequences can randomly integrate into X. laevis genome, protein-encoding genes or 
non protein-encoding regions, and that some of the resulting embryos containing targeted 
intron integrations can develop into healthy tadpoles. This strategy can potentially be 
used for forward mutagenesis method in X. laevis. 
4.8 DISCUSSION  
4.8.1 Intron target sites in Xenopus 
In this chapter, I developed a new method for group II intron-based gene targeting 
via site-specific DNA modification in X. laevis sperm nuclei. Potential target sites were 
identified in four genes (Tx1, 28s, mitf and tyr). The Ll.LtrB intron was retargeted to 
insert into those sites in sperm nuclei. For the targetron Tx1-2768a, the integration 
efficiency determined by real-time PCR was about 12% and was efficient enough to 
readily generate embryos containing the targeted modification following in vitro 
fertilization. For the single copy genes, mitf and tyr, the integration efficiencies were 
0.3% and 0.2% respectively. 
Recent findings showed that chromatin structure impedes intron targeting in X. 
laevis oocyte nuclei (Mastroianni et al. 2008), and this also appears to be the case in 
sperm nuclei, as judged by higher targeting efficiency found for Tx1-2786a RNPs in 
extracted sperm DNA than in sperm nuclei (Figure 4.4B). The use of strategies 
employing an Ll.LtrB intron with randomized EBS and δ sequences developed in section 
4.7 should provide additional information about group II intron targeting preference in 
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eukaryotic cells, as well as identify accessible target sites that are not blocked by 
chromatin structure. 
4.8.2 Sperm reaction conditions 
The research described in this chapter identifies several factors that are critical for 
group II intron gene targeting in X. laevis sperm nuclei. First, the amount of 
nucleoplasmin used in the reaction needs to be sufficient to decondense the chromatin 
structure of the target site, but not so great as to affect the fertilization activity of the 
sperm nuclei or cause abnormalities during embryo development. In the absence of group 
II intron RNPs, nucleoplasmin in the concentration range of 0 to 10 µM had no effect on 
the fertilization, but concentrations higher than 10 µM caused developmental 
abnormalities at the beginning of gastrulation or later stages (unpublished data). Since the 
nucleoplasmin is an acidic protein, it may have relatively high binding affinity for 
exposed intron RNA in the RNPs. Data from Mitf-α-M-609s intron targeting showed that 
too much nucleoplasmin can inhibit the intron targeting activity (data not shown), 
suggesting that an optimal balance of nucleoplasmin and RNP concentrations may be 
required. 
In addition to the amount of nucleoplasmin, the activity of RNPs used in the 
sperm TPRT reaction needs to be calibrated in vitro using the TPRT assay. Sperm TPRT 
assays with the Tx1-2768a intron targeting showed that targeting efficiency increased 
with increasing RNP concentrations (Figure 4.4). However, the highest amount of RNPs 
tested was 60 µg in a 27µl sperm reaction.  
Finally, my results suggest that optimal temperatures for intron targeting in sperm 
nuclei are between 30oC and 33oC. Lower temperatures result in decreased intron 
integration efficiency, while higher temperatures are detrimental to the sperm, with 
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temperatures higher than 33oC dramatically decreasing the fertilization rate during 
transgenesis. 
4.8.3 Reactions of linear Ll.LtrB intron 
In this chapter, the reverse splicing activity of RNPs reconstituted with linear 
Ll.LtrB intron RNP was characterized both in vitro and in vivo. In vitro biochemical 
assays demonstrated that such linear RNPs can recognize DNA target sites, carry out the 
first step of reverse splicing, resulting in attachment of linear intron RNA to the 3’ exon 
DNA, cleave the bottom strand, and carry out target DNA-primed reverse transcription of 
the attached intron RNA. Although linear RNPs cannot carry out full reverse splicing, 
they could, surprisingly, still integrate at reduced efficiency into DNA target sites in X. 
laevis oocyte nuclei in vivo experiments. Analysis of the junction sequences from such 
experiments suggests that the integration (“retrohoming”) mechanism for linear RNPs 
involves partial reverse splicing followed by reverse transcription of the attached intron 
RNA, followed by the use of host factors to ligate the 5’-end of the intron cDNA to the 
5’-exon DNA. Host factors also presumably remove the intron RNA template strand and 
carry out second-strand DNA synthesis. Although some retrohoming events for linear 
intron RNPs precisely integrate the full-length or almost full-length intron, others have 
insertions, deletions, and/or mutations at the 5’-integration junction, as expected for 
inaccurate nonhomologous end joining. Additionally, retrohoming events with linear 
intron RNPs have a tendency to integrate 5’-truncated introns, probably because the 
unprotected 5’-end of linear intron RNA is more accessible to ribonucleases in vivo. In 
addition to revealing a novel retrohoming mechanism that might be used by group II 
introns that are excised as linear rather than lariat RNAs, these findings suggest that 
RNPs containing linear intron RNA might be useful for gene targeting, not only for 
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introducing a recombinogenic double-strand break, but also for site-specific integration 
into DNA target sites.  
4.8.4 Random integrations with a linear Ll.LtrB-GFP-RAM intron library 
The Ll.LtrB-GFP-RAM intron library with randomized EBS1/2 and δ sequences 
developed here may be useful as a tool for forward genetic screens in X. laevis. The 
disrupted genes with specific GFP expression patterns can be identified by TAIL-PCR 
and integrated introns can be isolated by PCR and potentially used to obtain the desired 
single disruptants. Further experiments with this library may also provide information 
about group II intron targeting rules in eukaryotic cells, as well as identify validated 
target sites that are accessible in Xenopus sperm nuclei. Importantly, the GFP-RAM 
library RNPs contain linear intron RNAs, which can be obtained readily by in vitro 
transcription without the RNA splicing step required to generate lariat RNAs. In addition 
to being easier to prepare, the base-pairing rules obtained by analysis of integration 
events with the linear intron RNA library will pertain exclusively to the reverse splicing 
reaction without potential bias for base-pairing interactions required for forward splicing 
needed to generate lariat RNA, as is the case for current gene targeting rules determined 
in bacteria (Perutka et al. 2004). The procedures developed here for group II intron gene 
targeting via sperm DNA modification should be generally applicable to X. tropicalis and 
potentially to other organisms. 
4.9 METHODS  
4.9.1 Recombinant plasmids 
pACD2 contains the 0.9-kb Ll.LtrB-ΔORF intron and flanking exons cloned 
downstream of a T7/lac promoter in a pACYC184-based vector with a camR gene, and 
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has the LtrA ORF cloned downstream of the 3’ exon. The LtrA ORF was removed from 
the intron DIV and replaced by a phage T7 promoter (Guo et al. 2000; Karberg et al. 
2001). pACD3 is a derivative of pACD2 without the T7 promoter in intron DIV (Perutka 
et al. 2004). 
pMod4 is related to pACD3 but contains an alternate ΔORF construction based on 
the predicted intron secondary structure, with MluI and EcoRV sites introduced at the site 
of the ORF deletion site to facilitate the insertion of selectable markers. To make the 
intended deletion and add the two restriction sites, the 5' and 3' parts of the intron with an 
overlapping sequence were amplified separately by PCR of pLE12, which contains the 
full-length Ll.LtrB intron (Matsuura et al. 1997). Primers Ex1F (5’-
AGCTTgaattcCTTAGAGAAAAATAATGCGGTGC-3’) and Mod4R (5’-
CGTGTGGGCGATAAAacgcgtGTCTTGTAAAAACTTCGTCT-3’) were used to 
amplify the 5' part of Ll.LtrB intron, and primers Mod4F (5’-
TTTTATCGCCCACACgatatcTCCCGTTAAAAGCTAAATGT-3’) and Ex2R (5’-
AGCTTaagcttCTTTGCCGCTTTTTGTTTTCTC-3’) were used to amplify the 3' part of 
Ll.LtrB intron. The lower case letters indicate the appended restriction enzyme sites used 
for cloning. In the second round of PCR, the two first round PCR products were mixed 
and amplified by PCR with the outside primers Ex1F and Ex2R. The second round PCR 
product was digested by EcoRI and HindIII and inserted between the EcoRI and HindIII 
sites of pBSIISK+ (Stratagene) to yield plasmid pMod4. The bsd gene from pCMV/bsd 
(Invitrogen) was then inserted into this pMod4 to generate pMod4Bsd. For this step, the 
bsd gene was amplified by PCR, using pCMV/bsd as a template, and, BsdEV (5’-
ATCGTgatatcTTACATAACTTACGGTAAATGGC-3’) and BsdML (5’-
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ATGCAacgcgtCAGACATGATAAGATACATTGATG-3’) as primers. The PCR product 
was digested by EcoRV and MluI and inserted into the pMod4 to generate pMod4Bsd. 
To generate pACD-Mod4-GFP, the GFP ORF was amplified from pCSGFP2 
(provided by Enrique Amaya) using primers pModGFP2s (5’-
GCGGCcggaccgATGAGTAAAGGAGAAGAACTTT-3’) and pModGFP2as (5’-
GCGGCgcttagcTTATTTGTATAGTTCATC-3’). Primer pModGFP2s contains an RsrII 
restriction site and pModGFP2as contains a BlpI site (the restriction enzyme sites are 
shown in lower case letters). The PCR product containing the GFP gene was digested 
with RsrII and BlpI and used to replace the bsd gene in pMod4Bsd. 
pACD-GFP-RAM and pACD-GFP-RAM1363 contains a wild-type 393-bp td 
intron or mutant td intron (td1363) inserted within the GFP gene of pACDMod4GFP. The 
mutant intron contains a G to A mutation at nucleotide residue 67 with the intron’s P5 
stem element (Mohr et al. 1992). The wild-type td intron and mutant td1363 intron were 
amplified from pACD2KanRAM (Zhong et al. 2003) and pTZtd1363 (Belfort et al. 
1987), respectively, using primers GFPRAM3s (5’-
GTGGTCTCTCTTTTCGTTTGGGTTAATTGAGGCCTGAGTATAAG-3’) and 
GFPRAM2as (5’-
CACACAATCTGCCCTTTCGAAAGCATTATGTTCAGATAAGGTCG-3’). The td 
intron was inserted by combining three PCR products. Primer pModGFP2as and 
GFPRAM3as were used to amplify a segment of pACD-Mod4-GFP upstream of td intron 
insertion site (named fragment A), and primers pModGFP2s and GFPRAM2s were used 
to amplify a DNA segment of pACDMod4GFP downstream of td insertion site (named 
fragment B). The 3’ end of fragment overlaps the 5’ end of td intron and the 5’ end of 
fragment B overlaps the 3’ end of td intron. The amplified td intron and fragment A and 
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B were mixed and use as templates for PCR with the outside primers pModGFP2as and 
pModGFP2s, which contain BlpI and RsrII sites respectively. The combined PCR 
product was digested with BlpI and RsrII and cloned between the corresponding sites of 
pACD-Mod4-GFP to generate pACD-GFP-RAM or pACD-GFP-RAM1363.  
4.9.2 Preparation of Ll.LtrB RNPs 
Transcription 
The Ll.LtrB intron was transcribed from a linearized plasmid or PCR product 
containing T3 or T7 promoter followed by the Ll.LtrB intron sequence. For lariat introns, 
the 50 µg plasmid (pACD3 or pACD-GFP-RAM or derivatives with modified IBS1/2 
and EBS1/2 sequences) was linearized by digestion with NheI (New England Biolabs) at 
37oC overnight. The linear plasmid DNA was phenol-chloroform extracted, ethanol 
precipitated at -20oC for 2 h and dissolved in 100 µl of distilled H2O. The linear intron 
RNA was synthesized PCR product generated from pACD3, pACD-GFP-RAM or 
derivatives with modified IBS1/2 and EBS1/2 sequences using T3-LIS-1G (5’-
aattaaccctcactaaaGTGCGCCCAGATAGGGTGTTAAGTCAAG-3’) and LtrB940a 
primers as described previously (Mastroianni et al. 2008). To generate a homogenous 3’ 
end of intron RNA, the LtrB940a primer was purified by HPLC. The transcribed RNA 
was extracted by phenol-chloroform twice and precipitated with 2.5 M LiCl at -20oC for 
30 min. The RNA was then pelleted at 16,000×g for 15 min at 4oC, and the pellet was 
washed twice with 70% ethanol. After air drying, the pellet was dissolved in nuclease-
free water and precipitated in the presence of 2.5 M ammonium acetate to further remove 





The Ll.LtrB intron was self-spliced as previously described (Mastroianni et al. 
2008).  
To splice the td intron in GFP-RAM construct, RNA was spliced at 10-25 mM 
Mg2+ in the presence of 0.2 mM GTP, 20 mM Tris-HCl, pH 7.5, 100 mM KCl at 37oC for 
1 h. Prior the splicing reaction, the RNA was renatured by heating to 55oC and then 
slowly cooling to 37oC in 8 mM MgCl2, 20 mM Tris-HCl, pH 7.5, and 100 mM KCl. The 
Mg2+ and GTP were added to the desired concentration as the temperature reached 37oC. 
The RNA was precipitated by 1/10 volume of 3 M sodium acetate and 2 volumes of 
ethanol at -20oC for at least 2 h. After ethanol precipitation, the RNA was spun down and 
washed with 70% ethanol. The RNA pellets were dissolved in 1 ml of nuclease-free 
water. The splicing reaction was subsequently checked by electrophoresis on a denaturing 
4% polyacrylamide gel.  
Preparation of LtrA protein and RNP reconstitution 
The LtrA protein was expressed in E. coli BL21 (DE3) using an intein-based 
affinity purification system (Impact; New England Biolabs) (Saldanha et al. 1999). RNP 
reconstitution was done with 100 nM self-spliced intron RNA, 200 nM purified LtrA, 40 
mM Tris-HCl, pH 7.5, 5 mM MgCl2, and 450 mM NaCl in 10 ml of reaction medium as 
previously described (Mastroianni et al. 2008). The reaction was incubated at 30oC for 30 
min. After pelleting the RNP particle by ultracentrifugation in a Beckman 50.2 Ti rotor at 
145,000 x g for 16 h at 4°C, the pellet was dissolved in 30-100 µl of 40 mM HEPES, pH 
7.5, 10 mM KCl and 5 mM MgCl2. 
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4.9.3 Target DNA-primed reverse transcription (TPRT) 
TPRT reaction was used to determine the in vitro reconstituted RNP activity. The 
reaction were carried out by incubating 1 µg of unlabeled target plasmid with 1 µl of 
reconstituted RNP particles in 20 µl of reaction medium [10 mM KCl, 10 mM MgCl2, 
and 50 mM Tris-HCl (pH 7.5)] containing 0.2 mM dNTP and 20 µCi of [α-32P]dTTP 
(3000 Ci/mmol; Perkin-Elmer). The reactions were initiated by addition of the RNP 
particles, and the mixtures were incubated for 30 min at 37°C. Products were purified and 
analyzed as previously described (Saldanha et al. 1999). 
4.9.4 Nucleoplasmin purification  
E. coli BL21(DE3) was transformed with the plasmid expressing CORE8D 
(Banuelos et al. 2003) and plated on LB medium containing ampicillin. For starter 
cultures, a single colony from the plates was inoculated into 50 ml of LB medium 
containing ampicillin and incubated overnight at 37oC. 10 ml of the overnight culture 
were then inoculated into 1 liter of LB containing ampicillin in a 4-liter flask and shaken 
vigorously at 37oC, until the cell density reached O.D.595 0.6. The cultures were then 
shifted to 18oC and induced with 1 mM IPTG overnight. The cultures were harvested by 
centrifugation in a Beckman JA-14 rotor (4,000×rpm for 10 min), and the resulting 
bacterial pellet was resuspended in a homogenization buffer (25 mM Tris-HCl pH 7.5, 
120 mM NaCl, 1mM DTT) supplemented with phosphatase inhibitors (10 mM beta-
glycerophosphate, 10 mM Na molybdate, 100 mM Na vanadate), protease inhibitors (0.2 
mM AEBSF and one Roche Protease inhibitor cocktail tablet without EDTA) and 0.1 
mg/mL lysozyme. 15ml of this homogenization buffer was used to resuspend each liter of 
cell pellet. Cells could then be stored at -70oC for months. Cells to be lysed were thawed 
and incubated on ice for 1 h and then subjected to two or three cycles of freezing and 
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thawing between -70oC and 25oC, followed by sonication (Branson 450 Sonifier, Branson 
Ultrasonics Inc., Danbury, CT; four 10 s bursts at amplitude 60, with 10 s between 
bursts). After sonication, insoluble material was pelleted by centrifugation in a Beckman 
JA20.1 rotor (11,000×rpm for 15 min). The supernatant was further heated at 70oC for 15 
min with slight shaking from time to time, and insoluble material was pelleted by 
centrifugation at 100,000×g for 1 h. The clear supernatant was applied directly to a Q-
Sepharose column in 25 mM Tris-HCl, pH 7.5, 0.2 mM PMSF 
(phenylmethanesulphonylfluoride), and proteins were eluted with a gradient of 100 mM 
to 1 M NaCl in the same buffer. The eluted protein was further purified by gel-filtration 
though a Superdex 200 16/60 column in 25 mM Tris-HCl, pH 7.5, 100 mM NaCl. 
4.9.5 Group II intron (Ll.LtrB)-mediated transgenesis by sperm nuclear 
transplantation into unfertilized eggs 
Preparation of buffers, transplantation apparatus, needles, agarose-coated 
injection dishes and frogs was as described previously (Kroll and Amaya 1996). The 
reaction was prepared by adding 4 µl sperm nuclei stock (1~2×105 nuclei) to a reaction 
mix consisting of 3.6 µl of 5× Sperm Dilution Buffer (SDB; 250 mM sucrose, 75 mM 
KCl, 0.5 mM spermidine trihydrochloride, 0.2 mM spermine tetrahydrochloride, adjusted 
to pH 7.3-7.5 with NaOH), 3 µl of 2 mM dNTP, 2 µl of 150 mM MgCl2, indicated 
amounts of purified nucleoplasmin (Core8D NP) and RNP. The Core8D NP 
concentration was optimized for different target sites. The total reaction volume was 
adjusted to 27 µl with distilled water. The reaction was mixed gently by pipetting up and 
down with a wide bore tip, and the mixture was incubated for certain amount of time at 
temperatures specified for individual experiments. After the incubation, 5 µl of reaction 
mix was diluted into 150 µl SDB with 5 mM MgCl2 at room temperature. The treated 
sperm nuclei were injected into eggs as described previously (Kroll and Amaya 1996).  
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Fertilized embryos were kept in an 18oC incubator. When healthy embryos 
reached the 4-cell stage (Nieuwkoop 1994), they were transferred into 60×15 mm petri 
dishes containing 0.3×Marc’s Modified Ringers (MMR) + 4% Ficoll + 50 µl/ml 
gentamycin. The culture medium was changed 3~4 times per day, and dead embryos 
were periodically removed from the plates. When the embryos reached stage 12, the 
medium was replaced with 0.3×MMR + 50 µg/ml gentamycin without Ficoll. The 
embryos were kept in this media until they hatched with 2 or 3 buffer changes per day. 
After hatching, the embryos were transferred into a 10 cm × 20 cm plastic container with 
0.3× MMR at room temperature. Tadpoles were fed with Nasco Frog Brittle for tadpole 
Xenopus (Nasco) every other day. Water was changed 3~4 h after every feeding. 
4.9.6 Tail clipping from tadpoles 
Tadpoles were anaesthetized by transferring them to dishes containing 0.025% 
ethyl 3-aminobenzoate methanesulfonate salt (Tricaine; Sigma) in 0.3× MMR. 
Anaesthesia usually took 1 to 2 min, depending on the size of the tadpole. A sterile 
scalpel was then used to cut away the posterior 1/4 to 1/3 of the tail (as measured from 
the posterior of the gut to the tip of the tail). A clean forceps was used to transfer the tail 
sample out of the dish. Using a clean teaspoon, tadpoles were returned to tanks 
containing 1 to 2 inches of 0.3× MMR to recover. Recovery usually took 5-10 min, after 
which the tadpoles were able to swim and feed normally. Regeneration of the tail took 
around five days. The DNA from tail was extracted by using a Mammalian Genomic 
DNA Extraction kit (Sigma). 
4.9.7 PCR analysis of intron integrations into target sites 
Ll.LtrB intron integration efficiency in sperm TPRT reactions was analyzed by 
real-time PCR. After the sperm TPRT reaction, RNPs were inactivated by heating at 75oC 
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for 10 min, and the reaction mixture was then incubated with 0.5 µl of RNase H (2 
units/µl; Invitrogen) at 37oC for 30 min to remove the RNA strand of RNA/cDNA hybrid 
nucleic acid. The sperm DNA was then extracted by using a Mammalian Genomic DNA 
Extraction kit (Sigma). 
Two sets of primers, one for targeted sites and the other for untargeted sites, were 
used to determine intron integration efficiency. For targeted sites, a sense strand primer 
annealing 4-bp upstream of the intron’s 3’ end and an antisense gene-specific primer 
complementary to a sequence 120-bp downstream of the intron insertion site were used to 
quantitate the amount of intron-target site 3’ junction in reacted sperm DNA. For 
untargeted sites, a set of primers amplifying a segment of the mitf exon 6 was used. 
Because mitf is single copy gene in Xenopus, the copy number of mitf gene is equal to 
the number of sperm nuclei in the reaction. The primers were designed with similar GC 
content and Tm value to minimize differences in amplification efficiency between primer 
sets. The intron integration efficiency was calculated using the equation specified for 
each experiment (See Figure 4.4D and 4.12C). 
To check 3’ intron integration junctions in sperm TPRT or embryos, an intron-
specific primer LtrB816s (5’-CAGTGAATTTTTACGAACGAACAATAAC-3’), which 
anneals to a sequence 120-bp upstream of intron 3’ end, and a gene specific primer 
complementary to a sequence located 150~300 bp downstream of intron insertion site 
were used. If nested PCR was required, a nested intron specific primer was LtrB890s (5’-
GTGCAAACCAGTCACAGTAATGTG-3’) and a nested gene specific primer anneals a 
few bases "internal" to the first primer binding sites.  
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To detect the 5’-integration junctions in transgenic embryos, a gene specific 
primer located upstream of intron-insertion site, and an intron specific anti-sense primer 
LtrB256a (5’-CATTTTGAGGTTTTCCTCCCTAATC-3’) were used.  
To check the intron integration in the plasmid target site in Xenopus oocyte, both 
5’- and 3’-integration junctions were checked by PCR. For 5’ integration junction, the 
primers were ForpBRR (5’-CTGATCGATAGCTGAAACGC-3’), which anneals to a 
sequence upstream of the intron target site, and an antisense primer LtrB174a (5’-
CGGCTCTGTTATTGTTCGTTCG-3’), which anneals to 112 bp upstream of the intron 
3’ end. The 5’-integration junction PCR product was sequenced using the primer Rseq 
(5’-CCATGCGAGAGTAGGGAAC-3’). For 3’-integration junction, the primers were 
LtrB816s, which anneals to a sequence 120-bp upstream of intron’s 3’ end, and 
RevpBRR (5’-AATGGACGATATCCCGCA-3’), which anneals to a sequence 
downstream of the intron target site in the recipient plasmid. The 3’ junction product was 
sequenced using the primer LtrB816s. 
4.9.8 TAIL PCR 
TAIL PCR used to identify intron integration sites in the Xenopus genome was as 
previously described (Liu et al. 1995). The 5’-integration junctions were amplified using 
two intron specific primers, LtrBtailP1 (5’-
CCCTTGCAAGATTTTCAAGCTCTAGTGC-3’) for the first PCR step and LtrBhitailP2 
(5’-
ACGATGGACTCCAGTCCGGCCATTAGGCATTCTTGTTTAGGGTATCCCCAG-
3’) for the second PCR step. The 3’ integration junction were amplified using two intron 
specific primers, HiTailLtrB816s (5’-





the second PCR step. The degenerate primers used in the reaction are LAD1 and LAD2, 
as described by Liu et al. 1995. The final PCR product was gel-purified and sequenced 
using the same intron-specific primer used for the second PCR step. 
4.9.9 DNA endonuclease assay 
DNA endonuclease assays were carried out with a 129-bp DNA substrate, which 
was internally labeled by PCR in the presence of [α-32P]dTTP (3,000 Ci/mmol; Perkin-
Elmer, Waltham, MA) (San Filippo and Lambowitz 2002), or with 60-bp DNA 
oligonucleotide substrates labeled at the 5’ end of the top or bottom strand with [γ-32P] 
ATP and phage T4 polynucleotide kinase (New England Biolabs). The 60-bp DNA 
substrates were prepared by annealing complementary synthetic oligonucleotides and 
purified using a Centri-Sep spin column (Princeton Separations, Adelphia, NJ). For 
assays with the internally labeled DNA substrate, the DNA (1.5 nM; 56,000 cpm) was 
incubated with RNPs (815 nM) for 30 min at 37oC in 20 µl of reaction medium 
containing 10 mM KCl, 10 mM MgCl2, and 50 mM Tris-HCl, pH 7.5. For assays with the 
5’-labeled DNA substrates, the DNA (50 nM) was incubated with RNPs (100 nM) for 30 
min at 37oC in 20 µl of the same reaction medium plus 0.2 mM each of dATP, dCTP, 
dGTP, and dTTP (referred to as dNTPs). After the incubations, the reactions were 
terminated by extraction with phenol-chloroform-isoamyl alcohol (25:24:1; phenol-CIA) 
followed by ethanol precipitation, and the products were analyzed by electrophoresis in 

















Figure 4.1: The Ll.LtrB group II intron and its DNA target site recognition mechanism. 
(A) Predicted secondary structure of the Ll.LtrB intron RNA. The intron RNA 
consists of six double-helical domains (DI-VI) radiating from a central wheel. The 
EBS1/IBS1, EBS2/IBS2, and δ-δ’ base-pairing interactions between the intron and 
flanking exons are indicated by dashed lines. The IEP (LtrA protein) is encoded in DIV. 
(B) DNA target site recognition by Ll.LtrB RNPs. The EBS1, EBS2, and δ sequences in 
DI base pair with complementary sequences IBS1 and IBS2 in the 5’-exon and δ’ in the 
3’-exon. The LtrA protein recognizes specific nucleotide residues in the distal 5’-exon 
and 3’-exon regions, including T-23, G-21, A-20, and T+5 (highlighted with gray 
















Figure 4.2: Group II intron-based transgenesis in X. laevis. 
Sperms are isolated from male frog testes and are treated with lysolecithin to 
permealize the sperm nuclei. The sperm nuclei are then incubated with in vitro 
reconstituted group II intron RNP particles and nucleoplasmin (NP) in the presence of 
magnesium (Mg2+) to achieve site-specific intron integration into the sperm genome. The 
reaction mixture is diluted to optimal sperm nuclei concentration for in vitro fertilization 

















Figure 4.3: Ll.LtrB intron target sites in the X. laevis genome and RNP activities in in 
vitro TPRT assays. 
(A) Diagram of X. laevis tyr and mitf genes. Retargeted introns were designed to 
insert into exon 2 of the tyr gene and exon 5 of the mitf gene. The black boxes represent 
the exons and the black lines denote the introns of these genes. The intron-insertion sites 
in the genes are indicated by arrows. (B) DNA target site sequences in the X. leavis 
genome. The base pairing between the EBS1, 2 and δ sequences of the retargeted introns 
(targetrons) and their DNA target sites are shown. The “a” or “s” in the targetron names 
indicates that the intron inserts into the antisense or sense strand of the gene, respectively. 
The arrows represent the intron-insertion site. Introns are designed based on X. laevis 
gene sequences and the corresponding regions in X. tropicalis are also listed. Nucleotide 
sequences that differ between X. laevis and X. tropicalis are shown in lower case letters 
with asterisks below. (C) In vitro TPRT assay of reconstituted targetron RNPs. RNPs 
were incubated with unlabeled target plasmids in the presence of [α-32P]dTTP, other 
dNTPs and TPRT buffer to support reverse transcription (Saldanha et al. 1999). After 
incubating at 37oC for 30 min, the reaction was stopped by phenol-chloroform extraction. 
Unincorporated [α-32P] dTTP was removed by running the extracted reaction mixture 
through a Micro Bio-Spin 30 Column (Biorad). The eluted products were analyzed in a 
1% agarose gel, which was dried and scanned with a phosphorimager. Schematics of 
partial and full reverse splicing products are shown on the right of the gel. DNA and 
intron RNA are shown as solid double lines and dashed lines, respectively. The smaller 




Figure 4.4: Tx1-2768a intron targeting in X. laevis sperm nuclei.  
(A) Schematic of intron targeting in X. laevis sperm nuclei. Sperm nuclei were 
partially decondensed with purified nucleoplasmin, and the decondensed sperm nuclei 
were incubated with in vitro reconstituted group II intron RNPs. After terminating the 
targeting reaction by heat inactivation, genomic DNA was extracted for PCR detection of 
the 3’-integration junction. (B) PCR detection of the Tx1-2768a intron integration 
junction in sperm nuclei. Different amounts of RNPs and nucleoplasmin were used in 
sperm TPRT reactions to achieve the highest targeting efficiency. The intron and target 
site junction can be detected in the reactions with 5 or 10 µl of RNP (1.8 mg/ml lariat 
RNA based on O.D.260). However the targeted product can’t be detected in the sperm 
reaction with 1 µl of RNP. As the positive control, the RNP was incubated with extracted 
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sperm genomic DNA (lane 9). Parallel reactions with heat-inactivated RNPs did not show 
the junction (lane 4 and 8). The insertion efficiency is proportional to the amount of RNP 
used in the reaction. At the bottom, the intron-integration efficiency was determined by 
PCR of the serially diluted sperm reaction DNA. The amount of sperm nuclei in the PCR 
reaction was determined as described in Methods. The identity of correct-sized PCR 
product (arrow) was confirmed by DNA sequencing. Site-specific intron integration 
could be detected in as few as 54 sperm nuclei for the Tx1-2768a intron. All other bands 
detected were also sequenced and found to be PCR artifacts (target site without 
integration or unknown sequences). (C) Sequence analysis of the 3’-integration junction 
by Tx1-2768a RNP. (D) Quantitative analysis of Tx1-2768a intron targeting in sperm 
nuclei by real-time PCR. The DNA from a sperm TPRT reaction was extracted by a 
Mammalian Genomic DNA Extraction kit (Sigma) and eluted in 100 µl H2O. The amount 
of DNA used in the real-time PCR is 3 µl of diluted DNA from the elution. The Ct values 
are plotted as a bar graph for dilutions that give optimal PCR amplification efficiency. 
PCR product “Target” detects the 3’-intron integration junction. PCR product “Mitf” 
detects the single copy gene mitf, which is equivalent to the number of sperm nuclei in 
the reaction. The bar graphs show the mean for three determinations. The error bar 
indicates the standard deviation. The equation used to calculate the intron targeting 
























Figure 4.5: Temperature optimization of sperm TPRT reaction for targetron Tx1-2768a 
and Mitf-α-M-609s. 
Tx1-2768a or Mitf-α-M-609s targetron RNPs were incubated with sperm nuclei, 
nucleoplasmin, dNTP and Mg2+ at temperatures ranging from 25oC to 33oC. Reactions 
were stopped by heat inactivation and DNA was extracted for PCR analysis. To detect 
the targeted product, an intron-specific primer and a target site-specific primer were used 
to amplify the specific 3’-integration junction. The arrows indicate the PCR product 
corresponding to the correct 3’-integration junctions, whose identities were confirmed by 
sequencing. For Tx1-2768a, the targeted product can be detected at all temperatures 
ranging from 25oC to 33oC. For Mitf-α-M-609s intron, the targeted product can be 
detected only at 29oC or higher by nested PCR. Genomic DNA from untreated sperm 
nuclei denoted “Sperm” and PCR blank controls denoted “H2O” were negative controls 
for the PCR reactions. The “boiled RNP” represents the sperm TPRT reaction using the 

















Figure 4.6: Transgenic tadpoles with Tx1-2768a intron integrated in the Tx1 gene.  
(A) Schematic of procedure used to screen for tadpoles with a targeted group II 
intron inserted into the Tx1 gene. The genomic DNA of an individual tadpole was 
extracted from the clipped tail, which was removed by a tail-clipping surgery. PCR was 
used to detect tadpoles with both 5’- and 3’- intron integration junctions. Primers used for 
PCR detection are indicated as arrows. The Tx1 gene and inserted intron are shown as 
blue and red lines, respectively. (B) Tx1 transgenic tadpoles with a targeted group II 
intron inserted into the Tx1 gene. 2,200 eggs were injected with sperm nuclei that had 
been incubated with the Tx1-2768a targetron. Forty eight of them developed to the 
tadpole stage. Tadpoles B34, 80 and 93 had intron integrations at the correct site in the 
Tx1 gene. The sequences at the 5’ and 3’ integration junction are shown below. Small 
sequence differences (highlighted in gray color) near the 3’-junctions in the three targeted 
tadpoles may reflect polymorphism of different Tx1 elements and/or misincorporation 
errors during a DNA repair process used for cDNA integration. The sequences in introns 
and exons were in upper and lower cases respectively. The numbers ahead the integrated 
intron 5’ ends were the nucleotide positions in the full length intron. (C) Tx1 transgenic 
tadpoles with full length Tx1-2768a intron integrated into the target site. In this 
experiment 1,500 eggs were injected. Three embryos were found to have the correct 3’-
integration junction. Among them, embryo 28 was also found to have the correct 5’-
integration junction. The picture shows embryo 28 at 76 h post fertilization. Sequencing 











Figure 4.7: Targeting the tyr and mitf gene in X. laevis sperm nuclei. 
In vitro sperm TPRT reactions and PCR showing the site-specific integration of 
retargeted Ll.LtrB-ΔORF introns into single copy protein coding genes, tyr and mitf. (A) 
Sperm TPRT of Tyr-401a RNP. Sperm nuclei were incubated with purified 
nucleoplasmin and Tyr-401a RNP. A parallel reaction with heat-inactivated RNPs was 
used as a negative control. After incubation for 30 min at 33oC, total nucleic acid was 
extracted and analyzed by nested PCR to detect the 3’ intron integration junction. The 
correct-sized PCR product (arrow) was detected in cells incubated with active RNPs, and 
its identity was confirmed by DNA sequencing. (B) Sperm TPRT of Mitf-α-M-609s 
RNPs. The Mitf-α-M-609s RNPs were incubated with sperm nuclei and nucleoplasmin at 
30oC for 15 min. After the reaction, nucleic acids were extracted and diluted for nested 
PCR. The number of sperm nuclei for each sample was determined, as described in 
Methods. The PCR product corresponding to the correct 3’ integration junction is 
indicated by the arrow, and its identity was confirmed by sequencing (below). Lane 
“Sperm” refers to the sperm TPRT reaction without Mitf-α-M-609s RNPs. Lane “H2O 1” 
and “H2O 2” are the distilled water controls for the first and second step of the nested 
PCR. All other bands detected were also sequenced and found to be PCR artifacts (target 
































Figure 4.8: Target DNA cleavage and target DNA-primed reverse transcription reactions 
of RNPs reconstituted with lariat or linear Ll.LtrB intron RNA.  
Ll.LtrB RNPs containing lariat or linear intron RNA were incubated with 32P-
labeled DNA oligonucleotide substrates containing the Ll.LtrB target site (positions -56 
to +73 from the Ll.LtrB intron-insertion site), and the products were analyzed in a 
denaturing polyacrylamide gel. (A) Lariat and linear RNPs were incubated with internally 
labeled DNA substrate for 30 min at 37oC, as described in Methods. (B) and (C) Lariat 
and linear RNPs incubated with DNA substrates labeled (asterisk) at the 5’-end of the top 
and bottom strand, respectively in the presence of 0.2 mM dATP, dCTP, dGTP, and 
dTTP for 30 min at 37oC. In (A)-(C), products are indicated to the right of the gel. The 
schematic at the bottom diagrams the products expected for each reaction. All lanes are 













Figure 4.9: Retrohoming of linear Ll.LtrB intron RNPs in X. laevis oocyte nuclei 
analyzed using an E. coli genetic assay for retrohoming products. 
A recipient plasmid containing the Ll.LtrB target site cloned upstream of a 
promoterless tetR gene and RNPs containing a linear Ll.LtrB-ΔORF intron RNA with a 
phage T7 promoter near its 3’ end were injected sequentially into X. laevis oocyte nuclei. 
After incubation for 2 h at 25oC, nucleic acid was extracted and transformed into E. coli 
HMS174(DE3), which was then plated on LB agar containing ampicillin with or without 
tetracycline. Site-specific integration of the intron containing the T7 promoter into the 
target site activates the tetR gene, and integration efficiency is calculated as the ratio of 
(TetR + AmpR/AmpR colonies). The integration efficiency for linear RNPs in this 
experiment was 0.04% compared to 3% for lariat RNPs. Site-specific integration was 
confirmed by the colony PCR using primers For-pBRR and Rev-pBRR flanking the 
target site in the recipient plasmid, and the 5’ integration junction was sequenced by 
using the primer Rseq. (A) Colony PCR of eleven tetR colonies using primers For-pBRR 
and Rev-pBRR flanking the recipient plasmid target site. A PCR product of 1.9 kb is 
expected for integration of the full-length intron. Smaller PCR products reflect 
integration of 5’-truncated introns. Colony PCR of a tetR colony obtained with lariat 
RNPs (LA) is shown for comparison. Lane M, 1-kb plus DNA ladder (Invitrogen). (B) 
Sequencing of 5’-integration junctions. Six of sixteen colonies showed precise insertion 
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of the full-length intron; two colonies had mutations at the 5’ junction, presumably 
reflecting inaccurate DNA repair; five had 5’ truncated introns; two had 12-nt insertion at 
the 5’ junction. The 5’ exon and intron sequences are shown in upper and low case 
respectively. The number before the first intron nucleotide indicates its nucleotide 
position in the full-length intron. Mutant nucleotides in the intron are highlighted in gray. 
Homologous sequences in the 5’ exon, which are not present in the retrohoming product, 







































Figure 4.10: Retrohoming of linear Ll.LtrB intron RNPs in X. laevis oocyte nuclei 
analyzed by direct PCR analysis of integration junctions. 
In vitro reconstituted intron RNPs and recipient plasmids containing intron target 
sites were injected into the X. laevis oocyte nuclei, as described in Methods. After 
incubating the injected oocytes at 25oC for 2 hrs, nucleic acids were extracted. (A) PCR 
analysis of 5’- and 3’-integration junction. For the 5’-integration junction, For-pBRR, 
annealing to the upstream of the intron target site, and LtrB174a, an intron specific 
antisense primer, were used. For the 3’-integration junction, an intron specific sense 
primer (LtrB816s) and an antisense primer (Rev-pBRR) annealing to the downstream of 
the intron target site were used. Lanes: (1) Linear RNP; (2) GG-Lin RNPs; (3) Lariat 
RNP; (4) Wild-type oocyte genomic DNA; (5) distilled H2O. (B) Sequence analysis of 5’ 
junction of linear intron retrohoming products. For the 5’-integration junction, the PCR 
for retrohoming products of linear RNP resulted in two major bands (bands “a” and “b”). 
Gel-purified DNA was cloned into Topo TA cloning vector, pCRII-topo (Invitrogen) and 
the inserted DNA fragments were sequenced. The 5’-exon and intron sequences are 
shown in upper and low case respectively. The position of first intron nucleotide is 
indicated at the start of the intron sequence. Mutations in the intron are highlighted in 
gray. Homologous sequences in the 5’ exon, which are not present in the retrohoming 

































Figure 4.11: Model for retrohoming of linear group II intron RNA.  
RNPs containing linear group II intron RNA recognize DNA target sites and carry 
out the first step of reverse splicing into the intron-insertion site (IS), resulting in ligation 
of the 3’ end of the intron RNA to the 5’ end of the 3’ exon DNA. The IEP then uses its 
En domain to cleave the bottom strand between positions +9 and +10 of the 3’ exon (CS) 
and reverse transcribes the attached linear intron RNA. After resection of the 5’ overhang 
resulting from the initial staggered double-strand break at the target site, the intron cDNA 
is ligated to the 5’ exon via non-homologous end joining (NHEJ). The ligation step is 
inaccurate and often occurs with loss of 5’-exon sequences due to excessive resection, 
insertion of 5’-truncated introns due to incomplete cDNA synthesis, and/or insertion of 
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extra nucleotide residues at the ligation junction, presumably due to DNA synthesis by a 
repair DNA polymerase. Retrohoming is completed as for lariat RNA by degradation or 
displacement of the intron RNA template strand, second-strand DNA synthesis, and 
sealing of nicks using host enzymes. Intron RNA, red; LtrA, gray; recipient DNA, black; 



























Figure 4.12: The 5’ ends of truncated Ll.LtrB introns integrated into the plasmid target 
site in X. laevis oocyte injection and X. laevis transgenic tadpoles. 
The 5’ ends of truncated introns are indicated on the predicted secondary structure 
of Ll.LtrB RNA. The highlighted green and blue nucleotides are the 5’ ends of truncated 
introns in X. laevis oocyte injection experiments and Tx1-2768a transgenic tadpoles 
generated in Figure 4.6B respectively. The green numbers near the green nucleotides 
represent the number of times the same truncation occurred in the X. laevis oocyte 
injection. The tadpole names (blue) were also shown near the 5’ end of its cDNA. The 
intron structure consists of six double-helical domains (DI-DVI). The 5’- and 3’-splice 
sites are indicated by arrows. The Shine-Dalgarno (SD) sequence, initiation and 
termination codons of the intron ORF, and sequences involved in tertiary interactions 









Figure 4.13: The Ll.LtrB-GFP-RAM targetron construct and its splicing activity. 
(A) pACD-GFP-RAM constructs. pACD-GFP-RAM is a derivative of pACD3, 
which contains a 0.9 kb Ll.LtrB-ΔORF group II intron and flanking exons, with the 
intron-encoded protein, LtrA, expressed from a position downstream of the 3’ exon (Guo 
et al. 2000; Karberg et al. 2001). pACD-GFP-RAM contains a streamlined GFP gene 
with a CMV promoter and SV40 polyA signal inserted in group II intron domain IV in 
the orientation opposite intron transcription. The GFP marker is disrupted by a self-
splicing td group I intron inserted in the forward orientation. During retrotransposition 
via an RNA intermediate, the td intron is spliced, activating the GFP marker, which can 
be used for screening tadpoles with the intron integrated into a DNA target site. (B) 
Analysis of in vitro RNA splicing products in a denaturing 4% urea polyacrylamide gel. 
The pACD-GFP-RAM plasmid was linearized with NheI (New England Biolab). 
“Transcript” represents the transcript from linearized pACD-GFP-RAM vector using a 
MEGAscript T7 kit (Ambion). The spliced product contains spliced lariat RNA, linear 
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RNA and small amount of unspliced precursor RNA. All other bands on the gel are 
intermediates of td intron splicing, which occurred during the transcription reaction. (C) 
RT Real-time PCR analysis of td intron splicing efficiency. The spliced RNA (1 mg/ml) 
was purified and diluted 1,000, 10,000 and 100,000 times to achieve optimal RT PCR 
amplification efficiency. Two primer sets, Ppre/Prev and Psp/Prev, were used to detect RNA 
with the td intron (Precursor) and without the td intron (Spliced). The blue arrows in 
panel A show the locations of the primers. The Ppre primer specifically anneals to 
sequences within the td intron. The Psp anneals to the ligated junction after splicing of the 
td intron. Prev is the common antisense primer for PCR amplification and also is the 
primer for the cDNA synthesis in the RT real-time PCR. The y-axis represents the Ct 
values of the PCR products. The bar graphs show the mean for three determinations. 
Error bars indicates the standard deviation. The equation used to calculate the td splicing 















Figure 4.14: Chromosomal integration of the Ll.LtrB-GFP-RAM intron with randomized 
EBS and δ sequences in X. laevis. 
(A) Schematic of random GFR-RAM intron library and its interaction with DNA 
target site. LtrA and the EBS2/1 and δ sequences are involved in DNA target site 
recognition. The random EBS2/1 and δ sequences in the intron RNA recognize accessible 
DNA target sites in the genome. As a result, introns insert into different target site within 
the genome. After intron integration, the GFP gene, which is incorporated into the intron 
DIV as shown in Figure 4.13, is expressed from its own CMV promoter. Embryos with 
intron integrations show GFP fluorescence under UV light. The LtrA protein is shown in 
gray. The black solid line represents linear intron RNA with gfp inserted in the opposite 
orientation. The randomized EBS1, 2 and δ nucleotide residues in the intron RNA 
indicated as “N”. The 45-nt DNA target site is shown with wild-type nucleotide 
sequences flanking the random IBS1/2 and δ’ sequences. The intron insertion site and 
protein cleavage site are indicated as “IS” and “CS”, respectively. (B) Transgenic 
embryos generated from sperm nuclei treated with the GFP-RAM Ll.LtrB RNP library. 
The same embryos under UV and bright visible light are shown. (C) Transgenic tadpoles 
with GFP-RAM intron insertions and the GFP expression in the tadpoles. The same 
tadpoles are shown under visible and UV light. The whole tadpoles were shown at the 
right upper corner of visible pictures. The non-uniform expression of GFP presumably 
reflects the chromosomal location of the integration. 
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Condition    Exp. 1    Exp. 2    Exp. 3    Exp. 4 
WT Lar   8.26     8.97     22.3     19.9 
WT Lin       0.04    0.018 
WT GG-Lin    0.004    0.004    0.016    0.008 
WT GG-Lin-2’ OMe   0.002    0.005   
WT GG-Lin-ΔA 2486   0.0016    0.001     0.002 
DD- GG-Lin      <0.00004 
Table 4.1: Retrohoming efficiencies of Lar and Lin RNPs in X. laevis oocyte nuclei. 
Retrohoming assays were done by injecting recipient plasmid pBRR3-ltrB and the 
indicated Ll.LtrB RNPs into X. laevis oocyte nuclei, as described in Fig. 1 and Materials 
and Methods. Different RNPs contained lariat intron RNA (Lar); linear intron RNA 
(Lin); linear intron RNA transcribed from a DNA template with two extra 5’ G residues 
(GG-Lin); GG-Lin transcribed from a DNA template with 2’OMe nucleotide residues at 
the two terminal positions; GG-Lin RNA with the branch-point A-residue deleted 
(ΔA2486); and GG-Lin RNA + RT-deficient LtrA protein (DD-; YADD→YAAA). After 
incubating the injected oocytes for 2 h at 25oC, nucleic acids were transformed into E. 
coli HMS174(DE3) for plating assays. Retrohoming efficiencies were calculated as the 
ratio of (TetR + AmpR)/AmpR colonies. These experiments were done in collaboration 








Table 4.2: Summary of integrated Ll.LtrB-GFP-RAM linear introns and its insertion sites 
in X. laevis genome. 
The table shows integrated Ll.LtrB-GFP-RAM linear introns in X. laevis genome 
from three independent experiments using GFP-RAM library RNPs. The intron EBS1, 2 
and δ sequences and its upstream genomic sequences were identified by TAIL PCR and 
confirmed by direct PCR. Multiple occurrences of the same intron in different embryos 
are indicated by “Occurrence”. The upstream genomic sequences were blasted against X. 
laevis EST and nucleotide databases in NCBI. Information about the upstream genomic 
sequences is indicated in the last column. Sequences that did not align with any genes in 
the above databases are denoted as “Unknown”. The intron and X. laevis genomic 
sequences flanking the 5’-integration junctions are indicated in lower and upper case 
letters respectively. The number in front of the first nucleotide of intron corresponds to its 
nucleotide position within the intron. In Exp.3, the column “Tadpole” refers to the 
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